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ABSTRACT
Canine herpesvirus 1 (CHV -1) is as yet the only described canine herpesvirus.
Only limited information on this virus, in terms of both its molecular biology and
pathogenesis, was available at the start of this project.
Degenerate primer polymerase chain reaction was used to amplify a small part of
the glycoprotein B (gB) gene of CHV -1. This product was cloned and sequenced in
order to provide some initial sequence information on the virus, thus assisting in its
definitive classification and permitting further study using molecular biology
techniques. Conventional primers were then designed from the known gB sequence and
used to test a variety of canine tissues for the presence of viral genome. Viral sequences
were found in a number of tissues, and it would appear that on the basis of these
experiments, the prevalence of CHV -1 is much higher than previously reported.
The molecular biology techniques used in the first part of this project were then
applied to the study of canine lymphoma, one of the most common neoplasms affecting
the dog. Following the success of the degenerate primer system in amplifying a portion
of the gB gene of the known canine herpesvirus, a degenerate primer system was
designed that was capable of amplifying part of the gB gene of any known
gammaherpesvirus. This system was used to test tissues from a number of cases of
canine lymphoma for the presence of garnmaherpesvirus sequences. Representation
difference analysis was also used to analyse cases of canine lymphoma for genetic
differences from normal tissue. A number of differences were identified using this
technique; their significance, and avenues of further study, are discussed.
XI
CHAPTER!
INTRODUCTION AND LITERATURE REVIEW
1.1 CANINE HERPESVIRUS AND THE HERPESVIRIDAE
The Herpesviridae are a large family of double stranded DNA viruses. To date,
more than a hundred members of the family having been at least partially characterised.
The potential hosts of this viral family are remarkably well disseminated amongst the
animal kingdom: upon examination, most animal species have yielded at least one
member of the family. Eight herpesviruses have so far been isolated from humans, five
from horses, four from cattle, three from chickens, and two from pigs (Roizman et al.
1992). At present the dog and cat appear a little unusual in each being infected by only
one member of the family, both of these viruses being assigned to the alphaherpesvirus
sub-family.
The clinical signs associated with herpesvirus infection may vary from mild or
even sub-clinical, to severe overwhelming infection/reaction and death of the host. In
the dog, severe signs of herpesvirus infections may be associated with a lack of immune
protection due to immaturity or concurrent illness, or alternatively an abnormal or
excessive immune response to a virus normally associated with a closely related host
species (Fenner et al. 1993).
1.1.1 Virion Structure and Properties
Membership of the family has classically been based on four key features of the virion
architecture; a core containing linear double stranded DNA, an icosadeltahedral capsid
of approximately 110 nm diameter, an amorphous tegument surrounding the capsid, and
a lipid envelope containing viral glycoprotein spikes (Roizman, 1995). It has been
suggested that a slightly more detailed definition of the family should include certain
aspects of their life cycle within the cell. Noteworthy features might then include the
replication and encapsidation of DNA in the nucleus envelope; the initial or primary
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acquisition of the viral envelope by budding through the nuclear membrane; the ability
to establish latent infections, with recurrent or continuous shedding of infectious virus;
and the participation of essential viral encoded products in replication of viral DNA
(Honess, 1984). Table 1.1 catalogues many of the typical properties ofa member of the
herpesvirus family.
1.1.2 Classification of Herpesviruses and Genomic Organisation
The Herpesviruses were originally classified into three sub-families: alpha, beta, and
gamma-virinae, according to their biological properties in their natural host,
experimental models, and in tissue culture (Roizman et al. 1981). The alphaherpesvirus
sub-family typically have a variable experimental host range, a short reproductive cycle,
spread rapidly in tissue culture and destroy infected cells. They also commonly
establish latent infections in sensory ganglia. On the basis of its biological properties,
canine herpesvirus (CHV-l) has historically been assigned to this sub-family, along with
many other viruses, such as the herpes simplex viruses (l and 2), equine herpesvirus 1
and 4, and Pseudorabies Virus. The betaherpesvirus sub-family tend to have a more
restricted experimental host range, with infection only progressing slowly in cell culture.
Infected cells become enlarged, and carrier cultures are easily established. Latent virus
may be maintained in secretory glands, lymphoreticular cells, kidneys and other tissues.
Members of this sub-family include human cytomegalovirus (HHV-5) and the more
recently discovered human herpesvirus 6 (HHV -6) and human herpesvirus 7 (HHV -7).
The experimental host range of the gammaherpesvirus sub-family is generally limited to
the family or order of the natural host. In cell culture members of the sub-family tend to
replicate in lymphoblastoid cells, and generally are specific for either T or B
lymphocytes.
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Table 1.1 Typical Properties of Herpesviruses. (Fenner et al: 1993)
• Enveloped virions, 120-200nm in diameter, with several different peptomers up
to 8nm long projecting from envelope.
• Icosahedral capsid with 162 capsomeres.
• Linear dsDNA genome, 120-240 kbp; variable G+C ratio (32-74%)
• Sequential transcription and translation of immediate early (a.), early (P), and
late (y) genes, the earlier products sequentially regulating transcription of later
genes.
• Produce eosinophilic intranuclear inclusion bodies.
• DNA replication and encapsidation occur in nucleus; envelope is acquired by
budding through nuclear membrane.
• Production of infectious progeny virus invariably accompanied by destruction of
infected cell.
• Establish latent infections, with recurrent or continuous shedding of infectious
virus.
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Infection in the lymphocyte is often held at a pre-lytic or lytic stage without production
of infectious progeny although latent virus may frequently be isolated from lymphoid
tissue in vivo (Roizman, 1990).
Herpesvirus DNA's vary considerably in terms of composition, size, and
structure. There is some correlation between the classification outlined above and the
physical properties of the genome. In general, the betaherpesviruses have the largest
genomes, whereas the alphaherpesviruses tend to have high (>60%) G + C content, and
the gammaherpesviruses lower G + C ratios (Honess, 1984). A particular exception to
this rule appears to be CHV -1 with a GC content of only 32% (Lust and Carmichael,
1974). Variance in the composition of herpesvirus genomes may therefore not be a
particularly important feature in classification terms, and may be explained by
differences in codon bias for a given amino acid, perhaps dictated to some extent by the
codon bias of the host species.
One of the most striking features of herpesvirus genomes is their sequence
arrangement, and in particular, the presence and location of reiterations of terminal
sequences (Roizman, 1990). Six genome types, designated A to F have been identified,
although insufficient information exists on many viruses to classify them in the scheme
(Figure 1.1). It is interesting to note that the various genome arrangements show some
parallels with the biological based classification outlined previously, in particular the D
group appears broadly equivalent to the Varicellovirus genus, and the E genome group
equivalent to the Simp/exvirus genus of the alphaherpesvirus sub-family.
Although this system of classification based on biological properties has proved
useful, more objective criteria have become available for some of the herpesviruses
since 1981 when the system was proposed. The criteria that have been proposed
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Figure 1.1 Herpesvirus Genome Arrangements (Roizman, 1995)
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Schematic diagram of the various possible organisations of the herpesvirus genomes.
A to F are modelled respectively on Channel Catfish herpesvirus, Herpesvirus saimiri,
EBV, VZV, HSV, and Tupaia herpesvirus.
In the diagram horizontal lines represent unique regions, and rectangles represent
reiterated domains.
LTRlRTR: LeftlRight terminal repeats (Class A)
RI-R4 Internal repeats (Class C)
IRand TR Internal and terminal repeats (Class D)
Unique long and unique short domains
for a new classification are conservation of genes and gene clusters, arrangement of
gene clusters relative to each other, arrangement of terminal sequences involved in the
packaging of viral genome, and the presence and distribution of nucleotides that are
subject to methylation (Roizman et al. 1992). Although serology has been used
successfully in the classification of many virus families, it has not been applied
consistently to the classification of herpesviruses.
The majority of herpesviruses assigned on biological properties to their
respective sub-families would remain in the same sub-families under the criteria
outlined above, although no sequence or gene arrangement data is yet available for many
herpesviruses. Some of the earlier mis-classifications that have arisen may be due to an
over-reliance on a single biological feature to the exclusion of all others. Sequence data
concerning Marek's disease herpesvirus suggest that it should be categorised as a
member of the alphaherpesvirinae. Originally this virus was assigned to the
gammaherpesvirinae due to its ability to cause tumours, while ignoring features more
reminiscent of an alphaherpesvirus, such as growth in fibroblasts and its ability to
spread rapidly in tissue culture (Roizman et al. 1992). EHV -2 and EHV -5 have also
recently been re-classified from beta to gammaherpesviruses; their original classification
also ignored certain growth characteristics that were atypical for a betaherpesvirus, such
as the ability to infect cells from more than one species in vitro (Telford et al. 1993).
The discovery of a new member of the herpesvirus family is now almost invariably
accompanied by the publication of at least some sequence information. Sequence is
now regarded as the gold standard for classification. The placing of a new virus into its
definitive sub-family can be considered simpler than in earlier times, where sequence
information was not always available.
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Recent information suggests that the CHV -1 genome is organised with the
sequence from one terminus repeated internally in an inverted orientation, thus placing it
in genome class D. On the basis of this information, and amino acid alignments of the
thymidine kinase gene, CHV -I can be placed definitively in the Varicellovirus genus of
the alphaherpesvirus sub- family (Remond et al. 1995). A particular quirk of CHV-I
suggested by investigations into the organisation of its genome is that there appear to be
no open reading frames for the large and small sub-units of the viral ribonucleotide
reductase gene (Remond et al. 1996). It is interesting to note that a ribonucleotide
reductase null mutant of HSV -I shows a temperature sensitive growth phenotype, so
this feature of the CHV -I genome may account for the observed temperature
dependence ofCHV-1 both in vitro and in vivo.
1.1.3 Sequence Based Analysis of Herpesvirus Evolution
As well as shedding light on contentious areas of herpesvirus classification,
sequence data has been used extensively in studying the development of the modern
herpesvirus genome and for elucidating phylogenetic trees between the various
herpesviruses. This has also encouraged the development of theories concerning
evolutionary relationships between the various herpes viruses and their natural hosts. As
the availability of sequence data has increased, the extent and strength of such
interpretations has increased accordingly. The rationale for such analysis stems from the
proposition that modem herpesviruses evolved from a common progenitor virus, which
must have possessed a set of perhaps 40 genes, which are still held in common between
all the present day herpesviruses. These essential genes would have been those involved
in functions such as DNA replication and maintenance of virion structure (McGeoch,
1989).
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Analysis of relatively closely related viruses such as HSV and VZV has shed
light on the development of the herpesvirus genome. The S segment of the VZV and
HSV genomes shows considerable homology: every VZV gene in this region has an
HSV counterpart, but HSV also has six additional genes (Davison and McGeoch, 1986).
Further examination of the HSV genes in the same region implies that the additional
genes may have arisen by a process of duplication and divergence (McGeoch, 1990).
Certain regions of the herpesvirus genome are therefore capable of expansion or
contraction during evolution, perhaps in a response to selective pressures, and these
recombinational events may have led to the development of HSV and VZV from a
common ancestor.
A second feature of herpesvirus evolution is the ability to acquire and adapt host
genes into the viral genome. An example of this is thought to be the thymidine kinase
gene, which is related to a cellular deoxycytidine kinase (Harrison et al. 1991). The
mechanism for these acquisitions is not known, although presumably some form of
recombination with host genetic material occurs. The possibility of retroviral
integration into the herpesvirus genome has also been raised from the observation of
retroviral LTR-like sequences in the genome of MDHV (Isfort et al. 1992). The
integration of an oncogenic retrovirus into the genome of an alphaherpesvirus might
well explain the unusual tendency of MDHV to cause tumours in at least some
instances(Kost et al. 1993). Although the general significance of this phenomenon is
not known, the possibility exists that in some instances retroviruses may shuffle genetic
material between herpesvirus and host, and may offer a plausible explanation of the
capture of structural and regulatory elements from the host during herpesvirus evolution
(Brunovskis and Kung, 1995).
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Phylogenetic trees based on amino acid sequence analysis of a variety of genes
have been used to particular effect in the study of the alphaherpesviruses due in part to
the availability of a considerable number of sequences on which to base the analysis. It
has been suggested that the avian alphaherpesviruses branched first from the lineage
leading to the mammalian alphaherpesviruses, then the mammalian viruses split into
their two groups, Varicellovirus and Simplexvirus, around the time of the mammalian
radiation (McGeoch and Cook, 1994). While some details are still to be resolved, a
phylogenetic tree for the complete herpesvirus family based on analysis of the amino
acid sequences of eight conserved genes has also been proposed (McGeoch et al. 1995).
It has been suggested that the ancient herpesvirus progenitor species existed about 200
million years ago. The present herpesvirus sub-families are proposed to have evolved
more than 80 million years ago prior to the great radiation of placental mammals, and
the evolution of contemporary viruses took place within the last 80 million years by a
process of co-speciation with the host species.
A different analysis of evolutionary relatedness, based on relative abundances of
di-nucleotides has yielded slightly different results and suggested that avian species are
the more ancient hosts of the herpesvirus family and that HHV -6 is the closest relation
to a progenitor mammalian herpesvirus (Karlin et al. 1994). The differences between
these two methods of comparison may be due to di-nucleotide relative abundances
discriminating DNA structure specificity rather than sequence specificity. Di-nucleotide
abundance may also be a reflection of features of the viral life cycle. Low CpG
frequencies are found in the genomes of the gammaherpesviruses (Bublot et al. 1992),
this feature probably follows from the tendency of the latent genome to be methylated
and hence be maintained as an episome in dividing cells that carry out such methylation
(Honess et al. 1989).
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It may appear superficially that sequence specificity, particularly at the amino
acid level where the function of proteins is determined, must be the more important
marker of evolutionary relatedness. Sequence analysis alone has given rise to some
contradictions however, particularly towards the roots of the phylogenetic trees where a
degree of speculation is required. Analysis of the channel catfish herpesvirus, which is
one of the most evolutionarily distant herpesviruses (Davison and McGeoch, 1986),
suggest that any interpretation of herpesviruses evolution and function based on amino
acid sequences alone must be treated with a degree of caution.
Alignments of the major capsid gene (UL 19) of the alphaherpesviruses indicate
that it is one of the most conserved viral genes, and it might be assumed from this that
this conservation of sequence is essential to maintain the capsid architecture. The
capsid structure of CCHV appears remarkably similar to HSV however (Booy et al.
1996), despite the lack of any appreciable sequence homology (Figure 1.2). In the
absence of functional considerations acting as a restraint on sequence variation,
divergence may become so great that appreciable homology between genes which in fact
encode the same function may be lost. A second consideration is that some viral genes
have evolved from related cellular genes. If this acquisition has occurred independently
for two or more different viruses and was relatively recent in evolutionary terms, i. e.
after the split of their respective host species, the sequence analysis of such genes may
simply be a reflection of the evolutionary relationship between the herpesvirus host
species, rather than the viruses themselves.
1.1.4 Viral Replication
The first stage in the replication of any virus is attachment to cellular receptors,
followed by entry of the viral genome into the cell. In the herpesviruses, these functions
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Figure 1.2 Comparison of Channel Catfish and Herpes Simplex Capsid Architecture
A channel catfish virus capsid
B herpes simplex virus capsid
Despite highly divergent major capsid protein amino acid sequences, the capsids of two
evolutionarily distant herpesviruses have a remarkably similar architecture (Booy et al.
1996).
appear to be carried out by the surface glycoproteins, expressed in the lipid envelope of
the virion. Nine such glycoproteins have so far been discovered (gB to gJ), and some,
particularly gB and gH have been shown to be homologous for all the human
herpesviruses so far identified (Manservigi and Cassai, 1991). The role of some of the
glycoproteins in mediating adsorption, envelope fusion, and penetration has been
identified in many cases and is described in Table 1.2. While some of these
glycoproteins are essential for viral replication, others may apparently be dispensed
with, the gene for the gD glycoprotein apparently being absent from VZV (Davison,
1983).
The role of CHV -1 glycoproteins in mediating the various viral functions and
effects has not yet been elucidated. The observation that the gB homologue of one
alphaherpesvirus can rescue a gB negative mutant of another suggests that the function
as well as the sequence of at least some of the glycoproteins is conserved (Kopp and
Mettenleiter, 1992). Itmay therefore be reasonable to assume that the relatively high
degree of homology between gB, gC and gD of CHV -1 and the other alphaherpesviruses
may indicate that they share similar functions (Limbach et al. 1994).
Following entry into the cell, viral capsids are transported to the nuclear pores,
from where viral DNA can be released into the nucleoplasm by a specific viral function
(Batterson et al. 1983). It is in the nucleus that replication, transcription and packaging
of viral DNA occurs for all herpesviruses. The genome of herpes simplex codes for
over 70 genes, and it is clear that replication of the herpesviruses is a highly complex
and tightly regulated procedure. There is a sequential transcription and translation of
immediate early (a), early «(3), and late (y) genes, the earlier products sequentially
regulating transcription oflater genes (Honess and Roizman, 1974). All herpesviruses
are capable of carrying out lytic and latent infections, and the control of these alternate
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Table 1.2 Functions of the Herpesvirus Glycoproteins
Function (;I~coprotcints) Implicated
Adsorption gB, gC,
Penetration gB, gD, gH,
Virion Release and Re-entry gD,
--
Cell Fusion gB, gD, gH, gK,
_._---- ----:_--- --
Receptors for C3b, and Fe gC and gE/gI respectively,
14
pathways has been a subject of much study. Due to the nature of their behaviour in
tissue culture, it has generally proved easier to study lytic infections in Herpes Simplex
Virus (Roizman and Sears, 1990), and latent infections in Epstein-Barr Virus (Kieff and
Liebowitz, 1990). The discovery that animals such as the mouse can maintain latent
HSV -1 infections has aided the study of alphaherpesvirus latency; HSV -1 infection does
not appear to affect the replicative capacity oflatently infected cells (neurones), and a
2.0-2.3 kb RNA transcript appears to be the dominant viral product. The exact role, if
any, of this product in maintaining latency is not known however, although it is
fascinating to note that the transcript is complementary to the 3' end of an immediate
early (a) gene mRNA (Baichwal and Sugden, 1988).
For viral replication, the lytic pathway must be selected. It is believed that
interplay between both cellular and viral factors may determine progression between
lytic and latent cycles. The three classes of RNA , a, p, and y are sequentially
transcribed by cellular RNA polymerase II, and when appropriately processed to mRNA,
are subsequently translated to a proteins (initiating transcription of B mRNA's), p
proteins (suppressing further a gene transcription), and, following viral DNA
replication, y proteins. Most a proteins are involved in regulation of viral replication,
most p proteins are enzymes or involved in DNA binding, and most y proteins are
structural. It is also known that in herpes simplex virus, components of the original
infecting virion are involved in shut down of host cell macromolecular synthesis
(Kwong et al. 1988), and also act in trans following transport into the nucleus to induce
a genes (Batterson and Roizman, 1983).
Viral proteins are synthesised from their respective mRNA's in the cytoplasm on
both free and bound polyribosomes. Most viral proteins are extensively processed
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following synthesis and some of this modification may be carried out by viral enzymes
(Purves et at. 1991). Viral capsids are assembled in the nucleus, and processed viral
DNA is then packaged into the preformed capsids. Viral glycoproteins are found in
both the cytoplasmic membrane (where they are a potential target for the host immune
system) and the nuclear membrane. Viral capsids containing DNA in the nucleus attach
to patches of nuclear membrane containing the viral glycoproteins and become
enveloped as a part of this process. They are then transported, probably via the Golgi
apparatus, to the exterior. Production of infectious progeny virus is invariably
accompanied by destruction of the infected cell (Roizman and Sears, 1996).
In the absence of specific data, it is likely but unproven that CHV -1 follows this
general pattern. There is some limited evidence to confirm this: studies of the time
course of CHV -1 infection in cell culture have been carried out using Monoclonal
Antibodies to the herpesvirus glycoproteins(Limcumpao et al. 1991). Glycoproteins are
produced in a time ordered fashion, and virions appear to be assembled at the inner
nuclear membrane. Small amounts of CHV -1 glycoprotein have also been found in the
cytoplasm, and on the surface of the infected cell.
1.1.5 Canine Herpesvirus Pathogenesis
The clinical signs and pathological features of CHV -1 infection have been
subject to many more reports than the structure and organisation of the virion, and these
features have been well reviewed in a number of publications (Appel, 1987; Carmichael
and Greene, 1990). The virus has been isolated world-wide, and typical case reports
involve fatal infections of litters of puppies in breeding establishments (Love and
Huxtable, 1976). Puppies older than 2 weeks of age are relatively resistant to disease
however, and tend to have mild or inapparent infections. Possible explanations
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proposed for this observation include optimum growth of virus at the lower body
temperature of neonates, inability of neonates to mount an effective cell-mediated
response, incapability of fever production, and the levels of protection acquired from the
dam (Carmichael et al. 1969).
Following oronasal exposure, primary viral replication is believed to occur in
epithelial and mucosal cells. Virus spreads systemically by infection of macro phages,
leading to a cell associated viraemia, followed by infection of other mononuclear
lymphoid cells, and parenchymal organs. Progressive multifocal necrosis occurs in
lymphoid tissue, and is also commonly encountered in the adrenals, kidneys, lungs,
spleen, and liver. Widespread cellular and endothelial damage often leads to
disseminated intra-vascular coagulation with associated thrombocytopaenia and
multifocal haemorrhage. Death generally intervenes in affected puppies prior to onset
of neurological signs, although ganglioneuritis in the trigeminal nerve can be identified
in puppies infected by the oronasal route (Carmichael et al. 1965a).
In older dogs with fully competent immune systems, overwhelming systemic
infection and death are not generally seen. Herpesvirus can be isolated from a number
of sites however, and there are reports of isolation from the genital tract being associated
with infertility, abortion, and stillbirths (Poste and King, 1971), and possibly infection
of neonates as described above. It has been suggested that the vaginal lesions seen in
natural adult herpesvirus infection are very similar to those seen in herpes simplex
infection, comprising vesicles immediately beneath the thin cornified layer in the
epidermis (Hashimoto et al. 1983). Experimental intra-genital inoculation of CHV-l
into dogs and bitches led to preputial and vaginal lesions respectively, and the virus was
able to spread to the nasopharynx and conjunctiva in some cases; the only clinical signs
seen however were a mild preputial discharge in the male dogs, and occasional
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conjunctivitis, both of these signs being self-limiting, regressing spontaneously by 7
days post inoculation (Hill and Mare, 1974). The ability of canine herpesvirus to
latently infect apparently healthy bitches has been shown by the isolation of virus from
nasal, oral, vaginal and ocular secretions, and also sub-mandibular and tonsilar
lymphoid tissue, of prednisolone treated bitches (Okuda et al. 1993). Figure 1.3
presents a schematic diagram of the suspected pathogenesis of CHV -1 in the dog.
The role of CHV -1 infection in other clinical syndromes is less clear. It has been
suggested that latent CHV -1 may re-activate in animals immuno-suppressed by
concurrent infections and playa part in the pathology and/or that neonatal CHV-I
infection may lead to thymic atrophy and thus a relatively poor development of cell
mediated immunity and increased susceptibility to other viral infections (Kraft et at.
1986). CHV -1 can also be isolated from many dogs with kennel cough, although it is
not now generally considered to be the primary cause of this syndrome.
There have also been reports of a herpesvirus involved in cases of acute
diarrhoea, in puppies over two weeks of age (Evermann et al. 1982). Although it was
already established that CHV -1 could cause diarrhoea in puppies (Yanagisawa et al.
1987), the virus that was claimed to be isolated from these cases of diarrhoea was found
to be antigenically related to FHV -1 rather than CHV -1. It has not proved possible to
cause clinical disease in dogs inoculated with relatively high doses of these FHV -1 like
isolates, although virus could be isolated from the spleen and a viral neutralisation
antibody titre measured (Kramer et al. 1991). The precise relationship of these viruses
to FHV -1 has never been shown although it seems likely that they are the same (feline)
virus. It is therefore a possibility that some strains of FHV -1 may be able to infect dogs,
although an alternative explanation might be that the original isolation of the FHV-like
virus may have been the result of post mortem room contamination (Carmichael, 1997).
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Figure 1.3 Pathogenesis o/CHV-1 in the Dog (Modified/rom Carmichael and
Greene, 1990)
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1.1.6 Immune Response to CHV-1 Infection
The ability of the immune system to respond to infection by CHV -1 is likely to
be one of the key determinants of the progress of infection. It has already been
mentioned that older pups are unlikely to show the fatal systemic infection typical of
neonates, and although ability to maintain and increase body temperature is clearly a
factor in this, maturation of the immune system is also likely to be important. Two
week old puppies immunised with anti-thymocyte serum and then inoculated with a
relatively avirulent strain of CHV -1 developed severe illness: severe thymic atrophy and
reduced lymphocyte activity profoundly affect the course ofCHV infection (Carmichael
and Medic, 1978). Maternal antibody may also be a factor in protecting young puppies
from the full effects of the virus. By the time this protection decreases, puppies are
likely to be able to maintain their body temperature sufficient to reduce viral replication,
and mount an effective immune response of their own.
In HSV infection, both B and T lymphocytes are induced a few days after
primary infection. It is believed that virion glycoproteins and capsid proteins are the
most important targets for these cells. Mechanisms such as natural killer cells and
macrophages also playa part in the effector arm of the immune response, although the
effect of these is generally to suppress virus rather than eliminate it entirely from the
body (Blacklaws and Nash, 1989). CHV -1 infection also leads to production of
antibodies against virion glycoproteins, particularly gp 145 (Xuan et al. 1992). The
exact nature of the immune response and the relative importance of cellular and humoral
immunity in the control of CHV -1 infection has not been studied.
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1.2 CANINE LYMPHOMA
1.2.1 Incidence & Classification
Lymphoma can be defined as a lymphoid malignancy originating from solid
organs. It is the most common neoplasm affecting the canine haemolymphatic system,
and represents 8 to 10 per cent of all canine tumours. The average annual incidence rate
of lymphoma has been estimated at 24 per 100,000 dogs in a study based on two
Californian counties (Dorn et al. 1967). This is higher than the annual incidence rate in
man, but lower than that for the cat, although direct comparisons of annual incidence
rates between species are difficult due to differences in longevity and ageing patterns.
In man, cases of lymphoma are divided into two main categories, Hodgkin's
(1I3rd of cases) and non-Hodgkin's (2/3rds). While the Hodgkin's group seems to
represent a clear clinicopathological entity, the non-Hodgkin's group is a heterogeneous
mix of at least 10 different types of lymphoma (Isaacson, 1992). These are mostly B
cell in origin, although in areas where HTLV is endemic, the proportion of T cell
lymphomas may rise considerably. Lymphomas in animals are categorised in a variety
of ways. The most simple classifications describes the anatomical distribution of the
lesions or their pattern as nodular or diffuse. Alternative methods of classification may
describe the cytological appearance, or immunological type of the cancerous cells
(Moulton and Harvey, 1990).
There are at least four recognised anatomic forms of lymphoma in the dog.
Multicentric lymphoma is characterised by a generalised lymphadenopathy, often with
involvement of the liver, spleen or bone marrow. In cases of mediastinal lymphoma
there is a mediastinal lymphadenopathy which mayor may not be accompanied by bone
marrow infiltration. Alimentary lymphoma is characterised by solitary, diffuse, or
multi-focal gastro-intestinal tract infiltration, sometimes also involving the mediastinal
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lymph nodes. Finally in extranodal cases of lymphoma, the tumour may affect any
organ or tissue (Couto, 1992). The multicentric and alimentary forms of the disease are
the most common (Jarrett et al. 1966), with the multicentric form predominating (50-
80% of cases). Cutaneous lymphoma is the most common extra-nodal presentation, and
can be a diagnostic challenge as the lesions may mimic those of other skin diseases.
There have been some attempts to classify canine lymphoma according to the
cell type involved. In a histological examination of 23 cases, three main types of cells
were observed; poorly differentiated lymphocytic, histiocytic, and well differentiated
lymphocytic. Most cells of each lymphoma had relatively uniform cytological features,
and this dominant cell type was used to classify the neoplasms (Holmberg et al. 1976).
The same study showed that most of the lymphomas expressed surface Ig and were
therefore likely to be of the B-cell type, despite the fairly wide morphological variances.
A subsequent larger scale study confirmed that most cases of multicentric lymphoma
were B cell in origin, whereas cases of thymic lymphoma and cutaneous lymphoma
showed properties ofT-cells, or lacked surface markers altogether (Onions, 1977).
More specifically, it has now been shown that the predominant class ofT-cell involved
in canine cutaneous lymphoma is CD3/CD8 positive, a clear difference from the human
condition where the CD4 +ve immunophenotype is more typical (Moore et al. 1994).
Success in the treatment of human lymphoma has followed on from the accurate
description and classification of the different types of the disease, and the subsequent
design of appropriate therapeutic protocols. One objective of canine lymphoma
classification has therefore been to assist in the design of appropriate therapeutic
protocols; the desire to classify canine lymphomas in a manner analogous to human
non-Hodgkin's lymphoma may also stem from a desire to draw comparisons between
the two species, and possibly use canine lymphoma as a model for the human disease.
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Canine lymphomas may be classified according to grade (low, intermediate, or high
according to clinical behaviour), and cell type according to the National Cancer
Institute's working formulation for non-Hodgkin's lymphoma (Carter et al. 1986). It
has been suggested that the human lymphoma Kiel classification is the most appropriate
system to be adapted to the dog. Using terms borrowed from this classification, the
most common canine lymphomas would be either diffuse large cell (centroblastic) or
immunoblastic (Greenlee et al. 1990). Despite using different classification systems,
both these studies agree that follicular and low grade tumours are rare in the dog in
comparison to humans. As yet differing therapeutic protocols for different types of
lymphoma in the dog have not been proposed.
1.2.2 Possible Aetiologies
In man there are clear associations between at least three viruses and lymphoid
neoplasms. EBV is perhaps the primary oncogenic virus, and has been associated with
five different human malignancies of which four are types of lymphoma; Hodgkin's
disease, Burkitt's lymphoma, some T-cell lymphomas, and immunoblastic lymphoma,
the non-lymphomatous exception being nasopharyngeal carcinoma (Rickinson and
Kieff, 1995). HHV -8, while primarily associated with Kaposi's sarcoma, is involved in
some B-celllymphomas, sometimes in association with EBV (Cesarman et al. 1995).
The T-Iymphotropic retroviruses HTLV-I and HTLV-ll are primarily associated with T-
cell leukaemias, although there is some evidence of a role for HTLV-I in some types of
T-cell lymphoma (Cann and Chen, 1995). An example of an animal virus involved in
lymphoid neoplasia is Feline Leukaemia virus (Hardy, 1980), which is responsible for
the very high incidence of mostly T-cell lymphomas in this species, as well as a variety
of other neoplastic and non-neoplastic conditions.
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A predominant cause, viral or non-viral, for canine lymphoma has not as yet
been determined. There have been sporadic reports of a putative canine retrovirus from
dogs with lymphoma or leukaemia, including reverse transcriptase activity in cultured
cell supernatant (Onions, 1980), and retroviral particles from cases of lymphoma
(Tomley et al. 1983), and a granulocytic myeloproliferative disease (Sykes et al. 1985).
The significance of all these findings is unclear and has been further complicated by the
existence of a number of endogenous retroviral elements in the canine genome (Squires
et al. 1989), whose ability to express themselves at the RNA or protein level is
undetermined. Despite the identification two years ago of a suspected canine retrovirus
that could be propagated in cultures ofPBMC's and supposedly produced a 3.8kb
mRNA species (Modiano et al. 1995), no sequence information has been forthcoming to
prove that this was a genuine exogenous canine retrovirus. In the absence of
confirmatory sequence information, the possibility must be considered that these
findings all represent either the products of endogenous retroviral elements in the canine
genome, or contamination of the cultures with non-canine retroviruses.
In the absence of clear evidence of viral involvement, there have been sporadic
reports of other possible aetiologies for lymphoma in the dog. Two possible
associations with environmental factors; 2,4-Dichlorophenoxyacetic acid (Hayes et al.
1995) and strong magnetic fields (Reif et al. 1995), have been suggested. There is also
a statistically significant association between the development of lymphoma and
immune mediated thrombocytopaenia. While a causal relationship has not been
established, it is possible that auto-immune disease may compromise the immune
system and allow the growth of tumour cells to go unchecked, or alternatively that
lymphoid neoplasia may lead to the generation and release of auto-antibodies and
immune complexes, leading to auto-immune disease (Keller, 1992).
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Evidence that a genetic predisposition to the development of lymphoma exists is
provided by the differing incidence rates in different breeds of dog. The risk of
developing lymphoma in boxers has been estimated as 9.5 times greater than the risk for
all other breeds of dog (Dorn et al. 1970), and the annual incidence rate of lymphoma in
bull mastiffs has been estimated at 5000 cases per 100,000 based on a study of three
households (Onions, 1984). The familial aggregations oflymphoma that have been
noted in these studies may reflect the operation of both genetic and/or infectious agents.
It has been postulated that the particular husbandry arrangements of pedigree dogs,
which may include stress, hyperimmunisation, inbreeding, and exposure to infectious
agents, may pre-dispose them to both immune-mediated disease and haematopoietic
neoplasms (Theilen, 1997).
1.2.3 Chromosomal and Genetic Alterations in Canine Lymphoma
There has been only limited investigations of the genetic lesions responsible for
lymphoma in the dog. Karyotyping of lymphoma cells has been carried out on a number
of occasions, the largest study of 61 dogs showed that the primary chromosomal
aberration was numerical in 2/3rds of dogs, and structural in the remainder (Hahn et al.
1994). At a cytogenetic level, the pathogenesis of canine and human lymphoma may
therefore differ, as the initiating event in the pathogenesis of human non-Hodgkin's
lymphoma is thought to be a reciprocal translocation of chromosomal material, rather
than a failure of segregation at mitosis. Few oncogenes have as yet been studied in the
dog, although alteration of either an oncogene or a tumour suppressor gene is the true
genetic determinant of cancer. The only oncogene associated with the development of a
canine lymphoma has been activation of c-N-ras in a single case, by a point mutation
(Edwards et al. 1993).
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Despite the fact that it is one of the most common neoplasms of the dog, and its
apparent similarity in at least some respects to certain types of human non-Hodgkin's
lymphoma, canine lymphoma remains relatively poorly studied, particularly at the
molecular level. Many questions remain unanswered concerning the aetiology of the
disease, answers to which would prove fascinating given the similarities between the
environments to which humans and dogs are exposed.
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1.3 PERSPECTIVES ON THE IDENTIFICATION AND
CLASSIFICATION OF NOVEL VIRUSES
In recent years one of the most interesting features of herpesvirus research has
been the frequent discovery of novel members of the family in both human and
veterinary medicine. New viruses are often subsequently associated with previously
unexplained clinical syndromes; definitive association of disease and pathogen may in
itself present problems and challenges in that classical measures of causation such as
Koch's postulates are unlikely to be fulfilled (Fredricks and ReIman, 1996).
Molecular techniques are now essential to the identification of novel infectious
agents. For herpesviruses in particular some sequence information is important in that it
shows definitively that the proposed new agent is different to known viruses infecting
the same species. Perhaps the most exciting use of molecular biology in the
identification of novel infectious agents is where the agent has previously proved
difficult or impossible to culture (Gao and Moore, 1996).
1.3.1 Identification of New Viruses by Non-Molecular Techniques
It is possible to take some steps in the identification of a new virus without the
use of molecular biology. To greater or lesser extent, non-molecular methods of
identification rely either on direct visualisation of the virus or its cytopathic effects.
The ability to culture cells of animal origin in vitro corresponded with the first
major advance in the study and discovery of viruses. A suspected infected tissue was
first trypsinised to disperse the cells, then maintained in a nutrient medium. The cell
culture was then observed for a number of days to look for evidence of viral cytopathic
effect which could take a number of different forms according to the nature of virus that
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was present. Itwas by this method that the known canine herpesvirus was first
identified and characterised, when canine kidney cultures from 2 week old puppies
showed degeneration typified by rounding of cells and loss of adhesion, and when
stained appropriately, the presence of intra-nuclear inclusion bodies (Carmichael et al.
1965b; Spertzel et al. 1965).
The discovery of Epstein-Barr virus followed a slightly different route, although
still making use of early techniques in establishing cell lines. It was marked first by the
establishment of permanent lymphoblastoid cell lines from a case of Burkitt's
lymphoma (Epstein and Barr, 1964). Although a classical cytopathic effect was not
observed in these cell lines, when examined by electron microscopy, herpesvirus
particles were observed in the cells (Epstein et al. 1964).
Electron microscopy is a powerful method of visualising viral particles in both
infected tissues and cell cultures. The appearance of a viral particle may give some
clues as to the nature of virus involved: herpesvirus particles have a typical appearance
when negatively stained. The size of the viral particles observed may give further clues
as to its identity: for Epstein-Barr virus, the early electron micrographs suggested
strongly the virus present was a herpesvirus, but that this virus was not herpes simplex
because the particles were too small.
Similar techniques are now used routinely in diagnostic virology applications
(Schmidt, 1979), and these techniques can still be applied in the search for new viruses.
The establishment and characterisation of a variety of permanent cell lines derived from
various tissues such as kidney (Gaush et al. 1969), and fibroblast (Binn et al. 1980), in
the dog has further facilitated the study of viruses in this way.
It was suggested a number of years ago that the ability to develop and maintain
long term cultures of a greater variety of primary cells might lead to the discovery of a
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number of new viruses (Popovic et al. 1984). Primary culture may be coupled with the
exposure of cells to conditions that could affect the status of viruses that the cells may
be harbouring. Application of these techniques has led to the discovery of human
immunodeficiency virus 1 from cultures of peripheral blood mononuclear cells (Gallo et
al. 1984), and also to the discovery of further human herpesviruses.
Tissue culture based techniques still rely on the production of a cytopathic effect
in the cells by the emergent virus, typically ballooning of the cells or the formation of
syncitia. Culture of PBMC preparations in a medium supplemented with hydrocortisone
has yielded a new B-lymphotropic herpesvirus (HHV -6) (Salahuddin et al. 1986), and
incubation of CD4+ve T cells under conditions designed to promote T cell activation led
to the discovery of HHV -7 (Frenkel et al. 1990). It is also interesting to note that the
outgrowth of EBV infected lymphoblastoid cell lines from EBV immune donors can be
enhanced by the addition to the primary culture of a T cell inhibitor such as cyclosporin
A (Bird et al. 1981). This illustrates the point that when deciding the best conditions to
allow outgrowth of a virus in a primary culture of PBMC's, consideration must be made
of both the likely host cell of the virus, and also the potential controlling or suppressing
functions of the various types of cells present in the culture, ( i.e. T cells in this
example).
A virus identified by these techniques still needs to be characterised further to
assess the significance of the observations. The properties of a virus in cell culture may
give significant clues as to the family and genus of virus under investigation. Other
properties such as the stability of the virus under various conditions (for example
sensitivity to lipid solvents is a typical feature of enveloped viruses), and the type of
nucleic acid comprising the viral genome, may provide further insights.
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Serological studies can also give further evidence as to whether a suspected new
virus is closely related to any other known virus. When canine herpesvirus was first
identified, a range of immune sera to a variety of other herpesviruses, and also to
infectious canine hepatitis and canine distemper viruses, failed to neutralise viral
infectivity, thus providing strong evidence that this virus was different to other known
viruses. Subsequent studies using a variety of serological methods, including gel
immunodiffusion, radioimmunoassay, neutralisation of infectivity and western blotting
showed some cross-reaction between CHV-I and HSV, SHY-I, BHV-2 and EHV-l
(Manning et al. 1988). Some of the potential pitfalls of serological analysis are also
shown by the early work on HIV, where the interpretation of the serological data
contributed to the erroneous classification of the virus as a member of the Human T-
Lymphotropic Virus (HTLV ) group (Schupbach et al. 1984), rather than as a lentivirus.
It is therefore important to remember that closely related but different viruses may show
some cross-reactivity depending on the particular serological method employed, so it is
always likely to be difficult to obtain a definitive picture of a virus by serology alone.
The problem with the non-molecular identification of new viruses is that it has
become increasingly difficult to show definitively that a putative new virus is genuinely
different from existing known viruses. Nucleotide sequence of a suspected the new
virus provides conclusive proof that it is not a contaminant from another species, a
previously characterised virus from the same host species, or simply a slightly different
strain ofa known virus.
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1.3.2 Molecular Techniques
Sequence information is likely to be the conclusive proof that a new virus is a
genuine observation. It will also give a definitive identification of the family and sub-
family of the virus, and unlock the door to a whole range of techniques to further study
and characterise the virus. A variety of strategies can be employed to obtain sequence
information from a viral genome.
Conventional Cloning Strategies
A conventional cloning strategy makes use of the tissue culture techniques
already described to grow up a significant quantity of a virus. Provided a virus can be
grown in this way it is then a fairly simple step to prepare genomic viral DNA or RNA
by a variety of techniques. Pure herpesvirus particles are generally prepared after lysis
of infected cell culture by centrifugation on a sucrose or dextran gradient (Killington
and Powell, 1985). Once a pure preparation of virus has been obtained, pure viral DNA
or RNA can be produced by lysis of the virus, phenol/ chloroform extraction and ethanol
precipitation (Tartaglia et al. 1990). An alternative method of herpesvirus DNA
preparation is to preferentially precipitate viral DNA from lysed infected cells as first
proposed by Hirt for polyoma DNA preparation (Hirt, 1967), thus avoiding
centrifugation on a gradient to purity viral particles. Viral DNA can then be digested
with a variety of restriction enzymes, then cloned and sub-cloned into plasmid vectors.
Southern blot analysis of cloned fragments against viral genomes of the same or related
viruses and infected tissues can be sufficient to provide conclusive evidence that a virus
has no known equivalents, but the chain is usually now completed by sequencing of at
least part of the viral genome contained within the array of plasmids.
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This protocol has been successfully applied to a many different viruses. Indeed,
the complete genomes of various herpesviruses have now been cloned and sequenced.
HHV -6 was first identified in tissue culture by its distinctive cytopathic effects, but the
observation that this was indeed a new virus was backed up to a great extent by the
simultaneous publication of the results of southern blot analysis using a 9000bp cloned
fragment of the new virus which would not hybridise to DNA from the other human
herpesviruses (Josephs et al. 1986). Sequencing of21kbp of the HHV-6 genome made
possible the definitive classification of the virus and its relatedness to human
cytomegalovirus (Lawrence et at. 1990), and the process of discovery was completed
within ten years of the initial observation of the cytopathic effect by the complete
sequencing of the viral genome (Gompels et al. 1995).
The Identification of Unculturable Novel Infectious Agents
Techniques based upon a conventional cloning strategy have proved invaluable
in characterising large numbers of both existing and newly identified viruses.
Unfortunately, not all viruses can as yet be grown in culture, so the first step of
obtaining pure viral genomic material can be problematic. A number of techniques have
been described which facilitate the cloning of sub-genomic fragments from a suspected
novel agent without direct culture, thus circumventing the initial growth and isolation of
virus/viral DNA. These techniques have led to the identification of several previously
unculturable infectious agents.
Degenerate Primer Polymerase Chain Reaction
The polymerase chain reaction (Pf'R) allows the specific amplification of a
small part of the genome of an organism (Saiki et at. 1985). Degenerate primer
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polymerase chain reaction is a variation upon this technique where the primers, upon
which the specificity of any peR is based, are synthesised as a mixture of related
sequences. In the identification of novel viruses, the degenerate primers are based upon
amino acid or sequence alignments between conserved genes of related viruses.
There are four key steps to the successful use of degenerate primer peR in the
identification of a novel viral agent; sequence or amino alignments are first made of
viruses related to the putative new viral agent and analysed for conserved regions,
degenerate primers are then designed to cover all possible nucleotide sequences in the
conserved regions (at least two such regions are required a maximum of lkb apart).
Depending upon the genetic content of the proposed new virus, DNA or RNA is
extracted from the infected tissue, or cell culture (without the need to purify viral
DNAfRNA). The final step involves thermal cycling in the polymerase chain reaction,
which will hopefully lead to selective amplification of the viral sequence of interest
between the two degenerate primers. Alternatively, if an area or areas of sequence
conservation exist between the two original primers selected, then a second nested or
herni-nested degenerate peR may be applied to increase the sensitivity and specificity of
the process.
Parts of this strategy has been used successfully a number of times in herpesvirus
research to obtain sequence information on specific viral genes or to obtain the first
piece of DNA sequence information from a particular virus, while still relying to some
extent on either conventional growth of virus in culture, or a conventional cloning
strategy. Genes identified in this way include FHV-I thymidine kinase (Nunberg et al.
1989), and the DNA polymerase gene ofHHV-6 (Teo et al. 1991); often the degenerate
primer peR product is used as a probe in subsequent experiments to identify which of a
set of conventionally obtained clones contains the gene of interest, and thus obtain the
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sequence of the whole gene. The technique has been used to obtain initial sequence
information on HHV -7 (Berneman et at. 1992), and PhHV -1 (Harder et al. 1996),
allowing the definitive classification of both viruses.
Degenerate primer polymerase chain reaction can also been applied to the search
for a novel pathogen in an infected tissue without the need to culture the proposed
infectious agent. The use of degenerate primers tends to reduce both the sensitivity and
specificity of the PCR by comparison to conventional PCR however, so successful
application of the technique might be expected to require relatively high concentrations
of an infectious agent in the tissues under examination. Once again there must be an
indication, or at least a suspicion, of the likely family of the infectious agent, which
must again share with the related viruses on which the consensus primers are based, the
particular conserved region of sequence.
Perhaps the most fascinating example of this technique in virology has been its
use in elucidating the cause of an outbreak of acute respiratory illness in the south-
western United States (Marshall, 1993). Patients presented with a fever, muscle-aches
and other non-specific symptoms, followed by the development of a severe interstitial
pulmonary oedema and inmost cases death. The search for either a known or novel
infectious agent that might be causing this outbreak by conventional culture techniques
proved unsuccessful, but serological studies revealed that the pathogen might be a
previously unrecognised hantavirus (Hughes et al. 1993). Consensus primers for use in
a reverse transcriptase nested peR were based on conserved regions of the capsid gene
of the known hantaviruses, and PCR with these primers successfully amplified a 278bp
fragment ofhantavirus-like sequence from affected tissues (Nichol et al. 1993).
Hantaviruses sequences were found to be present in many tissues of the victims of the
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disease and also in captured deer mice, suggesting that the deer mouse might be the
carrier species.
It is important to note that this example of degenerate primer peR being used
successfully to identify a novel virus without any form of culture was where the target
gene showed considerable conservation of residues. The primers therefore had only a
minimal level of degeneracy. The advantage of this is that there is likely to be only a
small sacrifice of sensitivity and specificity in the peR as compared to the situation
where more highly degenerate primers have to be used. While it is desirable to restrict
the degeneracy of a primer set when attempting to obtain sequence of a novel pathogen,
this requires a highly conserved gene on which to base the primer design.
Screening of cDNA Expression Libraries
All viruses must, at some point during their replicative cycle, produce mRNA
that encodes for their specific proteins. In some cases the viral genome itself may act as
the mRNA molecule. This represents a possible detection point for a novel virus,
although it must be remembered that at some stages of their life cycle, particularly
during latent infections, DNA viruses such as the herpesviruses may transcribe very
little RNA, from only a small selection of their genes.
When accurate serological tests for hepatitis A and B became available, it was
discovered that most cases of post-transfusion hepatitis were not related to either of
these agents (Feinstone et al. 1975; Knodell et al. 1975). Further studies indicated that
at least one of the agents involved in these hepatitis cases was a small enveloped virus,
probably with an RNA genome (Bradley et al. 1985). On this basis, a random primed
cDNA expression library was constructed from chimpanzee plasma which contained a
high infectious titre of the proposed agent. Screening of approximately 106 clones from
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this library with convalescent human serum led to the identification of a single positive
cDNA clone that was shown to encode an antigen specific for non-A non-B hepatitis
(Choo et al. 1989). Analysis of the cloned sequence confirmed that it was derived from
the genome of the hepatitis agent, and that it was most likely to be a new type of
flavivirus. Subsequent analysis showed that this was the major cause of non-A non-B
hepatitis throughout the world (Kuo et al. 1989), and led to the designation of the agent
as the hepatitis-C virus.
Representation Difference Analysis
Representation difference analysis is a complex molecular technique that aims to
clone the difference between two complex genomes (Lisitsyn and Wigler, 1993). RDA
allows a large genome to be scanned for possible differences with another genome,
making it a powerful technique for the identification of a foreign sequence, such as a
viral genome, in an infected tissue by comparison with an uninfected tissue (Brown,
1994). Careful selection of tissues that are to be analysed is extremely important, as the
potential differences that can be detected by RDA are not confined to viral genomes: for
DNA samples at least, the analysis of samples has to be restricted to tissues from the
same individual as the technique will efficiently identify genetic polymorphisms
(Lisitsyn et al. 1994b).
Selection for the differences between two genomes in RDA is carried out by a
combination of PCR and subtractive hybridisation. The enrichment of target sequences
that differ between two samples is achieved by both the PCR amplification of double-
stranded tester DNA molecules after each subtractive hybridisation, and, once an initial
enrichment of target has been achieved, is aided by the second order kinetics of DNA re-
association in subsequent hybridisations.
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In using RDA to search for a novel DNA virus, the intention is to subtract the
genetic information for normal tissue from DNA sequences in infected tissue of the
same animal, so that remaining DNA sequences represent a small part of the viral
genome. Slight modifications of the technique allow it to be similarly applied to the
search for a virus with an RNA genome; in this case isolated RNA from tissues or
plasma must be reverse transcribed to cDNA prior to the first round peR which
generates the representation. RDA has been used to dramatic effect in both the novel
isolation of DNA and RNA viruses.
The observation that Kaposi's sarcoma was at least ten times more common in
homosexual or bisexual men with acquired immunodeficiency syndrome (AIDS) than in
other HIV transmission groups had led to the suggestion that Kaposi's sarcoma in
people with AIDS was likely to be caused by an unidentified sexually transmitted
infectious agent (Beral et al. 1990). A number of known human pathogens were
suggested as being responsible for Kaposi's sarcoma, but extensive investigations failed
to demonstrate an aetiological association. RDA was used to search for foreign DNA
sequences in AIDS-Kaposi's sarcoma by subtracting normal tissue from Kaposi's
sarcoma tissue of the same individual, and yielded sequences which coded for
polypeptides homologues with a capsid protein of herpesvirus saimiri (Chang et al.
1994). The implication of this was that AIDS-Kaposi's sarcoma was caused by a
previously unidentified human herpesvirus. This virus has now been further
characterised as a new human gammaherpesvirus (HHV -8) (Moore et al. 1996). HHV-8
is thought to be the cause of all forms of Kaposi's sarcoma (Moore and Chang, 1995),
and also be involved in some AIDS related non-Hodgkin's lymphomas (Cesarman et al.
1995).
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RDA has also been used successfully to identify two flavivirus-like genomes
from tamarin monkeys (Simons et al. I 995b). An infectious hepatitis agent had been
passaged through tamarins, but had proved resistant to conventional culture techniques
and hence to molecular characterisation. Once again, the initial provision of new
sequence allowed detailed characterisation of both viruses (Muerhoff et al. 1995).
Further studies in fact showed that neither of these agents were implicated in
human hepatitis as had originally been suggested, but the work led indirectly to the
identification of a third flavivirus that is considered to be a human pathogen (Simons et
al. 1995a). Ironically, sequence of this third flavivirus was obtained in a degenerate
primer hemi-nested RT-PCR on human sera, with primers based on an alignment of the
helicase gene of the two flaviviruses obtained from tamarins, and hepatitis C virus. An
independent isolation of this third flavivirus (Hepatitis G virus) was also obtained by
cDNA library expression screening (Linnen et al. 1996). The clinical implications of
this new human virus remain unresolved at present however (Alter, 1996).
A third fascinating example of the use of RDA which deserves comment has
been the identification of viral candidate cDNAs in infectious brain fractions from
Creutzfeldt-Jakob disease (Dron and Manuelidis, 1996). While this work is still in its
preliminary stages, it appears to show cDNAs isolated from infectious fractions of
hamster brain that are not present in either the equivalent extracted fraction of
uninfected brain, or the hamster genome. If these findings prove to be genuine, they
may finally disprove one of the more contentious theories of contemporary science, i.e.,
the concept of infectious proteins as the causal agent of the transmissible spongiforrn
encephalopathies (Prusiner, 1995).
In comparison to degenerate primer PCR, RDA is both expensive and time
consuming to perform. A further complicating factor is that depending on the size of
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the viral genome present as a difference between two tissues, multiple RDA reactions
may also have to be carried out using alternate restriction enzymes to increase the
probability of a portion of the viral genome being present in the initial representation. A
significant advantage of RDA is its potential sensitivity; in the first tests of the
technique, the equivalent of single copy per cell of pathogen could be detected (Lisitsyn
and Wigler, 1993). There are also advantages inherent in the technique from the point
of view of identifying novel viral pathogens over methods based on PCR alone; in
particular, that no knowledge of the proposed viral agent in terms of sequence or likely
family is required. The potential exists therefore to pick up the presence of any DNA
virus in a given experiment; or with certain modifications to the protocols, to carry out
RNA virus searches on the same basis.
Differential Display
Differential display is another RNA based technique that relies on arbitrarily
primed cDNA synthesis from total RNA (Welsh et al. 1992) or mRNA (Liang and
Pardee, 1992) to generate a tissue specific fingerprint. RNA is first extracted from a
tissue and converted to cDNA by reverse transcription at low stringency. PCR is then
carried out with random primers, again under conditions oflow stringency. Despite the
low stringency, when the peR products are run on a high resolution gel a ladder of
bands is generated which is both tissue and individual specific: the potential therefore
exists for any such difference to be observed and cloned.
This technique has been used primarily to look at different levels of gene
expression between tissues, either normal against neoplastic or normal against
regenerating tissue (Liang et al. 1995). On the basis that a suspected virally infected
tissue is likely to be producing different mRNA to an uninfected control, the potential
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also exists for it to be applied to the identification of a novel viral agent. The hope
would be in any such investigation that the abnormal tissue would display one or more
additional bands corresponding to viral mRNA in the original tissue. While it is likely
that an infected tissue will show different patterns of gene expression by differential
display, a proportion of any such genes are likely to be induced or up-regulated cellular
genes. Successful application of the technique invirus hunting might therefore involve
the analysis of a large number of clones to differentiate between host and viral genes,
although the number of clones that need to be screened may not be particularly high in
comparison to the examination of cDNA expression libraries.
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1.3.3 Future Perspectives
It seems likely that there are still a considerable number of unidentified human
and animal viruses which may be involved in a variety of disease processes. Molecular
techniques, and in particular the ability to isolate nucleic acid of a novel pathogen
without dependance on in vitro propagation of the organism, are powerful tools in the
identification and study of such pathogens, and have led to the discovery of a number of
new viruses in the last 10 years.
Sequence information from a novel pathogen is the key to its definitive
identification and classification. While sequence information does not in itself prove
that the novel agent is pathogenic in its natural host, it unlocks the door to a variety of
further studies and diagnostic tests. Characterisation of a new virus by molecular
methods may assist the development of culture techniques or permit the identification of
virus positive cell lines, as was the case for HHV -8 (Moore et al. 1996). Alternatively,
where the virus remains refractory to conventional culture, recombinant DNA
technology may allow the expression of viral proteins in vitro and thus the development
of diagnostic tests (Feldmann et al. 1993).
Where necessary or expedient, molecular techniques alone may provide for the
rapid identification, characterisation and subsequently the diagnosis, of an emerging
disease without recourse to conventional methods of culture. The first crucial steps in
controlling an epidemic caused by a novel pathogen may therefore now be taken without
the ability to culture or directly visualise the suspected agent.
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1.4 PROJECT AIMS
There are many details of the nature and pathogenesis of CHV -1 still waiting to
be discovered. At the start of this project, little was known about its genomic
organisation, and its homology with, and evolutionary relatedness to, other
herpesviruses. Although the clinical syndrome it causes in neonatal puppies has been
well described, the mechanisms and sites of latency of the virus, and its ability to infect
older dogs was far from clear. The aim of the first part of the project was therefore to
address some of these questions.
It also seems highly likely that there are a number of as yet uncharacterised
canine pathogens. In particular, the dog appears unusual in hosting only a single
example of the herpesvirus family. The application of new molecular techniques has
recently yielded a number of new viruses from various viral families. Two such
techniques were therefore applied to a number of cases of canine lymphoma, with the
hope of identifying a novel canine pathogen.
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CHAPTER2
MATERIALS AND METHODS
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2.1 MATERIALS
2.1.1 Cell Lines
Madine Darby Canine kidney (MDCK) and A72 (Canine fibroblast) cell lines
were kindly provided by Anne Weir (canine diagnostic virology laboratory within
veterinary pathology).
2.1.2 Bacteria
E.coli strain INVaF' was obtained as high efficiency, chemically competent
cells in single transfection 50J..lLaliquots (OneShot™ cells) from Invitrogen BV, De
Schelp 12,9351 NV Leek, The Netherlands.
2.1.3 Viruses and Viral Templates
Canine herpesvirus isolates were kindly provided by Anne Weir from cases
presented to the Canine diagnostic virology laboratory within veterinary pathology.
Epstein-Barr virus template DNAs (lymphoblastoid cell line and Raji cell line )
were provided by Alice Gallagher (LRF Virus Centre, Veterinary Pathology, University
of Glasgow).
EHV-2 viral DNA was provided by Liz Telford (Institute of Virology, University
of Glasgow).
MHV -68 lymphoblastoid cell line DNA was provided by James Stewart, (Dept.
of Veterinary Pathology, University of Edinburgh).
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2.1.4DNAs
Size marker DNAs (lOObp ladder, ~xIHaeIII, 1Kb Ladder) were mostly obtained
from Gibco BRL Life Technologies Ltd., PO Box 35, Trident House, Renfrew Rd,
Paisley. PA3 4EF.
Low range PFG molecular weight marker was obtained from New England
Biolabs (U.K.) Ltd., 67 Knowl Piece, Wilbury Way, Hitchin, Herts. SG4 OTY.
PCR™II and peR ™ 2.1 TA Cloning Vectors were obtained from Invitrogen
BV, De Schelp 12,9351 NV Leek, The Netherlands as part of the TA cloning kit.
Oligonucleotides for use as PCR primers and probes were obtained from
Cruachem Ltd., Kelvin Science Park, Glasgow.
2.1.5 Chemicals
Unless stated to the contrary, all chemicals were obtained from Sigma-Aldrich
Company Ltd, Fancy Road, Poole, Dorset, BH 12 4QH.
Agarose, TEMED, Tissue Culture Media; Gibco BRL Life Technologies Ltd., PO Box
35, Trident House, Renfrew Rd, Paisley. PA3 4EF.
Bacterial culture media (L.Agar and L.Broth) were provided by the bacteriology
section within Veterinary Pathology.
Radiochemicals, a.32pdCTP and y2p ATP; Amersham International plc,
Amersham place, Little Chalfont, Bucks., HP7 9NA.
Acrylamide/Bis-Acrylamide 29: 1Mix; Anachem Ltd., 20 Charles Street, Luton,
Beds. LU2 OEB.
Polymerase Chain Reaction core reagents (nucleotides, buffers) were supplied by
PE Applied Biosystems, Kelvin Close, Birchwood Science Park North, Warrington,
WA37PB.
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2.1.6 Enzymes and Antibodies
Unless otherwise stated restriction enzymes, with their appropriate reaction buffers were
supplied by Gibco BRL Life Technologies Ltd., PO Box 35, Trident House, Renfrew
Rd, Paisley. PA3 4EF. T4 DNA ligase and T4 kinase enzymes were supplied by the
same company, also with appropriate reaction buffers (lOx ligation buffer, and 5x
forward kinase reaction buffer).
Mung bean nuclease was provided with its appropriate lOxbuffer by New
England Biolabs (U.K.) Ltd., 67 Knowl Piece, Wilbury Way, Hitchin, Herts.
SG40TY.
Amplitaq DNA Polymerase was supplied by PE Applied Biosystems, Kelvin
Close, Birchwood Science Park North, Warrington, WA3 7PB.
Taqstart antibody was supplied by Cambridge BioScience, 24-25 Signet Court,
Newmarket Rd, Cambridge. CB5 8LA.
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2.2 METHODS
Methods used throughout the thesis are described in this chapter; methods
specific to one section of work are described in subsequent chapters.
2.2.1 Recombinant DNA techniques
Preparation of oligonucleotides
Oligonucleotides were synthesised at the 0.21lM scale by Cruachem and supplied
lyophilised. Oligos were dissolved in 110IlL of sterile ultra pure water in a PCR clean
room, and a IOIlL aliquot removed and diluted 1 in 100. Concentration of DNA was
then measured by adsorbance at 260nm and calculated directly by the spectrophotometer
(Genequant II, Pharmacia; for 1 in 100 dilutions ofssDNA the adsorbance at 260nm
was multiplied by a factor of three to give the concentration of oligo DNA). Oligos
were then diluted in water to an appropriate working concentration, divided into single
use aliquots, and stored at -20°C in a PCR clean environment until required.
Polymerase Chain Reaction
The Polymerase Chain Reaction was used throughout the project to amplify
DNA fragments of interest, and will be described in more detail in the relevant sections.
With the exception of Taq polymerase, core PCR reagents were dispensed into single
use aliquots sufficient for 14 reactions of 50llL outside the department and stored in a
PCR clean fridge/freezer as appropriate until required. Taq polymerase and Taqstart
antibody were supplied direct from the manufacturers, dispensed into 10llL single use
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aliquots containing 5J..lLTaq, and 5J..lLTaqstart in a peR clean room, and again stored at
-20oe until required.
Great care was taken during set up of all Pf'R's to avoid contamination of
reactions with previously generated product (Kwok and Higuchi, 1989). In addition to
the aliquotting of all reagents and preparation of master mixes in a dedicated clean
room, template DNA was prepared and added to reactions in a laminar flow hood in a
second room. Positive control templates were prepared in a further area and peR
products handled in a fourth (peR dirty) laboratory. A unidirectional movement
through the four rooms was established from preparation of master mixes, to template
addition, thermal cycling and finally analysis of products. Single use gowns, gloves,
caps and masks were worn during all preparative stages.
Between 10 and 20J..lLof a given peR was mixed with a 1/5th volume of gel
loading buffer prior to electrophoresis on either 7.5% polyacrylamide or 1.5-2.0%
agarose gels. both in 1 x TBE buffer. Acrylamide gels were stained in 100rnL of a
0.5J..lg/rnLsolution of ethidium bromide in 1 x TBE, ethidium bromide was generally
incorporated into agarose gels before pouring, also at concentration ofO.5J..lg/mL. peR
products in gels were visualised under UV light.
Cloning of peR Products
Products of peR were ligated directly into the peR IITM or peR 2.1™Vector
supplied by Invitrogen; taking advantage of the template independent addition of
adenosine overhangs to peR products by Taq polymerase. The concentration of the
peR product was assessed by comparison with a known amount of cpxlHaeIIImarker,
and ligated to the vector at a 1:1 molar ratio. Alternatively, where multiple Pf'R
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products resulted from a single reaction, the band of interest was cut out of the gel and
extracted using the Qiaex kit (Qiagen Ltd) according to the manufacturer's instructions.
Gel extracted DNA was resuspended in 15-20J.lIofTE buffer and 7J.lLincorporated into
a 10J.lLligation with 1J.lLeach of lOx Ligation buffer, vector, and T4 DNA Ligase (All
supplied in TA Cloning Kit, Invitrogen). Ligations were performed overnight at 14°C.
Ligations were transformed into competent INVaF' cells supplied in single use
50J.lLaliquots (One Shot™ cells, Invitrogen), as directed by the supplier. Transformed
cells were plated onto L-agar plates containing Kanamycin and spread with 50J.lLof X-
gal, and incubated at 37°C overnight. White colonies (containing vector with insert)
were picked off the plates and grown up in L-broth overnight at 37°C in a rotary
incubator. Transformed colonies were stored long term at -20°C after dilution with an
equal volume of glycerol (100%).
Isolation of Plasmid DNA from Transformed Bacteria
Single colonies of transformed cells were inoculated into an appropriate volume
ofL-Broth containing Kanamycin and incubated at 37°C overnight in a rotary incubator.
Plasmids were purified using the Qiagen plasmid purification system appropriate to the
volume of culture e.g., Qiawell 8 for 3mL mini-prep culture, Qiagen-tip 500 column for
a 100mL culture. These kits were found to produce high quality plasmid DNA suitable
for all downstream applications. Approximately lug of plasmid DNA was digested
with an appropriate restriction enzyme and run on a 1.5% agarose gel to confirm that the
insert was of the expected size.
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2.2.2 Southern Hybridisation
Preparation of radiolabelled probes
Oligonucleotides to be used as probes were kinase labelled with 32p.
Approximately 70pmol of oligo were placed in an eppendorfwith 61lL of 5x Forward
Reaction buffer (Oibco), Iul. ofT4 kinase (Oibco) and the volume made up to 291lL
with sterile distilled water (SDW). lul. -?2p ATP was added in the controlled radiation
area and the eppendorf placed in a lead pot in a water bath at 37°C for 1 Hour. The
reaction mix was diluted to a volume of 100llL with 1 x TE, and run down a Sephadex
0-50 Nick Column (Pharmacia) to separate unincorporated radioactivity from probe in
accordance with the manufacturer's instructions.
Radioactive labelling of purified dsDNA fragments with 32p dCTP (Redivue,
Amersham) was achieved by using a multiprime DNA labelling system (Amersham)
according to the manufacturer's instructions. Probe was separated from unincorporated
label by loading onto a pre-equilibrated Sephadex 0-50 polypropelene column. The
probe was allowed to completely enter the column before the continuous infusion of TE
buffer was resumed. As transport of products down the column occurred, two peaks of
radioactivity could be detected, the first corresponding to labelled probe, the second to
unincorporated label. Purified labelled product was collected in a series of 500j.lL
aliquots as the leading peak was eluted from the column. Aliquots from the trailing end
of the lead peak were not used in subsequent hybridisations due to the possibility that
they might contain significant amounts of unincorporated label.
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Separation of DNA Fragments According to Size
DNA fragments generated by peR or restriction digests were separated
according to size by electrophoresis through either agarose or polyacrylamide gels.
Larger DNA fragments were separated on 0.8-2.0% agarose gels in 1 x TBE buffer.
Smaller fragments, particularly those resulting from peR where rapid throughput of
samples was required, were separated on 7.5% vertical acrylamide gels in a Mini-
Protean II electrophoresis system (Bio-Rad Laboratories). Gel loading buffer (Sigma)
was added to the samples immediately prior to loading and gels allowed to run until the
marker dye neared the end of the gel.
Preparation of Blots
Following separation on agarose gels, DNA was blotted to Nylon membranes
(Duralon™, Stratagene) according to the method of South em (Southern, 1975). Briefly,
gels were first soaked in Alkali Buffer for 45-60', then in Neutralising Buffer 45-60' and
finally 10 x sse for at least 10'. The capillary transfer of DNA to the nylon membrane
was set up in a large tray, the apparatus being assembled in the following sequence:
Platform,
3MM filter paper acting as Wick on all sides ofplatform,(wetted once in place)
Gel blotting paper soaked in lOx sse,
Gel (Cut to size, and orientated appropriately),
Nylon membrane,
Gel blotting paper soaked in lOx sse,
3MM Filter Paper,
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Tissues,
Glass plate and weight.
The tank was then filled with 10 x sse, the effect of the tissues being to draw the sse
through the gel and nylon membrane by capillary action, thus transferring gel DNA to
the nylon membrane. DNA was fixed to the nylon membrane by irradiation with 120mJ
of UN light in a UV Stratalinker 1800 (Stratagene Ltd.).
Acrylamide Gels were electro-blotted to nylon membranes in a Bio-Rad mini
trans blot cell. Gels were first soaked in Alkali Buffer for 10', then in Neutralising
Buffer for 10', and finally transferred to pre-chilled 1 x TAE Buffer for at least 5
minutes. The gel sandwich was assembled as follows, ensuring no air bubbles between
components:
Black plate,
Foam cushion soaked in TAE,
One piece 3MM paper soaked in TAE,
Gel,
Nylon membrane soaked in TAE,
One piece 3MM paper soaked in TAE,
Foam cushion soaked in TAE.
The assembly was then clipped together and placed in the electro-blot cell with
chilled 1 x TAE (black electrode facing black plate), and a frozen cooling block
containing TAE also placed in the electro-blot cell. DNA was transferred effectively to
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the nylon membrane by applying 20V across the plates for a period of one hour. DNA
was fixed to the membrane with UV light as for Southern Blots prepared by capillary
transfer.
Hybridisation
Probes prepared by the multiprime method (50-100~ approximately 2 x 107
cpm) were mixed with 500J,lLof Geneblock, boiled for 3' and placed on ice.
Meanwhile the blot was placed in a roller bottle with 20mL of Quickhyb solution
(Stratagene) and prehybridised for 20', at 68°C. The probe/geneblock mixture was then
added to the roller bottle and allowed to hybridise for 3 hours. Blots were then washed
twice for 5' in 2 x SSC/O.I % SDS; final washes were varied according to the expected
degree of homology between probe and blotted DNA. For high stringency (identical or
near identical sequences) two further 20' washes in 0.1 x SSe/O.l %SDS at 60°C were
carried out, for less stringent conditions the concentration of SSC in the final washes
was increased.
For oligonucleotide probes, the Tmof the probe in Quickhyb solution was first
calculated according to the %GC method;
Tm (OC)= 81.5 + 16.6 * 10g[Na+]+ O.41*[GC] - (675lLength of Oligo).
In practice, calculation of the Tmof a given probe was performed by the primer analysis
software in the Oligo computer program (Rychlik, 1991). 125ul, of Geneblock was
boiled for 3' then placed on ice; blots were placed in a 50mL Falcon tube with 3mL of
Quickbyb and the Geneblock. Blots were prehybridised for 20' at SOCbelow the Tm of
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the probe ( as calculated from the sequence). Approximately 20llL of kinase labelled
probe was added and allowed to hybridise at the same temperature for 2-3 hours. Blots
were then washed twice for 5' in 6 x sse, 0.1% SDS at room temperature, and finally
for 30' in 6 x sse, 0.1% SDS at the Tm of the probe in 6 x SSe.
Autoradiography
Membranes were wrapped in Saran film, and exposed to Amersham hyperfilm at
-70°C in the presence of an intensifying screen. Films were developed in an automatic
processor.
2.2.3 DNA Sequence Analysis
Sequencing Reactions
Chain terminating Di-deoxy sequencing reactions were carried out using the
Thermo Sequenase fluorescent labelled primer cycle sequencing kit from Amersham
(RPN 2538). Approximately lug of plasmid DNA was suspended in 251lL of water
with 51lL of fluorescent primer (generally M13 forward or reverse primers). Four PCR
tubes were labelled G,A,T and C and 21lL of the respective Amersham reagent added to
each; 61lL of the plasmid/primer mix was then added to each tube. Thermal cycling was
performed on PCR9600 Thermal Cycler with an initial denaturation step at 95°C for 5
minutes, then 25 cycles of an annealing step at 55°C for 30s, followed by extension at
72°C for 40s, and denaturation at 94°e for 30s. Reactions were cooled to 4°C and 41lL
of stop/loading solution added to each tube.
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Electrophoresis
Electrophoresis was carried out on a Licor 4000L automated sequencer
according to the manufacturer's protocols. Samples were not denatured prior to loading
1. 5J.lLof each sequencing reaction into the sample wells.
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Table 2.1 General Stock Solutions
lOx TBE (2t): 50 x TAE (It):
Tris Base 216g,
Boric Acid 110g,
0.5M EDTA pH S.O SOmL,
Tris Base 242g,
Glacial Acetic Acid 57.1mL,
Na2EDTA.2H20 37.2g,
Adjust pH to approx. 8.5.
TE Buffer:
10mM Tris-CI at desired pH,
1mM EDTA pH 8.0,
80mg/mL in dimethyl formamide
stored at -20°C
24 x SSC: Neutralising Buffer (5L)
NaCI
Citric Acid
Water to 4.7L.
IKg,
500g,
Tris Base
NaCl
HCI
Water to 5L.
303.5g,
438.3g,
165mL,
Alkali Buffer (5L):
NaCI
NaOH
438.3g,
100g,
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CHAPTER3
CLONING AND SEQUENCING OF A PORTION OF THE
GLYCOPROTEIN B GENE OF CANINE HERPESVIRUS 1 USING
DEGENERATE PRIMER POLYMERASE CHAIN REACTION
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3.1 INTRODUCTION
Although a number of herpes viruses have been fully sequenced, at the start of
this project relatively little was known specifically about the genome and organisation of
canine herpesvirus (CHV -1). Classification of the virus, as a member of the
alphaherpesvirus sub-family, was purely on the basis of its biological properties
(Roizman et al. 1992).
The GC content of the genome was initially estimated at 65%, however later
studies on a more purified sample have shown a value of 31%, with the total molecular
weight of the DNA being 6.3 x 107 Daltons (Lust and Carmichael, 1974). A limited
amount of restriction endonuclease analysis of the genome has been carried out:
southern blot analysis using DNA prepared from a typical CHV -1 isolate has shown that
approximately 51% of the FHV genome is capable of hybrid ising to CHV-l DNA under
conditions of fairly low stringency (Rota and Maes, 1990).
Reports also exist of an apparently distinct herpesvirus, isolated from dogs with
diarrhoea. Digests of DNA extracted from this herpesvirus with the BamHl restriction
enzyme showed marked similarities with Bam HI digests of FHV-l DNA from clinical
cases in cats. Digests with other enzymes only showed similarities if comparison was
made to a laboratory strain ofFHV however. Southern Blot analysis also showed
homology between this isolate and FHV, while failing to show any homology under
conditions of high stringency between FHV and standard CHV -1 isolates (Rota et al.
1986). Unfortunately, no sequence information has been published for these isolates
and the relationship of the Herpesvirus isolated and analysed in these early experiments
to classical Canine Herpesvirus remains unclear. Indeed, it has been suggested in some
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quarters that the FHV -1 like isolate described in these experiments may have been due
to contamination between canine and feline tissues at post mortem (Carmichael, 1997).
At the start of this project, no sequence data for CHV-l was available.
Conclusive classification of the virus and further study using molecular biology
techniques was hampered by this lack of data. An important preliminary step in the
study of CHV -1 would therefore be to obtain some sequence information.
While a variety of molecular biology techniques could be used to clone a small
portion of the viral genome and thus permit sequencing, a variant of the polymerase
chain reaction (PCR), degenerate primer PCR was selected as the method for this study.
In this technique, a mixture of oligonucleotides which vary in sequence while having the
same number of bases (hence degenerate) are used as primers in the PCR to generate
gene-specific amplification products. Circumstances in which this would be useful
include when only limited protein sequence data of sought after gene is known, or when
the search is for new or uncharacterised sequences related to a known family of genes
(Compton, 1990). The method was first suggested as a means to identify
uncharacterised viral sequences related to known virus groups following successful
results in a hepadnavirus model system in which the degenerate primers were based on
alignments of the reverse transcriptase sequences of retroviruses and hepadnaviruses
(Mack and Sninsky, 1988). The technique has subsequently been used to identify the
thymidine kinase gene of FHV -1 (Nunberg et al. 1989), isolate a DNA probe for the
DNA polymerase gene ofHHV-6 (Teo et al. 1991), and characterise PhHV-l and
PhHV -2 as alpha and gammaherpesviruses respectively (Harder et al. 1996).
On the basis of these studies it was considered likely that degenerate primer peR
would prove a useful tool in obtaining some initial sequence information on eHV -1.
The use of degenerate primer peR side-steps the need to prepare and purify viral DNA
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for cloning, and also allows a gene that may be of particular interest to be targeted
directly for cloning.
It is clearly of considerable importance when considering the design of a
degenerate primer system to select a gene which is reasonably well conserved between
the viruses on which the alignment is being based, and hopefully therefore the unknown
gene which is to be amplified. The glycoproteins of the various herpesviruses mediate
essential virus functions and although no sequence data was available at the start of this
project, evidence did suggest that CHV -1 shared homologous glycoproteins with other
Alphaherpesvirinae. CHV -1 antigen cross reacts with HSV 1+2 antisera, and antiserum
to HSV -1 gD will neutralise CHV -1. CHV -1 antiserum cross-reacts with EHV-1, and
will neutralise HSV -1, 2, and pseudorabies virus. Immunoprecipitation studies have
also revealed that FHV and CHV -1 share virion glycoprotein antigens with molecular
weights of 60, and 68 kDa, and also weak cross-reactivity between two other non-
glycosylated virion associated antigens (Rota and Maes, 1990).
Of the various herpesvirus glycoproteins, gB and gH have been shown to be
homologous for all the human herpesviruses so far identified (Manservigi and Cassai,
1991). Alignments of the gB genes of widely divergent herpesviruses well as showing a
reasonable degree of sequence conservation (Griffin, 1991). It was therefore considered
highly likely that CHV -1 would both have a gB gene, and that it would show a sufficient
level of homology to other alphaherpesvirus gB genes to permit the design of degenerate
pnmers.
Sequence information was available for the gB gene of a considerable number of
alphaherpesviruses divided between both genera, making it possible to identify
conserved regions of amino acid sequence. The gB gene of CHV -1was also likely to
code for one of the most important surface glycoproteins of CHV -1, mediating
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adsorption and penetration of the cell. As gB satisfied all the requirements for the
design of degenerate primers, and was also considered to be an important viral gene
worthy of further analysis in its own right, it was selected as being the most suitable
gene to work on in the first instance.
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3.2 MATERIALS ANDMETHODS
3.2.1 Design of Degenerate Primers
Degenerate primers were designed to amplify a 605bp portion of the gB gene of
any alphaherpesvirus based on an alignment of the amino acid sequence of seven
different alphaherpesvirus gB sequences. All sequences were obtained from the viral
database of GenBank, and the alignments carried out using sequence analysis software
programs from the Genetics Computers Group of the University of Wisconsin
(Devereux et al. 1984) (Figure 3.1). Two areas of consensus amino acid sequence were
selected corresponding to positions 714-718 and 904-908 in the alignment, and
degenerate primers designed by back translation from the amino acid code to include all
possible codons in the conserved areas of sequence (Figure 3.2).
A feature of degenerate primer PCR is that as the level of degeneracy of the
primer increases, there is a corresponding decrease in the sensitivity and specificity of
the reaction. To reduce the level of degeneracy, each conserved area of amino acid
sequence was therefore covered by two degenerate primers with a maximum 64 fold
degeneracy (as opposed to 128 fold degeneracy if single mixes of sense and anti-sense
primers had been used); based on the preferred codon usage of the other
alphaherpesviruses on which the alignments were based, it was thought likely that the
primer corresponding to the true sequence of CHV -1 would be in the first of the two
primers covering each area (degenerate primers 1& 3 in figure 3.2).
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Figure 3.1 Amino Acid Sequence Alignments of Seven Alphaherpesviruses
Alignment was prepared using the pileup programme with a GapWeight of
3.0 and a Gap Length Weight of 0.1, alignment shown between positions
701 and 950.
701 - 750HSV-l FRYE ...DQG PLVEGQLGEN NELRLTRDAI EPCTVGHRRY FTFGGGYVYFCeHV-l FRYD ...GRR PLVEGQLGED NEIRLERDAL EPCTVGHRRY FTFGAGYVYF
AHV-l FRYT ...DEG ELVEGQLGED NEIRLEQNNV EPCTVGHKRY FVFGGGYVYF
SMHV-l FRYA ...DEG ELIEGQLGED NEIRLEQNNL EPCTVGHKRY FVFGDGYVYF
BHV-l FAFG ...NES EPVEGQLGED NELLPGRELV EPCTANHKRY FRFGADYVYY
SHV-l FEH ....NGT GVIEGQLGDD NELLISRDLI EPCTGNHRRY FKLGSGYVYY
EHV-l FTITKNANNR GSIEGQLGEE NEIFTERKLI EPCALNQKRY FKFGKEYVYY
FHV-l F...RALNDS EYIEGQLGEN NDLLVERKLI EPCTVNNKRY FKFGADYVYF-751 800
HSV-l EEYAYSHQLS RADITTVSTF IDLNITMLED HEFVPLEVYT RHEIKDSGLL
CeHV-l EEYAYSHQLG RADVTTVSTF INLNLTMLED HEFVPLEVYT RQEIKDSGLL
AHV-l EEYAYSHQVS RADVPVVSTF VDLNLTMLED HEFLPLEVYT RREIKDSGLL
SMHV-l EEYAYSHQVS RADVPVVSTF VDLNLTMLED HEFLPLEVYT RQEIKDSGLL
BHV-l ENYAYVRRVP LAELEVISTF VDLNLTVLED REFLPLEVYT RAELADTGLL
SHV-l EDYNYVRMVE VP ..ETISTR VTLNLTLLED REFLPLEVYT REELADTGLL
EHV-l ENYTFVRKVP PTEIEVISTY VELNLTLLED REFLPLEVYT RAELEDTGLL
FHV-l EDYAYVRKVP LSEIELISAY VDLNLTLLED REFLPLEVYT RAELEDTGLL
801 850
HSV-l DYTEVQRRNQ LHDLRFADID TVIHADANAA MFAGLGAFFE GMGDLGRAVG
CeHV-l DYTEVQRRNQ LHALRFADID TVlKADAHAA LFAGLYSFFE GMGDVGRAVG
AHV-l DYAEVQRRNQ LHALRFSDID RIMNDSANAA LMAGLARFFD GMGDAGKAIG
SMHV-l DYAEVQRRNQ MHALRFSDID HIINDTTNAA LMDGLFRFFD GLGAAGQAIG
BHV-l DYSEIQRRNQ LHELRFYDID RVVKTDGNMA IMRGLANFFQ GLGAVGQAVG
SHV-l DYSEIQRRNQ LHALKFYDID RVVKVDHNVV LLRGIANFFQ GLGDVGAAVG
EHV-l DYSEIQRRNQ LHALRFYDID SVVNVDNTAV IMQGIASFFK GLGKVGEAVG
FHV-l DYSEIQRRNQ LHALKFYDID SIVRVDNNLV IMRGMANFFQ GLGDVGAGFG
851 900
HSV-l KVVMGIVGGV VSAVSGVSSF MSNPFGALAV GLLVLAGLAA AFFAFRYVMRCeHV-l KVVMGIVGGV VSAVSGVSSF LSNPFGRLAV GLLVLAGLAA AFFAFRYVMR
AHV-l RAVLGVTEGL ISVVSGVSSF LSNPFGALAV GLLVLAGLVA AFFAMRYIMRSMHV-l KAVLGVTEAV ISVVSGVSSF LSNPFGALAV GLLVLAGLTA AFFALRYIMRBHV-l TVVLGAAGAA LSTVSGIASF IANPFGALAT GLLVLAGLVA AFLAYRYISRSHV-l KVVLGATGAV ISAVGGMVSF LSNPFGALAI GLLVLAGLVA AFLAYRHISR
EHV-l TLVLAAAGAV VSTVSGIASF LNNPFGGLAI GLLVIAGLVA AFFAYRYVMQFHV-l KVVLGAASAV ISTVSGVSSF LNNPFGALAV GLLlLAGIVA AFLAYRYISR
901 950
HSV-l LQSNPMKALY PLTTKELKNP T.NPDASGEG EEG ....... .GDFDEAKLA
CeHV-l LQRNPMKALY PLTTKELKSD G ..APLAGGG EDGA ...... .EDFDEAKLA
AHV-l LRANPMRALY PLTTSGlKAE ARAALGSGGD KGGAGDGAAG VEDFDEAKLE
SMHV-l LRANPMRALY PITTHGlKAE AKASLASGEP RSGPG ....G IEDFDEAKLE
BHV-l LRSNPMKALY PITTRALKDD ARG .....AT APGEEE .... .EEFDAAKLE
SHV-l LRRNPMKALY PVTTKTLKED .......... ..GVDE .... .GDVDEAKLD
EHV-l IRSNPMKALY PITTKALKNK AKTS ...YGQ NEEDDG .... .SDFDEAKLE
FHV-l LRANPMKALY PVTTRNLKQT AKSPASTAGG DSDPGV .... .DDFDEEKLM
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Key;
HSV-1
CeHV-1
AHV-1
SMHV-1
BHV-1
SHV-1
EHV-1
FHV-l
Herpes Simplex Virus 1 (Human herpesvirus 1)
Cercopithecine herpesvirus I (Simian herpesvirus SAB)
Spider Monkey herpesvirus l(Ateline herpesvirus 1)
Squirrel Monkey Alphaherpesvirus 1
Bovine Herpesvirus 1
Pseudorabies Virus
Equine Herpesvirus 1
Feline Herpesvirus 1
Arrows mark the position of the consensus areas of sequence used to design the
degenerate primers.
(sense primer consensus region amino acids 714-718, 3' primer consensus region amino
acids 904-908).
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Figure 3.2 Design of Alphaherpesl1irus Degenerate Primers
3' (antisense) Primer; 2 primers, one 64, other 16 fold degenerate, first
containing more likely codon usage. Both primers 25 nucleotides total including EcoR 1
restriction site and anchor.
5' 3'
Anchor EcoRI A KIR M P N
1. GC ATCGAATTC CC TTT CAT TGG ATT
CCG C G
A
G
Degeneracy: 2x2x2 x 4 x 2 == 64
2. GC ATCGAATTC CC ACG CAT TGG ATT
G C G
A
G
Degeneracy: 2 x 4 x 2 =16
5' (sense) Primer; 2 Primers, one 64, other 32 fold degenerate, first containing
more likely codon usage. Both primers 25 nucleotides total including HindIII restriction
site and anchor.
5' 3'
Anchor HindIII E G Q L G
3. GC TCAAAGCTT GAA GGT CAA CTT GG
G C G C
A A
G G
Degeneracy: 2 x 4 x 2 x 4 = 64
4. GC TCAAAGCTT GAA GGT CAA TTA GG
G C G G
A
G
Degeneracy: 2 x 4 x 2 x 2 = 32
Expected no. of amino acids between two primer sites = 185;
Therefore expected product size = (185 x 3) + (25 x 2) = 605bp
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3.2.2 Growth and Preparation of Canine Herpesvirus 1 Stocks
Virus was isolated from the tissues of a 2.5 week old puppy that had died
following typical signs of CHV -1 infection. Virus was propagated on Madine Darby
Canine Kidney (MDCK) cells for no more than three passages, and stocks of infectious
virus prepared using standard techniques (Killington and Powell, 1985). Cell cultures
were infected with virus at low multiplicity of infection, and virus harvested after 48-72
hours when the visible cytopathic effect (c.p.e.) extended to 50% of the culture. Virus
was freed from cells by one cycle of freeze thawing followed by 5' ultra-sonication.
Cellular debris was removed by centrifugation and virus aliquotted and stored at -70°C
until required.
A TCIDso was calculated for the stock aliquots according to the method of
Karber (Schmidt, 1979). Serial dilutions of virus stocks were made in tissue culture
medium and O.lmL of each dilution incubated in a minimum of four wells in a 96-well
plate containing confluent mono layers of MDCK cells. Plates were read for presence or
absence of viral c.p.e. in each well after 48-72 hours, and the TCIDso calculated
according to the equation below.
Negatin log of Negative Log of [ sum of% mortality at each dilution ] Logarithm
TCID~Endpoint = Highest Virus - - 0.5 X of
Titre Concentration Used 100 Dilution
Preparations of infectious virus were diluted in sterile distilled water and
steamed for 5' with or without the addition ofO.5% NP40 to assist in disruption of
virions, prior to incorporation in the PCR.
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3.2.3 Degenerate Primer peR
As two degenerate primers covered each conserved area, 4 individual reactions
were used on each template so that both sense primers were used with both anti-sense
primers. Amplification was carried out using 4 Units AmpliTaq DNA polymerase
(Perkin-Elmer) mixed with an equal volume of TaqStart antibody (Clontech) per
reaction in a total reaction volume of 100J.LL,containing SOpmol each primer and
200J.LmollLof each deoxynucleoside triphosphate in 10mM Tris (PH 8.4), SOmM KCl,
and 1.SmM MgCh. Ten J.LLof diluted, steamed virus was used as template in each
reaction. Thermal Cycles were performed on a Perkin-Elmer 9600; with an initial
denaturation step at 94°C for 5 minutes, annealing at S5°C decreasing by O.soC per
cycle for 60s, an extension period at 72°C for 60s, followed by denaturation at 94°C for
30s. After the first 20 cycles the annealing temperature was fixed at 45°C, and a further
20 cycles performed.
Ten J.LLofPCR product was run on a 7.5% Acrylamide gel and visualised by
staining with Ethidium Bromide. Two J.LLof the PCR product was ligated into the
PCRII™ vector and transformed into OneShot cells (TA cloning Kit, Invitrogen BV)
Plasmids were isolated from colonies, checked for inserts of the appropriate size, and
two plasmids containing the 60Sbp band sequenced in both forward and reverse
directions as described in chapter 2.
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3.3 RESULTS
3.3.1 Growth of CHV-1 Stocks
Confluent mono layers of MDCK cells were infected at a low multiplicity of
infection with 1st passage CHV -1 stocks. A cytopathic effect typical of CHV -1 was
seen in the cultures consisting of central plaques of cell loss surrounded by swollen
infected cells. Virus was harvested from cultures when approximately 50% of cells
were showing c.p.e., divided into ImL aliquots and stored at -70°C.
An aliquot of infectious virus was serially diluted in tissue culture medium, and
the dilutions incubated on confluent mono layers of MDCK cells in 96 well plates in
order to calculate a TCIDso for each preparation of virus. After three passages, the
TCIDso endpoint for a O.lmL innoculum of this virus isolate was typically 10-4·5.A
ImL aliquot of virus stock therefore contained 105.5TCIDso's.
3.3.2 Degenerate Primer Polymerase Chain Reaction
At the start of these experiments, no sequence of CHV -1 was available.
Degenerate primer PCR was therefore used to amplify a portion of the gB gene of CHV-
1 in a manner analogous to the technique used previously to identity the Feline
Herpesvirus 1 Thymidine Kinase gene (Nunberg et al. 1989). Steamed, diluted CHV-l
as prepared above was used as the template in all reactions. Degenerate primer PCR
was carried out with sets of two sense and two anti-sense degenerate primers, utilised in
all possible combinations.
Following amplification, reaction products were visualised on an acrylamide gel
after staining with ethidium bromide. Initial experiments revealed that only the
combination of primers 1 and 3 together resulted in significant amplification of the
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expected product. The amount of specific product generated was considerably enhanced
by use of a 'Hot Start' technique (Fig. 3.3). Optimum amplification of a band of the
expected size of 605bp was observed at a virus dilution of 1 in 50 without the addition
ofNP40 (Fig. 3.4). The poor amplification of product at a virus dilution of 1 in 20 is
likely to be due to factors in the tissue culture medium interfering with the Pf'R.
3.3.3 Analysis of the Degenerate Primer peR Product
The peR products were ligated directly into the PCRII™ vector. Two different
clones of the 605bp band were sequenced in both forward and reverse directions. The
sequence of the fragment and its translation, excluding the two regions corresponding to
the degenerate primers, is shown in Figure 3.5. The sequence obtained was compared to
the gB sequences of both FHV-I and EHV.:.l, showing a 74% and 65% homology to the
respective viruses at the nucleotide level (Fig. 3.6), and a 94% and 83% homology at the
amino acid level. The full sequence of CHV -1 gB was subsequently determined by
other workers (Limbach et al. 1994). This sequence corresponded to the sequence of
the cloned degenerate primer peR product; it was therefore not considered necessary to
confirm further the identity of the cloned sequence.
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Figure 3.3 Effect of Hot Start on Degenerate Primer peR
Lane
bp
1353
603
310
194
118
72
1 2 3 4 5 6 7
605bp Band
Figure 3.3 Effect of Hot Start on Degenerate Primer peR; Lane lcx/Haelll: Lane 2,
Blank; Lane 3, 1 in 50 virus dilution no hot start, Lane 4, 1 in 50 virus dilution with hot
start; Lane 5 Blank; Lane 6, no template no hot start; Lane 7, no template hot start.
Figure 3.4 Effect of Template on Degenerate Primer peR
Lane 1 5 86 72 3 4
bp
1353
603 605bp band
310
194
118
72
Fig 3.4; Effect of Template on Degenerate Primer PCR. Optimum amplification was
obtained using virus diluted 1 in 50 without NP40 as template. Lane 1, <l>xlHaeIII
Marker; Lane 2, Blank; Lane 3, 1 in 20 virus dilution; Lane 4, 1 in 50 virus dilution;
Lane 5, 1 in 20 virus dilution +NP40; Lane 6, 1 in 50 virus dilution +NP40; Lane 7 &
8, Water Controls.
Figure 3.5 Sequence of Cloned 605bp Band (Without Primers)
GAAAATAATGAACTATTAGTAGAACGAAAGCTAATTGAACCATGTACAGCTAACCATAAA
1 ---------+---------+---------+---------+---------+---------+ 60
E NNE L L V E R K LIE P C TAN H K
AGATATTTTAAATTTGGTGTAGATTATGTATATTTTGAAAACTATGCATATGTTCGAAAG
61 ---------+---------+---------+---------+---------+---------+ 120
R Y F K F G V D Y V Y FEN YAY V R K
GTACCTCTTAATGAAATTGAAATGATCAGTGCATATGTAGATCTTAATATTACATTACTT121 ----- + + + + + + 180
V P L N E I E M I SAY VOL NIT L L
GAGGATCGTGAATTTTTACCACTAGAGGTATATACTCGAGCAGAGTTAGAAGATACAGGA
181 ---------+---------+---------+---------+---------+---------+ 240
E 0 REF L P LEV Y T RAE LED T G
CTATTGGACTATAGTGAGATTCAACGTAGAAATCAACTACATGCACTTAAGTTTTATGAT
241 ---------+---------+---------+---------+---------+---------+ 300
LLD Y S E I Q R R N Q L HAL K F Y 0
ATTGACAGTGTTGTAAAAGTTGATAATAATGTTGTAATTATGAGGGGCATTGCAAATTTT
301 ---------+---------+---------+---------+---------+---------+ 360
IDS v V K VON N V V I M R G I A N F
TTCCAAGGACTTGGAGATGTTGGAGCGGGATTTGGAAAAGTTGTTTTGGGTGCTGCAAAT361 -- + + + + + + 420
F Q G L G D V GAG F G K V V L G A A N
GCTGTTATTGCAACTGTTTCTGGAGTGTCCTCGTTTCTTAATAACCCATTTGGGGCGCTA
421 ---------+---------+---------+---------+---------+---------+ 480
A v I A T V S G V S S F L N N P F GAL
GCCGTTGGATTGCTGATTTTAGCTGGACTATTTGCAGCGTTTTTGGCTTATAGATATGTT
481 ---------+---------+---------+---------+---------+---------+ 540
A V G L L I LAG L F A A F LAY R Y V
TCTAAACTTAAGTCA
541 ---------+----- 555
S K L K S
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Figure 3.6 Alignment of Cloned Sequence with FHV-l
Clone 1 GAAAATAATGAACTATTAGTAGAACGAAAGCT 32
I I I I I I I I II I I I I I II I II II I I I
FHV 1951 ATAGAAGGACAACTAGGGGAAAACAATGACCTTCTCGTGGAACGAAAACT 2000
33 AATTGAACCATGTACAGCTAACCATAAAAGATATTTTAAATTTGGTGTAG 82
I I I I I I I I I I I I I II I II I I I I I II I I I I I II I I I I
2001 AATTGAGCCTTGCACTGTCAATAATAAGCGGTATTTTAAGTTTGGGGCAG 2050
83 ATTATGTATATTTTGAAAACTATGCATATGTTCGAAAGGTACCTCTTAAT 132
I I II I I I II I I I I I I I I I I II I 11111 II I I I I I I II
2051 ATTATGTATATTTTGAGGATTATGCGTATGTCCGTAAAGTCCCGCTATCG 2100
133 GAAATTGAAATGATCAGTGCATATGTAGATCTTAATATTACATTACTTGA 182
I I I I I I I I I II I I I I I I II II II I I I II I III I I I I I
2101 GAGATAGAACTGATAAGTGCGTATGTGGATTTAAATCTTACTCTCCTAGA 2150
183 GGATCGTGAATTTTTACCACTAGAGGTATATACTCGAGCAGAGTTAGAAG 232
1111111111111 I 11111 II II 11111 11111 III I 1111
2151 GGATCGTGAATTTCTCCCACTCGAAGTTTATACACGAGCTGAGCTGGAAG 2200
233 ATACAGGACTATTGGACTATAGTGAGATTCAACGTAGAAATCAACTACAT 282
I I II I I I I I I I I I I I I I I I II I II II I II I I I I II II II
2201 ATACCGGCCTTTTGGACTACAGCGAGATTCAACGGCGCAACCAACTCCAC 2250
283 GCACTTAAGTTTTATGATATTGACAGTGTTGTAAAAGTTGATAATAATGT 332
II I II 11111111111 11111 I II I III 111111111 I
2251 GCCTTAAAATTTTATGATATAGACAGCATAGTCAGAGTGGATAATAATCT 2300
333 TGTAATTATGAGGGGCATTGCAAATTTTTTCCAAGGACTTGGAGATGTTG 382
III II III I II II 11111111111 II 11111 II 11111 I
2301 TGTCATCATGCGTGGTATGGCAAATTTTTTTCAGGGACTCGGGGATGTGG 2350
383 GAGCGGGATTTGGAAAAGTTGTTTTGGGTGCTGCAAATGCTGTTATTGCA 432
I II II II II II II II II II 11111 I III II II II
2351 GGGCTGGTTTCGGCAAGGTGGTCTTAGGGGCTGCGAGTGCGGTAATCTCA 2400
433 ACTGTTTCTGGAGTGTCCTCGTTTCTTAATAACCCATTTGGGGCGCTAGC 482
II II II II II II II 11111 II 11111111111 II I II
2401 ACAGTATCAGGCGTATCATCATTTCTAAACAACCCATTTGGAGCATTGGC 2450
483 CGTTGGATTGCTGATTTTAGCTGGACTATTTGCAGCGTTTTTGGCTTATA 532
III III 11 I 11 11111111 I I 11111 II 1111 III
2451 CGTGGGACTGTTAATATTAGCTGGCATCGTCGCAGCATTCCTGGCATATC 2500
533 GATATGTTTCTAAACTTAAGTCA 555
I III I 1111 I I II
2501 GCTATATATCTAGATTACGTGCAAATCCAATGAAAGCCTTATATCCTGTG 2550
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3.4 DISCUSSION
Degenerate primer polymerase chain reaction was used successfully to amplify a
region of the glycoprotein B gene of CHV -1 for which there had been no previously
published sequence.
Analysis of DNA sequence is increasingly recognised as the gold standard both
for identification of novel viral agents(Fredricks and ReIman, 1996), and the definitive
classification of new and existing viruses into families and sub-families. The partial
sequence of CHV -1 gB obtained in these experiments, together with the subsequent
publication of the sequence of the thymidine kinase gene(Remond et al. 1995; Xuan et
al. 1996), and the entire Ur. portion of the CHV -1 genome(Remond et af. 1996), have
therefore allowed CHV -1 to be placed firmly in the alphaherpesvirinae sub-family and
the genus Varicellovirus.
Based on the sequence of gB, gC, gD(Limbach et al. 1994), and the thymidine
kinase gene, CHV -I is closely related to FHV -1, and confirms earlier work suggesting
that the two viruses share a number of epitopes(Limcumpao et al. 1990). A degenerate
primer strategy has also been used to obtain part of the sequence of the PhHV -1 gB and
gO genes; CHV -1 appears to be the most closely related virus to PhHV -l on the basis of
this sequence data(Harder et al. 1996).
The high degree of homology between the entire gB amino acid sequences of
CHV-l and FHV-l (78%) is of particular interest given the identification a number of
years ago of an 'FHV -1 like' isolate of a herpesvirus from dogs(Evermann et al. 1982).
Given the degree of homology between CHV-l and FHV-I, and the knowledge that the
two viruses share at least some antigenic epitopes, the possibility has to be considered
that certain strains of each virus might be able to cross the species barrier. While it is an
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intriguing possibility that a strain of FHV -1 may have infected a nwnber of dogs, the
lack of further publications on the subject, and the absence of reliable infection study
data raises some questions as to the validity of the original findings.
It is also interesting to speculate on the basis of these homologies about the
evolutionary relationship between the various herpesviruses and their respective host
species. CHV -1 appears to show greatest homology to those viruses (FHV -1 and
PhHV -1) which infect host species that are fairly closely related to the dog. It may
therefore be the case that these viruses share a common ancestor, divergence occurring
at roughly the same time as the divergence of the host species that they now infect.
Indeed, it has been suggested that all mammalian herpesviruses are derived from a
progenitor herpesvirus similar to HHV -6; and that the alpha sub-family of
herpesviruses, due to their limited divergence, are of relatively recent ancestry, with an
EHV -1 like virus the possible progenitor alphaherpesvirus(Karlin et al. 1994). It is not
possible to rule out a more recent jwnp from one host to another, as is believed to have
occurred with canine parvovirus(Johnson and Spadbrow, 1979), although this is perhaps
made less likely by the relative stability of the herpesvirus genome in comparison to that
of some of the other viral families. Additional support for the concept of cospeciation
of host and parasite for most of the alphaherpesviruses is provided by the marked
similarity between the herpesvirus and host phylogenetic trees (McGeoch and Cook,
1994).
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CHAPTER4
DETECTION OF CHV-1 DNA IN CANINE TISSUES By THE
POLYMERASE CHAIN REACTION
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4.1 INTRODUCTION
Canine Herpesvirus 1 (CHV-l) is a member of the Herpesviridae family, and has
been placed in the alphaherpesvirinae sub-family, originally on the basis of its biological
properties (Fenner et al. 1993), but more recently on the basis of sequence information
and genomic organisation (McGeoch and Cook, 1994). It is believed to be restricted in
host range to members of the Canidae family. The virus is commonly associated with
two clinical syndromes; an acute and generally fatal widespread infection in puppies less
than four weeks of age (Appel, 1987), and localised mucosal (Kraft et al. 1986) or
genital lesions in adult dogs (Hill and Mare, 1974). It has also been reported that CHV-
1 is associated with infertility, abortion and stillbirths, and that vesicular lesions
observed in adult dogs appear similar to the lesions caused by Herpes Simplex in man
(Poste and King, 1971).
A typical characteristic of herpes viruses is their ability to cause lifelong latent
infections following the initial acute stage of the disease (Roizman et al. 1992).
Following corticosteroid administration, CHV -1 has been isolated from nasal, oral,
vaginal and ocular secretions of naturally infected dogs. In the same study, virus was
also isolated from nasal mucosa and tonsilar tissue of a single bitch at post mortem
(Okuda et al. 1993). No further detailed information on naturally occurring latent CHV-
1 infection is available however.
Little is known about the prevalence or significance of CHV -I in the general
population. In a study looking at canine respiratory tract infections, 6 out of 100 dogs
had serum antibody at significant titre to the virus (Fulton et al. 1974). Due to the
nature of latent herpesvirus infections however, and the tendency for antibodies to
CHV -1 to persist for no more than sixty days (Evermann, 1989), it is unlikely that an
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accurate assessment of the true level of CHV -1 latency would be obtained by this
method.
Identification of CHV -1 infection has previously relied on either direct virus
isolation from swabs and tissues or serological studies. In vitro amplification of viral
genomic sequence using the Polymerase Chain Reaction (PCR) has been used
successfully to identify herpesvirus infections in various different species (Ballagi-
Pordany et al. 1990; Jestin et al. 1990; Nahass et al. 1995). peR has the potential for a
considerable increase in sensitivity over the methods previously used to identify CHV-I
infection, and may therefore give a much fuller picture of the nature and extent of virus
within the population, and also some indication as to which tissues might harbour latent
VIrus.
This chapter presents the first use of PCR to examine canine tissues for the
presence of CHV -1 DNA, and thus attempts to provide some answers to key questions
regarding the nature and extent of CHV -1 infection in the dog.
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4.2 MATERIALS AND METHODS
4.2.1 Preparation of Viral DNA
In order to prepare CHV-I DNA, confluent monolayers ofMDCK cells were
infected with virus at a m.o.i. of approximately 1:1. Infection was allowed to proceed
for 24 hours, and viral DNA extracted according to the method described by Hirt (Hirt,
1967). Extracted DNA was separated by size on a Field Inversion Gel Electrophoresis
system (FIGE Mapper, Biorad), and the size of the genome estimated by comparison to
a known standard.
4.2.2 Sample Preparation
Tissue Samples
A selection of tissues were taken from twelve adult ( > 8 years) dogs at post
mortem. Dogs were euthanased for a variety of reasons, including old age, liver or
kidney failure, and neoplasia. Up to six 3mm3 pieces of each tissue were collected and
stored at -70°C until processed. Two alternative methods were used to extract DNA for
PCR from each tissue, the first method was based on a modification of the
manufacturer's protocols for the product:
Method1;
A piece of tissue was sliced on a fresh glass slide using a fresh scalpel blade and placed
in a sterile 1.5mL screw cap eppendorf. One mL of Trypsin/EDT A solution (Gibco)
was then added and the tissue incubated at room temperaure for 30', with occassional
shaking. Tissue was pelleted by centrifugation (13K, 2-3'), and all supernatant carefully
removed. 250).lL of Instagene suspension (Biorad Laboratories) was then added to the
eppendorf, mixed, and incubated at 56°C for 30'. The tube was then vortexed for 10
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seconds, and placed in a boiling water bath or 100°C heat block for 8', then vortexed for
a second time before centrifugation at 13K for 2-3 minutes. 20llL of the resulting
supernatant was used as template for each PCR (Burr, 1995).
Method 2;
The second method of DNA preparation used a commercial kit (Micro- Turbogen Kit,
Invitrogen BV) according to the Manufacturer's protocols.
Blood samples
Two mL of blood was taken from twenty-five canine samples submitted to the
department for routine haematology. DNA was extracted from these samples using a
commercial kit as directed in the Manufacturer's protocols (Turbogen, Invitrogen BY).
4.2.3 Conventional Primer DNA Amplification
Conventional PCR primers were designed with the assistance of the primer
analysis software in Oligo 4.1 (Medprobe A.S. (Rychlik, 1991)).
Positive control primers for exon 7 of the canine pancreatic lipase gene(Mickel
et al. 1989) were designed and synthesised in order to show that the chosen methods of
tissue preparation yielded PCR compatible DNA.
Upstream (Sense) Primer
Downstream (Anti-sense )Primer
5'-GGTTGGATCCTGTAGAAGCA-3'
5'-CCAGGAATGGGATCAGGGGA-3'
The expected product size for these primers was 120bp. All preparations of
DNA were tested for PCR compatibility using these primers. Amplification was carried
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out using 2 Units AmpliTaq DNA polymerase (Perkin-Elmer) mixed with an equal
volume of TaqStart antibody (Clontech) per reaction in a total reaction volume of 50,....L,
containing 50pmol each primer and 200J..U1l011Lof each deoxynucleoside triphosphate in
10mM Tris (PH 8.4), 50mM KCI, and 1.5mM MgCh. Thermal Cycling was performed
on a Perkin-Elmer 9600; Initial Denaturation 94°C, 5 minutes, followed by 40 cycles of
94°C for 30 seconds, 57.5°C 1 minute, then a final extend of 72°C for 7 minutes.
Conventional PCR Primers were also designed to amplify a short portion of
CHV -1 gB using the sequence obtained from the experiments described in chapter 3.
Upstream (sense) Primer
Downstream (anti-sense) Primer
5'-CAGGACTATTGGACTATAGT-3'
5'-TTGCAATGCCCCTCATAATT-3'
The expected product size for these primers was also 120bp. PCR was
optimised for Primer and Magnesium concentration, and the sensitivity of the reaction
assessed by spiking viral DNA into placental DNA or sheep blood. Amplification was
carried out using 2 Units AmpliTaq DNA polymerase (Perkin-Elmer) mixed with an
equal volume of TaqStart antibody (Clontech) per reaction in a total reaction volume of
50,....L,containing 50pmol each primer and 200llffiOlIL of each deoxynucleoside
triphosphate (substituting dUTP for dTTP in all reactions), in 10mM Tris (PH 8.4),
50mM KCI, and 1.5mM MgCh. 20,....Lof template was added to each reaction for
InstaGene preparations of tissues, and 10,....Lof template for Micro- Turbogen and
Turbogen preparations of tissue and blood. Thermal Cycling was performed on a
Perkin-Elmer 9600; with an initial denaturation step at 94°C for 5 minutes, annealing at
57.5°C for 60s, followed by denaturation at 94°C for 30s for a total of 40 cycles.
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Multiple negative controls (blank tubes left open throughout DNA preparation, and A72
cell line DNA prepared by method 1 or 2 as appropriate) were used in each batch of
reactions. Uracil-N-Glycosylase (Perkin-Elmer) was added to the master mix of
reactions where template was prepared with Micro- Turbogen and Turbogen kits to
eliminate the possibility of product carry over (Longo et al. 1995). The positive control
for each batch of reactions was 100fg of viral DNA.
4.2.4 Analysis of Conventional peR Product
IOul, of PCR product was run on a 7.5% Acrylamide gel and visualised by
staining with Ethidium Bromide and all gels electro-blotted (Mini-Trans Blot Cell, Bio-
Rad Laboratories) onto nylon membranes (Hybond-N, Amersham). Membranes were
probed with a 30mer y32P end-labelled oligonucleotide probe specific for the amplified
fragment of CHV -1 gB.
Probe: 5' -ATGATATTGACAGTGTTGTAAAAGTTGATA-3'.
Hybridisation was carried out for 2-3 hours at 55°C, followed by 2 washes of 5' at room
temperature and 2 washes for 30' at 60°C (all washes in 6 x SSe/O.1 % SOS). Signals
were detected by autoradiography.
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4.3 RESULTS
4.3.1 Preparation of Viral DNA
DNA extracted from infected cell cultures was dissolved in sterile water, and the
concentration of DNA estimated by measurement of adsorbance at 260nm.
Approximately Sug of the prepared DNA was run on a FlOE gel against a known
standard (Figure 4.1). The viral genome was assessed as being of about 120kbp in size;
some cellular DNA was also evident on the gel.
4.3.2 Assessment of DNA preparations by Pancreatic Lipase peR
All DNA preparations were tested for peR compatibility using primers for exon
7 of the canine pancreatic lipase gene. Following amplification, products were run on
7.5% acrylamide gels and visualised by staining with Ethidium Bromide. DNA
preparations were considered peR compatible and used in subsequent experiments if a
bright band of the correct size (l20bp) was apparent (Figure 4.2).
4.3.3 Assessment of sensitivity of diagnostic peR
Conventional primers were designed from the CHV -1 gB sequence obtained by
degenerate primer peR as described in the previous chapter, and used to screen for viral
DNA in a diagnostic peR. The conventional primer set was first optimised for
Magnesium and Primer concentration. Sensitivity of the PCR was assessed by spiking
viral DNA into placental DNA, and by spiking viral DNA into 2mL of sheep blood prior
to preparation using the Turbogen kit. After amplification, reaction products were run
on acrylamide gels and blotted onto Nylon membranes: use of oligonucleotide probes to
confirm sensitivity and
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Figure 4.1 FIGE Gel ofCHV-1 DNA isolates
Lane 1 2 3
194
Viral DNA
Band
Molecular
weight (kB)
145
97
48.5
Lane 1, Low range PFG high molecular weight marker (New England Biolabs);
Lanes 2 & 3, Viral DNA prepared according to method ofHirt (undigested,
approximately 5ug DNA in each lane).
Figure 4.2 Assessment of DNA preparations by Pancreatic Lipase peR
bp
1353
310
194
118
72
Lane: 1 2 3 4 5 6 7 8 9 10 11 12 13 14
+- 120bp Band
Fig.4.2; Analysis ofPCR Product from Pancreatic Lipase PCR using template prepared
from various tissues with InstaGene Matrix (DNA preparation method 1).
Lane 1: $x Marker, Lane 2-14 IOf..lLof PCR product from reactions using the following
templates; Lane 2: Tri-Geminal Ganglion, 3: Lumbo-Sacral Ganglion, 4: Brain, 5:
Mesenteric Lymph Node, 6: Sub-Mandibular Lymph Node, 7: Tonsil, 8: Sub-
Mandibular Salivary Gland, 9: Parotid Salivary Gland, 10: Spleen, 11: Liver, 12:
Kidney, 13: A72 Canine Fibroblast Cell Line (Standard Instagene Protocol), 14: Water.
specificity ofPCR has been shown to be a useful and reliable technique (Ballagi-
Pordany et al. 1990). It was possible to detect 1fg of viral DNA spiked into lug of
placental DNA (Figure 4.3A), and 250fg of DNA spiked into 2mL of sheep blood
(Figure 4.3B). The oligonucleotide probe was both highly sensitive and specific, failing
to hybridise to canine and human control DNA, or the molecular weight marker, under
the conditions used. The existence of multiple bands on all the blots is typical for blots
from PCR products, and is likely to be due to anomalous migration of single stranded
product and incompletely amplified fragments, to which the probe will hybridise. The
size of the viral genome had been previously estimated at approximately 120kbp; 1fg of
pure viral DNA would therefore correspond to approximately fourteen copies of viral
genome.
4.3.4 Screening of tissue and blood samples by diagnostic peR
The diagnostic PCR was then applied to the prepared samples of canine tissues
and blood. Multiple negative controls were incorporated in each batch of reactions;
there were no instances of positive reactions in negative control tubes throughout the
entire series of reactions.
Duplicate PCR's were carried out for each sample tissue under test and each
sample preparation method. In reactions where samples were prepared using Micro-
Turbogen, approximately five times the amount of DNA would be added to each PCR,
in comparison to InstaGene template preparation. An example of the results obtained
from the tissues of one dog by Ethidium Bromide staining of the acrylamide gel (Fig
4.4a) and subsequent probing of the Electro-Blot are shown (Fig 4.4b) (tissues prepared
using Micro-Turbogen), The results for all twelve dogs (Post Mortem Samples) are
summarised in Table 4.1; these results use
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Figure 4.3 Assesment of Sensitivity of diagnostic peR
CA)Spiking of viral DNA into Human Placental DNA
Lane 1 2 3 4 5 6 7 8
1120bp Band I
CB)Spiking of viral DNA into Sheep Blood
Lane 1 2 3 4 5 6 7 8
Fig. 4.3a + b; Autoradiograph of Southern Blots probed with CHV-1 Oligo following
electrophoresis ofPCRproducts from sensitivity assays. (A) Titration of Viral DNA
into lug Placental DNA; Lane 1, 10pg Viral DNA; Lane 2, 1pg Viral DNA; Lane 3,
O.lpg Viral DNA; Lane 4, 10fg Viral DNA; Lane 5, lfg Viral DNA; Lane 6, Blank;
Lane 7,8, Negative Controls. (B) Titration of Viral DNA into 2mL Sheep Blood; Lane
1, 250ng Viral DNA; Lane 2, 2.5ng Viral DNA; Lane 3, 25pg Viral DNA; Lane 4,
250fg Viral DNA; Lane 5, 25fg Viral DNA; Lane 6, Sheep Blood DNA only; Lane 7,8,
Negative Controls.
Figure 4.4 Typical Results of Diagnostic PCR on Canine Tissues
(A) Ethidium Bromide Staining of Acrylamide Gels
Lane 2 3 4 5 6 7 8 9 10
bp
1353
310
194
118 +- 120bp
72 Rand
1078
310
118
Lane 11 12 13 14 15 16 17 18 19 20
bp
+- 120bp
Rand
194
72
Fig 4.4A Ethidium Bromide Staining of Acrylamide Gels; Lane 1, ~xlHaeIII Marker; Lane 2,
Tri-Geminal Ganglion; Lane 3, Lumbo-Sacral Ganglion; Lane 4, Brainstem; Lane 5, Mesenteric
Lymph Node; Lane 6, Sub-Mandibular Lymph Node; Lane 7, Tonsil; Lane 8, Sub-Mandibular
Salivary Gland; Lane 9, Parotid Salivary Gland; Lane 10, Positive control; Lane 11, ~xlHaeIlI
Marker; Lane 12, Spleen; Lane 13, Liver; Lane 14, Kidney; Lane 15-19, Negative Controls;
Lane 20, Positive Control.
(B) Southern Blots of Figure 4A gels probed with CHV-l Oligo
Lane 1 2 3 4 5 6 7 8 9 10
Lane 11 12 13 14 15 16 17 18 19 20
+--1120bp
Fig 4.4B Autoradiographs of Southern Blot of figure 4A gels probed with CHV-l
Oligo; Lane 1, $x!HaeIII Marker; Lane 2, Tri-Geminal Ganglion; Lane 3, Lumbo-
Sacral Ganglion; Lane 4, Brainstem; Lane 5, Mesenteric Lymph Node; Lane 6, Sub-
Mandibular Lymph Node; Lane 7, Tonsil; Lane 8, Sub-Mandibular Salivary Gland;
Lane 9, Parotid Salivary Gland; Lane 10, Positive control; Lane 11, ex/Haeltl Marker;
Lane 12, Spleen; Lane 13, Liver; Lane 14, Kidney; Lane 15-19, Negative Controls;
Lane 20, Positive Control
Table 4.1; Summary of PeR results on Canine Tissues.
Dog no. 1 2 3 4 5 6 7 8 9 10 11 12 Overall Proportion
TGG - + + 2112
LSG + + + + + 5/12
SS ne ne ne + - + 219
MLN - + 1/12
SMLN + + + (-) (-) 3112
TON + (-) (+) (-) + - (+) + 5112
SMSG + + - + + 4/12
PSG ne ne ne + + + + 4/9
SPL + 1/12
LlV ne ne ne + + + + 4/9
KID ne ne ne + 1/9
ne = not collected.
Bracketed results refer to samples where Micro- Turbogen Kit failed to yield peR compatible DNA and
therefore results rely on Instagene Preparation of DNA alone.
TGG -Tri-Geminal Ganglion, LSG - Lumbo-Sacral Ganglion, BS - Brainstern, MLN -Mesenteric Lymph
Node, SMLN - Sub-Mandibular Lymph Node, TON - Tonsil, SMSG - Sub-Mandibular Salivary Gland,
PSG - Parotid Salivary Gland, SPL - Spleen, LlV - Liver, KID -Kidney.
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mainly the data from sample preparation using the Micro- Turbogen kit. The results
from sample preparation using Instagene were similar, but not all tissues that tested
positive following Micro- Turbogen preparations were positive following Instagene
preparations; the most likely explanation of this is the difference in amount of template
added to the PCR for the different preparation methods. The tissues most commonly
positive for viral genome were Lurnbo-Sacral Ganglion, Tonsil, Parotid Salivary Gland,
and Liver. Overall, 9 out of the 12 dogs tested showed some evidence of CHV-l
genome in their tissues.
All 24 blood samples were negative for CHV -1 in duplicate reactions by both
Ethidium Bromide Staining ofacrylamide gel, and CHV-l Probe (Results not shown).
We were able to detect 250fg of viral DNA (3500 copies of viral genome) in 2mL of
blood in the sensitivity assay. 2mL of canine blood would be expected to contain 7.J x
106Mononuclear cells, therefore these results indicate that there is likely to be less than
1 copy of viral genome per 2000 mononuclear cells in the 24 blood samples tested.
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4.4 DISCUSSION
The Polymerase Chain Reaction has been used successfully to detect a number
of animal viruses (Belak and Ballagi-Pordany, 1993). PCR is of particular use in
studying the presence of latent herpesviruses (Maes et al. 1990; Welch et al. 1992)
where conventional techniques for detecting virus may not be sufficiently sensitive to
detect the low copy numbers of viral genome present. Studies using PCR have often
shown that latent herpesviruses are both more prevalent than previously believed
(Edington et al. 1994; Pedneault and Katz, 1993), and also distributed within a wider
range of tissues within each individual host (Reubel et al. 1993). PCR is also being
used to shed light on the actual mechanisms of latency for other herpesviruses, in
particular Herpes Simplex(Ramakrishnan et al. 1994; Tanaka et al. 1994), by analysis of
the viral specific mRNA's produced during the maintenance of latency.
One of the most interesting features of the results obtained, is that 9 out of 12
dogs showed some evidence of latent CHV -1 at Post Mortem. This is in marked
contrast to previous estimates of prevalence ofCHV-l based on serology. While it is
not possible to claim that this sample of twelve animals is truly representative, the
results do suggest that CHV -1 is much more common than previously suspected. It has
in the past been argued that the relatively small number of puppies affected by neonatal
CHV -1 infection indicates that CHV -1 must be uncommon in the general population.
An alternative hypothesis is that high levels of maternal antibody, and prevention of
hypothermia, are capable of protecting puppies from the clinical consequences of
neonatal CHV -1 infection (Kraft et al. 1986). The results of our study would tend to
make the latter hypothesis the more likely explanation.
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The tissues selected for analysis in this study were believed to have a reasonable
chance of containing latent virus; based on the tissues known to be affected in the
neonate, the suspected mode of transmission of the virus, and studies on other
alphaherpesviruses. The concept that some alphaherpesviruses are latent in neural
tissues and others in lymphoid tissues has been thrown into question by results showing
herpes simplex in blood and bone marrow(Cantin et al. 1994), and equine herpesvirus 1
in the tri-geminal ganglion(Slater et al. 1994). We have found strong evidence of CHV -
1 genome in both neural and lymphoid tissues.
The tissues found to be most commonly affected in this study reflect closely the
likely modes of transmission of the virus, and the sites from which whole virus has
previously been isolated in adult dogs. The Lurnbo-Sacral Ganglion would appear to be
an important site of latency, and a possible source of recrudescent virus in venereal
infections. The frequent finding of viral DNA in Tonsil and Parotid Salivary gland
suggest that oronasal spread of virus may well be an important mode of transmission. It
is clear that in puppies, CHV -I is able to spread throughout the body, causing
haemorrhagic necrosis in many different organs and tissue types (Love and Huxtable,
1976). This is reflected in the wide range of tissues in which viral DNA was found in
this study, and in particular the frequent finding of viral genome within the liver.
It is possible that some of the negative results obtained from tissue samples are
due to failure to sample a localised area of infection within an organ, or may reflect very
low copy numbers of viral genome in some latently infected tissues. The level of CHV-
1 infection described may therefore be an under-estimate.
We failed to detect latent CHV-I within the blood using this assay. While this
does not prove that CHV -1 is totally absent from peripheral blood, it suggests that
infected cells must be quite rare ( less than 1 copy of viral genome per 2000
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mononuclear cells). This is similar to the situation for other alphaherpesviruses: in a
study on equine herpesvirus 4, a minimum of 5 x 105 Peripheral Blood Mononuclear
Cells were needed in the PCR to obtain a positive result during the latent phase of
infection (Sharma, 1994).
It has been suggested previously that CHV -1 would cause lifelong latency
following inapparent infection of older dogs (Anvik, 1991). Our results confirm that
latent CHV -1 infection is relatively common within the canine population. Latent
Herpes Simplex is implicated in a variety of clinical syndromes in man (Whitley, 1990),
and in the light of these findings, the clinical importance of CHV -1 in adult dogs may
need to be re-assessed.
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CHAPTER5
A DEGENERATE PRIMER POLYMERASE CHAIN REACTION
STRATEGY To SEARCH FOR GAMMAHERPESVIRUS SEQUENCES
IN CANINE LYMPHOMA
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5.1 INTRODUCTION
Lymphoma is one of the most common neoplasms of the dog, and probably the
most common neoplasm of the canine haemolymphatic system. It is similar in at least
some respects to certain types of human non-Hodgkin's lymphoma. Despite these facts,
canine lymphoma remains relatively poorly studied, particularly at the molecular level.
There is a clear association between viruses and tumours of the haemolymphatic
system in a number of other species, but a predominant cause for canine lymphoma,
viral or non-viral, has not yet been determined. Sporadic reports of the isolation of
retroviruses from various canine lymphomas and leukemias have never been confirmed
satisfactorarily and it seems likely that these reports resulted from endogenous retoviral
elements in the canine genome, or contamination of tissue culture by viruses of other
species.
The dog is unusual in that only a single member of the herpesvirus family has as
yet been characterised from this species. Interestingly, garnrnaherpesvirus sequences
have recently been identified in European and American seals, species which also have
the most closely related alphaherpesvirus to the known canine alphaherpesvirus (Harder
et aI, 1996).
The two human gammaherpesviruses, EBV and HHV -8, are both involved in
certain types of human lymphoma. It therefore would be plausible to suggest that if a
canine gammaherpesvirus exists, it might be involved in certain types of canine
lymphoma. Alternatively, even if the putative canine gammaherpesvirus were not
causally associated with lymphoma, the immunosuppression that may feature in some
cases of lymphoma might permit an increased viral load in the dog's tissues, and aid the
detection of any such virus.
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A degenerate primer polymerase chain reaction (technique reviewed in chapters
1& 3) was therefore designed to amplify part of the gB gene of any gammaherpesvirus.
This degenerate primer system was used to analyse a number of tissues from cases of
canine lymphoma for the presence of gamma-herpesvirus sequences.
97
5.2 MATERIALS AND METHODS
5.2.1. Design of Degenerate Primers
Degenerate primers were designed to amplify a portion of the gB gene of any
gammaherpesvirus based on an alignment of the amino acid sequence of five different
gammaherpesvirus gB sequences. All sequences were obtained from the viral database
of GenBank, and the alignments carried out using pileup from the sequence analysis
software programs from the Genetics Computers Group of the University of Wisconsin
(Devereux et al. 1984) (Figure 5.1). A number of conserved sites were identified on
examination of the alignment of the known gB sequences. Two areas of consensus
amino acid sequence were selected as the basis for the design of degenerate primers
corresponding to positions 519-523 and 719-723 in the alignment, and degenerate
primers designed by back translation from the amino acid code to include all possible
codons in the conserved areas of sequence (Figure 5.2). The two conserved regions
chosen were selected as they were approximately 200 amino acids apart (to give a PCR
product of about 600bp), and because many of the amino acids at these positions
included residues with lower numbers of possible codons, thus minimising the
degeneracy of the final primers. The expected size of the PCR product using these
primers was 632bp.
5.2.2 Collection of Lymphoma Samples
A variety of tissue samples were collected from dogs that were diagnosed as having
lymphoma. Samples included a variety of tissues taken at Post Mortem from dogs that
had been euthanased, lymph node biopsy specimens, and a number of blood samples.
Diagnosis was confirmed for Post Mortem samples and lymph node biopsies by
histopathology, or by
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Figure 5.1 Alignments of the Amino Acid Sequence of the Glycoprotein B genes of
Five Gatnmllherpesviruses
Alignment was prepared using the pileup programme with a GapWeight of
3.0 and a Gap Length Weight of 0.1, alignment is shown between amino
acids 501 and 800.
BHV-4
HVS
MuHV-68
EHV-2
EBV
BHV-4
HVS
MuHV-68
EHV-2
EBV
BHV-4
HVS
MuHV-68
EHV-2
EBV
BHV-4
HVS
MuHV-68
EHV-2
EBV
BHV-4
HVS
MuHV-68
EHV-2
EBV
BHV-4
HVS
MuHV-68
EHV-2
EBV
501
..DTKTFQGA
·.RDVSAGSE
·.SEVSKGSE
·.NGDNSTKE
TAPGKSLGTL
---+KGLSTAQVQY AYDHLRTSMN
NNVFLSQIQY AYDKLRQSIN
NPLITAQIQF AYDKLTTSVN
ESVAASQVQF AYDNLRKSIN
NNPATVQIQF AYDSLRRQIN
HILEELTKTW
NVLEELAITW
NVLEELSRAW
RVLGELSRAW
RMLGDLARAW
550
CREQKKDNLM
CREQVRQTMV
CREQVRDTLM
CREQYRASLM
CLEQKRQNMV
600
ASVNIHKSMR
SSVSIHKSLK
SSVNIHQSLR
KSVFVHKNMK
ATVTLRKSMR
650
HVETCRPTAD
LVENCHQNAE
NIETCKDESE
QVEVCQHSCE
MTEVCQATSQ
----700
DNIDFKTVEL
ENIDFKAVEL
ENIDFKTVEL
ENIDFKVIEL
ENIDFASLEL
750
DLNRDRLVKD
RNNRDRIIQD
DYNRDRLVQD
DHGRDSFIQT
SNGRNQFVDG
800
IGGVTIILLL
LGGMFTFLLI
LGGI FILLl 1
FGGMLLIVLI
FGGMLILVLV
BHV-4, bovine herpesvirus 4; HVS, herpesvirus saimiri; MuHV-68, murine herpesvirus 68; EHV-2.
equine herpesvirus 2; EBV, Epstein-Barr virus.
The position of the consensus areas of sequence used to design the degenerate primers is marked by
arrows, (5' primer based on amino acids 519-523, 3' primer on amino acids 719-723), and the position of
the degenerate probe consensus sequence by solid lines (amino acids 690-695).
551 ---+
WYELSKINPV SVMAAIYGKP VAVKAMGDAF MVSECINVDQ
WYEIAKINPT SVMTAIYGKP VSRKALGDVI SVTECINVDQ
WYELSKVNPT SVMSAIYGKP VAARYVGDAI SVTDCIYVDQ
WYELSKINPT SVMSAIYGRP VSAKLIGDVV SVSDCISVDQ
LRELTKINPT TVMSSIYGKA VAAKRLGDVI SVSQCVPVNQ
601
TDDPK.VCYS RPLVTFKFVN STATFRGQLG TRNEILLTNT
TENND.ICYS RPPVTFKFVN SSQLFKGQLG ARNEILLSES
LQHDKTTCYS RPRVTFKFIN STDPLTGQLG PRKEIILSNT
VPGKEDLCYT RPVVGFKFIN GSELFAGQLG PRNEIVLSTS
VPGSETMCYS RPLVSFSFIN DTKTYEGQLG TDNEIFLTKK
651
HYFFVKNMTH YFKDYKFVKT MDTNNISTLD TFLTLNLTFI
TFFTAKNETY HFKNYVHVET LPVNNISTLD TFLALNLTFI
HYFIVGEYIY YYKNYIFEEK LNLSSIATLD TFIALNISFI
HYFQAGNQMY KYKDYYYVST LNLTDIPTLH TMITLNLSLV
YYFQSGNEIH VYNDYHHFKT IELDGIATLQ TFISLNTSLI
701
YSETERKMA.
YSSGERKLA.
YSSTERKLAS
YSKTEKRL.S
YSRDEQR.AS
-SALDLETMFR EYNYYTQKLA SLREDLDNTINVFDLETMFR EYNYYAQSIS GLRKDFDNSQ
SVFDIESMFR EYNYYTYSLA GIKKDLDNTI
NVFDIETMFR EYNYYTQNLN GLRKDLDDSl
NVFDLEGIFR EYNFQAQNIA GLRKDLDNAV-751LSEMMADLGD IGKVVVNTFS GIVTVFGSIV GGFVSFFTNP
FSEILADLGS IGKVIVNVAS GAFSLFGGIV TGILNFIKNP
LSDMMADLGD IGRSVVNVVS SVVTFFSSIV TGFIKFFTNP
LGDIMQDLGT IGKVVVNVAS GVFSLFGSIV SGVISFFKNP
LGELMDSLGS VGQSITNLVS TVGGLFSSLV SGFISFFKNP
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Figure 5.2 Design of Gammaherpesvirus Degenerate Primers and Probe
Gammaherpesvirus degenerate primers;
Antisense Primer; 64 fold degenerate, 3' Phenylalanine residue at position 827 in
line-up of all known gB sequences. 25 nucleotides including EcoR 1 restriction site and
anchor.
5' 3'
Anchor EcoRl N y E R F
GC ATCGAATTC TT ATA TTC TCG AAA
G C C T G
A
G
Degeneracy: 2x 2x 4 x 2 x 2 = 64.
Sense Primer; 64 fold degenerate, 5' Glutamine residue at position 620 in line-up
of all known g8 sequences. 25 nucleotides total including HindIII restriction site and
anchor.
5' 3'
Anchor HindlII Q FN A y D
GC TCAAAGCTT CAA TIT GCT TAT GA
G AC C C
A
G
Degeneracy: 2x 2x2x 4x 2 =64.
Expected size of Amplification product: 632 base pairs.
Gammaherpesvirus degenerate probe;
5' 3'
IIV DIE N I D F
ATT GAT AAT ATT GAT TT
GC C C C C
A A A
G G
Degeneracy: 4x2 x 4 x 2 x 3 x 2 = 384
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cytology of fine needle aspirates where these were not available. Tissue samples were
stored at -70oe prior to DNA preparation, DNA from blood samples was prepared on
the day of collection. Details of each case, the samples collected, and the method for the
confirmation of each diagnosis, are presented in Table 5. I.
5.2.3 Preparation of DNA from Lymphoma Samples
DNA was prepared from all types of samples using a commercial kit (Turbogen,
Invitrogen BY) according to the manufacturer's protocols. Extracted DNA was
dissolved in a small volume of autoclaved ultra-pure water and the concentration of the
sample measured by measuring the adsorbance at 260nm. All DNA samples were
adjusted to a concentration ofO.IJ.Lg/J.LLand stored at -20oe until required.
All DNA samples were tested for peR compatibility using the primers for the
canine pancreatic lipase gene described in the previous chapter, incorporating I.OJ.lg
(1OJ.lL)of template into each reaction.
5.2.4 Optimisation of Degenerate Primer Polymerase Chain Reaction
InitiaI experiments were designed to optimise the reaction conditions for the
generation of specific gammaherpesvirus product. All optimisation reactions were
performed using IOOngoflymphoblastoid cell line (LeL) DNA as the template. The
key steps in this process of optimisation are described.
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Table 5.1 Clinical Details oj Lymphomtl Cases
Sample Case No. Age Sex Breed Lymphoma Chemotherapy Diagnosis
(years) Type (before
sample)
A 126248 6 M Boxer Alimentary yes histopathology
B 126342 9 F Cross- Multicentric no histopathology
Breed
C PM only 7 M Doberman Multicentric no histopathology
D 126860 5 FN Cross- Multicentric no cytology
Breed
E PM only 8 MN Cross- Multicentric no histopathology
Breed ---_-F 127010 4 F Labrador Thymic no histopathology
Retriever
G 127101 11 FN Cross- Multicentric no histopatholoQy
Breed
H 127170 10 M Cross- Multicentric no histopathology
Breed
J 126786 6 M Cross- Cutaneous no cytology
Breed
K 127494 7 F Cross- Multicentric no histopathology
Breed
-.--.-L 122461 8 F Cross- Multicentric no cytology
Breed
-----M PM only 7 M Boxer Multicentric no histopathology
--"-N 127680 12 FN Golden Cutaneous: no histopathology
Retriever
0 -----127812 2 FN Border Rectal no histopathology
Collie Lymphoma
----_. -T 128307 12 FN Cross- Multicentric yes histopathology
Breed
W 130274 --------.- _ ...7 FN Collie- Multicentric no histopathology
Cross
---~.-.-------
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Optimisation of Thermal Cycling Parameters
There are two different thermal cycling systems that can be applied when using
degenerate primers with 5' extensions. The first system uses between 1 and 5 cycles of
low annealing temperature followed by the remainder of cycles at a higher annealing
temperature, assuming that in the early cycles the short sequence-specific 3' ends of the
primers will anneal to template, requiring a low temperature, but in later cycles the
whole primer will anneal to generated product, allowing a higher annealing temperature
to be used. In the second protocol, the annealing temperature is decreased by O.soC or
I.O°C with each successive cycle; this is intended to ensure specific primer template
binding in early cycles, but then to allow mis-matched primers to participate in the PCR
once sufficient specific product has been generated (touchdown PCR).
These two thermal cycling regimes were therefore compared using a standard
PCR mastermix containing 4 Units AmpliTaq DNA polymerase (Perkin-Elmer) mixed
with an equal volume of TaqStart antibody (Clontech) per reaction in a total reaction
volume of 1OO~L, 100pmol of each primer, 200JlmolIL of each deoxynucleoside
triphosphate in 10mM Tris (PH 8.4), 50mM KCI, and 1.5mM MgCband 100ng ofLCL
DNA as template. Low anneal conditions were an initial5' at 94°C; 1 Cycle of 94°C
30s, 40°C 60s, 2' Ramp to 72°C 60s; then 40 Cycles of 94°C 30s, S5°C 60s. 72°C 60s.
followed by a 7' final extend at 72°C. Touchdown conditio~s were an initial 5' at 94°C.
10 Cycles of 94°C 30s, 55°C 60s decreasing by 1°C per cycle, 72°C 60s; then 31 Cycles
of 94°C 30s, 45°C 60s, 72°C 60s followed by a 7' final extend at 72°C. The optimum
number of low temperature annealing cycles (1,2,3 or 5) were also compared in a
separate experiment using the same mastermix.
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Titration of Magnesium and Primer Concentration
The sensitivity and specificity of any PCR is affected by the concentration of
magnesium and primers as variations in these reagents influence the binding of the
primers to the DNA template. Thus for optimal PCR efficiency, titration of these
reagents is required; since they act in tandem they must be titrated for optimum
concentration together. The low temperature anneal thermal cycling parameters (1 low
temperature cycle), and the same reaction mix as described previously were used. The
concentration of magnesium was varied from 1.25mM to 3.0mM in 0.25 mM steps,
against primer concentrations of 0.5, 1.0, 2.0 and 4.0,..,Min a grid comprising 32
reactions in total (8 x 4).
5.2.5 Assessment of System Efficacy and Sensitivity
Following optimisation, the efficacy of the system in amplifying known
gammaherpesvirus templates was determined. Amplification was carried out using 4
Units AmpliTaq DNA polymerase (Perkin-Elmer) mixed with an equal volume of
TaqStart antibody (Clontech) per reaction in a total reaction volume of 100,..,L,
containing 100pmol each primer and 200J.U110l/Lof each deoxynucleoside triphosphate
in 10mM Tris (PH 8.4), SOmMKCI, and 2.SmM MgCh. Thermal cycling conditions
were an initialS' at 94°C; 1 Cycle of 94°C 30s, 40°C 60s, 2' Ramp to 72°C 60s; then 40
Cycles of 94°C 30s, SsoC 60s, noc 60s, followed by a 7' final extend at 72°C.
Templates corresponding to EBV (LCL, B95-8 and Raji cell line DNA), EHV-2
(cloned portion of gB gene in M 13 vector), and MHV -68 (LCL) were tested in the
degenerate primer system. The sensitivity of the system was also tested, by both the
dilution of IOOngofEBV +ve LCL DNA into 0.1-1.0,..,g of placental DNA in 100ng
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steps, and the titration of the M13 plasmid DNA containing EHV-2 gB sequences (from
100ng to IOfg) into I.Ollg of placental DNA.
5.2.6 Testing for Gammaherpesvirus Sequences in Canine Lymphoma
Canine lymphoma DNA preparations were tested for gammaherpesvirus
sequences using the degenerate primer system. The tissues analysed are detailed in
Table 5.2; 10llL (1.0Ilg) of prepared template DNA was incorporated into each peR.
Thermal cycling conditions and reaction mixes used were as described and optimised in
the previous sections, i.e., each PCR contained 4 Units AmpliTaq DNA polymerase
(Perkin-Elmer) mixed with an equal volume of TaqStart antibody (Clontech), 100pmoi
of each degenerate primer, 200J.lffiollLof each deoxynucleoside triphosphate in 10mM
Tris (PH 8.4), 50mM KCI, and 1.5mM MgCh in a total reaction volume of 100JlL.
Thermal cycling was performed on a PCR9600 (Perkin-Elmer) with an initial 5'
denaturation at 94°C; 1 Cycle of 94°C 30s, 40°C 60s, 2' Ramp to 72°C 60s; then 40
Cycles of 94°C 30s, 55°C 60s, 72°e 60s, followed by a 7' final extend at 72°C.
5.2.7 Analysis of peR Product
Between 10 and 16 ul, of the each peR was run on either a 7.5% acrylamide, or
1.5% agarose gel and visualised by staining with ethidium bromide.
Acrylamide gels were electroblotted onto nylon membranes and probed with a
I7mer i2p labelled degenerate oligonucleotide probe, specific for part of the gB gene of
any known gammaherpesvirus situated between the two degenerate primers (see Figure
5.1 & 5.2) in order to confirm the identity of the product generated. The Tm of this
probe was estimated at
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Table 5.2 Tissues Analysed/or Gammaherpesvirus Sequences by Degenerate Primer
Polymerase Chain Reaction
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38°C in 6 x SSC. Blots were pre-hybridised and probed as described in chapter 2 at
35°C for 2 hours, then washed twice at room temperature in 6 x SSC/O.I% SDS for 5'
followed by two washes for 20'in 6 x sse/D. I% SDS at 38°C. Signals were detected by
autoradiography.
Where bands of the expected size of a gammaherpesvirus product were observed
on initial acrylamide gels, the PCR products were run on 1.5% agarose gels, and the
bands of interest excised with a clean scalpel. DNA was extracted from the agarose
using the Qiaex kit (Qiagen Ltd.), cloned into the PCR II vector (Invitrogen) and
sequenced as described in chapter 2. Sequences obtained were compared with the
known gammaherpesvirus gB genes using the gap and bestfit programs of the GCG
package.
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5.3 RESULTS
Degenerate primers were designed based upon amino acid sequence alignments
of the five known gammaherpesviruses. These primers were intended to amplify a
632bp fragment of the gB gene of any gammaherpesvirus in a degenerate primer
polymerase chain reaction.
5.3.1 Optimisation of Degenerate Primer peR
Initial experiments were designed to optimise the degenerate primer polymerase
chain reaction for the detection of gammaherpesvirus sequences.
Two different thermal cycling protocols were first compared, low temperature
early annealing, and a touchdown peR strategy using identical reaction mixes and
template. Following amplification, reaction products were separated on 7.5% agarose
gels, and stained with ethidiwn bromide. The low initial anneal temperature thermal
cycling strategy proved superior in the generation of product of the expected size
(Figure 5.3). In a further experiment, the effect of 1,2 and 3 low temperature anneal
cycles was compared (Figure 5.4). The optimwn thermal cycling strategy for this pair of
primers was therefore a single low temperature anneal protocol. This protocol was used
in all subsequent experiments.
The effect of variations in the concentrations of the primers (from 0.5 to 4.0JlM)
and magnesiwn (between 1.25 and 3.0mM) was then tested, in a total of 32 reactions
(Figure 5.5). After analysing these reactions, concentrations of 1.0JlM for the primers,
and 2.5mM for magnesiwn, were selected for all future reactions. It was considered that
these conditions would permit good amplification of specific product, without excessive
generation of non-specific bands.
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Figure 5.3 Comparison of Two Thermal Cycling Strategies for Degenerate PCR
Lane 1 2 3 4 5 6 7 8
Bp
1353
603 ... 632bp Band
234
118
72
Figure 5.3, Comparison oflow anneal and touchdown thermal cycling trat gie .
Lane 1, ~xIHaeIII marker; Lane 2, Blank; Lane 3, 10)lL of low anneal P R pr duct;
Lane 4, 5)lL oflow anneal peR product; Lane 5, water control low anneal cycling
strategy; Lane 6, l Oul, of touchdown PCRproduct; Lane 7, 5)lL of touchdown P R
product; Lane 8, water control touchdown PCR.
Figure 5.4 Comparison of the Optimal Number Of Low Temperature Anneal Steps
for Degenerate Primer PCR
Lane
Bp
1353
1078
872
603
2 3 4
+- 63211p Band
Figure 5.4, Comparison of the optimum number or low temperature annealing steps for
degenerate PCR with gammaherpesvirus primers. Lane I, ~x/ilaclil marker; I.ane 2,
low temperature anneal step; Lane 3, 2 low temperature anneal steps; Lane 4, 3 low
temperature anneal steps.
Figure 5.5 Titration 0/Magnesium and Primer Concentrations/or
Gammaherpesvirus Degenerate Primers
Lane
Bp
1353
603
234
118
72
2 4 5 6 873
632br Band
Figure 5.5, Typical gel of magnesium and primer titration PCR. Lane I, ~x/llaclll
marker, Lane 2, blank; Lanes 3-8, effect of increasing magnesium concentration with
primer concentration fixed at I.O~M; Magnesium Concentrations, Lane 3 1.25mM,
Lane 4 1.5mM, Lane 5 1.75mM, Lane 6 2.0mM, Lane 7 2.25mM, Lane 8 2.5mM.
5.3.2 Assessment of Degenerate Primer peR Efficacy and Sensitivity
The ability of the degenerate primers to direct the amplification of a variety of
known gammaherpesvirus templates was first confirmed. Amplification of a specific
gammaherpesvirus band of the expected size proved possible for all gammaherpesvirus
templates tested, these included a variety ofEBV templates (LCL DNA, Raji cell line
DNA, B95-8 DNA), an EHV -2 template, and an MHV -68 LCL DNA template.
The sensitivity of the degenerate primer system was tested by the spiking of the
EHV-2 gB containing plasmid into placental DNA (Figure 5.6), and the spiking of
100ng ofEBV LCL DNA into increasing amounts of placental DNA (Figure 5.7). After
amplification, products were visualised on acrylamide or agarose gels. It was possible
to detect a spike of IOpg ofEHV-2 plasmid in 1.0~g of placental DNA (an extremely
faint band may have been present in the lpg lane as well), and a I :10 dilution of 100ng
of EBV LCL DNA in placental DNA under the optimised conditions.
The presence of gammaherpesvirus specific product was confirmed by electro-
blotting the acrylamide gels onto nylon membranes, and probing with a
gammaherpesvirus specific degenerate probe situated between the two degenerate
primers (Figure 5.8). The existence of multiple bands on all the blots is typical for blots
from PCR products, and is likely to be due to anomalous migration of single stranded
product and incompletely amplified fragments, to which the probe will hybridise. No
binding of probe to non-specific sequences was identified.
5.3.3 Testing of Canine Lymphoma DNA for Gammaherpesvirus Sequences
DNA prepared from a selection of tissues taken from dogs with various types of
lymphoma was analysed using the gammaherpesvirus degenerate primer peR system.
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Figure 5.6 Detection of EHV-2 Sequences in Placental DNA
Lane 2 3 4 5 6 7 8 9
Placental DNA + + + + +
EHV-2 DNA 100ng 100ng lOng Ing n.1 ng
Bp
1353
603 632hp Band
271
118
72
10 1 I 12 13 14 15 16 17 18 19
Placental DNA + + + + + +
EHV-2 DNA 0.1 ng IOpg Ipg 0.1 pg IOfg
Bp
1353
603 ~ 632hp Band
31n
118
77
figure 5.6 Degenerate primer peR titration of EIIV-2 plasmid DNA into I.Opg or human
placental DNA. Lanes 1 & 1O. ~x/Haelll marker. Lane 2. E1IV-2 DNA template only: l.ancs 3-
6 & 12-16, titration of variable amounts or EIIV -2 DNA into placental DNA; Lanes 7. 1I & 17.
blank; Lanes 8 & 18, placental DNA template only; Lane 9 & 19. water control.
Figure 5.7Detection of LCL DNA in Increasing Amounts of Placental DNA
Lane 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15
100ng LCL DNA + + + + + + + + + + +
Placental DNA (f.!g) - 0.1 0.2 0.3 0.4 0.5 0.6 0.7 0.8 0.9 1.0 1.0 -
Bp
603
632bp and
1353
234
120
Figure 5.7 Effect of increasing amounts of background DNA on det ction f
gammaherpesvirus sequences in LCL DNA. Lane 1, cj>x/HaeIIImarker; ane 2, L
template only; Lane 3-12 LCL template in increasing amounts of placental DNA; ane
13, Placental DNA only; Lane 14, water control; Lane 15, blank.
Figure 5.8Detection of gamma herpesvirus gB amplification with a degenerate
oligonucleotide probe specific for any gammaherpesvirus
(A) LCL DNA template (EBV positive)
Lane 12345678
LCL DNA template lug lOOng lOng lng O.lng -
(B) EHV-2 gB plasmid inplacental DNA template (see figure 5.6)
Lane 1 2 3 4 5 6 7 8 9
Placental DNA + + + + +
EHV-2DNA G.lug O.lllg lOng 1ng 0.1ng
~
•
Figure 5.8; Autoradiographs of electro-blots prepared from 7.5% acrylamide gels f
gammaherpesvirus degenerate PCR products amplified from different t mplate . (A)
DNA; Lane 1, <J>xlHaeIIImarker; Lane 2-6, Iug-Olng LCL DNA template; Lane 7, lug
placental DNA; Lane 8, water control. (B) EHV-2 gB plasmid; Lane 1 <J>xIHaeIIlmarker'
Lanes 2-6, EHV-2 gB containing plasmid in lug placental DNA; Lane 7, blank; ane 8
placental DNA template only; Lane 9, water control.
The pattern of bands obtained when using canine DNA as template tended to be quite
complex. Bands of approximately the correct size were visualised when the tissues
from certain dogs were analysed, particularly blood from Dog G, spleen from Dog E,
and mediastinal lymph node and thymus from Dog M (Figure 5.9). The
gammaherpesvirus specific degenerate probe failed to hybridise to blotted peR products
from these reactions however.
In case the failure of the degenerate oligonucleotide probe to hybridise was due
to non-conservation of a canine gammaherpesvirus across the probe sequence, a number
of peR products obtained from these samples which appeared to be of the expected size
were cloned and sequenced. None of the sequences obtained showed any homology to
the known gammaherpesvirus sequences on which the degenerate primers were based.
It was therefore considered that these were all non-specific products, and that no
gammaherpesvirus sequences were detected in the canine tissues analysed.
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Figure 5.9 Testing of Canine Lymphoma Tissues/or Gammaherpesvirus Sequences
Lane 1 2 3 4 5 6 7 8 9 10
bp
1353
603 +- 632bp
234
118
72
Figure 5.9, Testing of tissues from canine lymphoma for gammaherpesviru equen
using degenerate primer peR. Lane 1, ~xlHaeIII marker, Lane 2, Dog bl d NA
template; Lane 3, Dog E spleen DNA template; Lane 4, Dog M media tinallymph n de
DNA template; Lane 5 Dog M thymus DNA template; Lanes 6 & 7 A72 cell line NA
template; Lanes 8 & 9 water controls; Lane 10 LCL DNA positive contr I.
5.4 DISCUSSION
A degenerate primer polymerase chain reaction was designed to amplify a
portion of the gB gene of any gammaherpesvirus. While this system was successful in
amplifying gammaherpesvirus specific product for all the known herpesvirus templates
tested, it failed to detect gammaherpesvirus like sequences in the canine lymphoma
samples.
Degenerate primer polymerase chain reaction has been shown previously to be a
useful technique in both the identification and classification of viruses. In herpesvirus
research, the technique has primarily been used in the identification of specific genes of
known viruses (Burr et al. 1996; Harder et al. 1996; Nunberg et al. 1989; Teo et £II.
1991), or alternatively to show that a newly identified virus is different to previously
described herpesviruses (Bememan et at. 1992). For other viral families, a degenerate
peR strategy has been successfully used to identify new members of the family which
have previously proved difficult or impossible to culture (Nichol et al. 1993; Simons et
al. 1995a).
There are a number of possible explanations for the failure to detect
gammaherpesvirus sequences in the tissues analysed. For a degenerate primer based
system to identify a novel virus, virus of the suspected family must be present, and must
share the regions of conserved sequence on which the primers are based. The most
obvious explanation for failure to detect novel virus in these experiments is therefore
that there were no sequences present to be detected. There is no firm evidence for the
existence of a canine gammaherpesvirus, although this may reflect lack of research in
this area. Tissues from dogs with lymphoma were selected for analysis on the basis that
a gamrnaherpesvirus might be involved in the aetiology of some cases of the
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disease. Alternatively, some affected dogs might have a degree of immunosuppression,
perhaps increasing the amount of virus present in lymphoid or other tissues, and
facilitating amplification of viral sequences. There has been insufficient study of the
various types of canine lymphoma, or their epidemiology, to either support or contradict
the hypothesis that a virus may be involved in the aetiology of the conditions. The
occasional reports of familial clusters of the disease may be attributed to either viral
involvement, or transmission of a deleterious gene that predisposes towards the
development of lymphoma. If a virus is involved in some cases of canine lymphoma. by
analogy with other species, the most likely candidate virus would be either a retrovirus
or a gamrnaherpesvirus.
Another possibility is that the degenerate primer polymerase chain reaction used
in these studies was insufficiently sensitive to detect relatively rare viral sequences that
were present in some of the samples. The use of degenerate primers leads to a
significant decrease in the sensitivity of the polymerase chain reaction. This assay was
able to detect a 1:10 dilution ofEBV LCL DNA into placental DNA suggesting that it
might be able to detect virus in the canine samples if it were present in one in ten cells.
although this would depend on the number of copies of viral genome in an infected cell.
The conclusion that can be drawn from these experiments therefore is that if
gamrnaherpesvirus sequences are present in canine lymphoma, they are relatively rare.
One unexpected problem with the degenerate primer system was that repeat
synthesis of the primers did not always yield primers that were equally effective in
subsequent PCR reactions as the original sets. This situation occurred on more than one
synthesis with more than one manufacturer. Despite extensive discussions with the
manufacturers of the primers, no convincing explanation of the repeated failure to
synthesise degenerate primers as effective as those previously supplied was obtained.
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One of the reasons that this degenerate primer system was not taken further was that
three successive preparations of primer were less effective in amplifying known gamma-
herpesvirus templates than the primers used in the initial experiments. As sensitivity of
the system was considered to be a critical factor, it was decided not to continue further
with attempts to use this set of primers at this level of degeneracy. There are a number
of ways in which these experiments could be revised or developed further. Both the
degenerate primer system, and the selection of the tissues to be analysed, might be
varied. The primers used in this system were 64-fold degenerate, one possible way of
improving the system might therefore be to divide these primers into 2 or 4 different
sets. While this complicates the set up of each PCR and requires multiple reactions for
each tissue under test, reduction of the degeneracy of each primer, particularly at the 3'
ends, would be likely to increase the sensitivity of the degenerate primer system and
thus facilitate the amplification of relatively rare viral sequences. Another possible
modification might have been to use a hemi-nested degenerate PCR strategy; the region
of conservation on which the degenerate probe was based could have been used to
design an additional degenerate primer. The degenerate probe system was useful in
confirming the presence of specific product. It also improved slightly the sensitivity of
the assay when looking at the dilution ofEHV-2 template into placental DNA. The
hemi-nested degenerate peR approach might have led to a greater increase in
sensitivity, and also improved the specificity of the amplification on complex templates,
reducing the amplification of non-specific bands.
An alternative way of increasing the sensitivity of the system might be to use a
fluorescent detection system with fluorescently labelled degenerate primers to improve
detection of specific product. A number of canine lymphoma samples and other canine
samples were in fact tested in such a system designed and utilised in the Leukemia
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Research Fund Virus Centre primarily to identify human herpesvirus sequences in cases
of human lymphoma. No herpesvirus sequences were detected in these samples,
although some of them were known to be positive for CHV-l, by the conventional peR
described in chapter 4. Itwould therefore appear that even with the fluorescent product
detection system, degenerate primer PCR is less sensitive than conventional PCR
assays.
The other main area worthy of further consideration would be the tissues and
material chosen for investigation. Both examples of the successful use of degenerate
primer polymerase chain reaction to identify novel viral sequences without conventional
virus culture involve the use of RNA as the template material (Nichol et al. 1993;
Simons et al. 1995a). This may reflect the less complex mixture of sequences when
using an RNA template, rather than a genomic DNA template, one of the problems of
the gammaherpesvirus primers used on the canine samples was the tendency to amplify
non-specific products. Clearly, the application of RNA based techniques to a DNA
virus presents problems in that not all viral genes may be transcribed to mRNA at all
times. If sufficient sequences have been published, it might be possible to base the
degenerate primers on genes that are involved in latency and therefore likely to be
transcribed in the absence of virus production; for a gammaherpesvirus this might
include either one of the latent membrane protein genes (LMP-l or 2), or a member of
the nuclear antigen (EBNA) or non-coding nuclear RNA (EBER) gene families
(RaabTraub, 1996). An alternative less complex template for a DNA based assay might
be to examine saliva; saliva might be expected to contain some cellular material, but be
relatively enriched for viral sequences, as it is an important route of transmission for
many viruses.
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On the basis of the sensitivity assays carried out with the gB degenerate primers,
there remains the possibility of detecting viral sequences against a background of
cellular DNA, and this has been found to be feasible by other studies within the
department (Gallagher, 1995). Investigation of diseases other than lymphoma, and other
tissue sources should perhaps be considered. A cryptogenic fibrosing alveolitis (CFA)
like condition has recently been identified in a group of West Highland White Terriers
(Corcoran, 1996). CFA in man has recently been associated with EBV replication in
pulmonary epithelium (Egan et al. 1995), so this condition in the dog might warrant
further examination for gammaherpesvirus sequences.
While the attempt to find evidence of a canine gammaherpesvirus was not
successful on this occasion, degenerate primer polymerase chain reaction, and primers
based on the conserved regions that have been identified in all the three herpesvirus sub-
families, could still prove useful in further investigations. An alternative strategy of
searching for a novel canine herpesvirus might involve attempts at culture of canine
lymphocytes under a variety of conditions, and in the presence of a variety of co-factors,
such as T-cell stimulators or inhibitors. Cultures of human lymphocytes under such
conditions has led to the identification of two new human herpesviruses. If evidence of
a canine herpesvirus was observed under these culture conditions, then a rapid way of
confirming the identity of this virus might be to use alpha, beta, and gamrnaherpesvirus
specific degenerate primers to obtain some initial sequence information. A combination
of conventional culture, and advanced molecular techniques, which will provide the
necessary sequence information to confirm any observations, may in some instances be
the most effective way of searching for new viruses.
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It remains a fascinating enigma that the dog and cat are yet to yield more than
one member of the herpesvirus family. There is no firm evidence at present for the
existence of a gamma or beta-herpesvirus in either species. It is interesting to note that
the species with the most closely related alphaherpesvirus to both CHV -1 and FHV -1,
the European harbour seal, is infected by a member of the gamma-herpesvirus sub-
family (Harder et al. 1996). If the techniques that have been applied in the identification
of novel human herpesviruses were used in a thorough study of the dog, it seems likely
that further canine herpesviruses would be discovered.
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CHAPTER6
EXAMINATION OF FIVE CASES OF CANINE LYMPHOMA BY
REPRESENTATION DIFFERENCE ANALYSIS
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6.1 INTRODUCTION
Alterations in the genetic material of an organism can be involved in a variety of
pathological processes. Losses or rearrangement of the cell's genetic material is the key
event in the development of neoplasia; infectious disease can be considered as the
addition of the genetic material of a pathogen to a cell, tissue, or organ. A technique
that is able to analyse any such genetic alterations between normal and abnormal tissues.
whether resulting from exogenous agents, or from internal influences, is therefore likely
to be extremely useful.
Subtractive hybridisation has long been recognised as a powerful tool in the
analysis of differential gene expression. The technique is able to facilitate the
identification oflow abundance RNA messages (target sequences) by specifically
removing sequences common to two populations ofmRNA's, therefore enriching
sequences that are unique or more abundant in the population of interest (Mackenzie.
1995). By convention when describing subtractive hybridisations, the population of
RNA or DNA containing the target sequences of interest is referred to as tester. and the
comparison population, without these sequences, is referred to as driver.
Subtractive hybridisation can also be applied to DNA samples, and on the basis
of a mathematical model it has been suggested that it should be possible to analyse the
genetic differences between two genomic DNA samples using this technique (Milner et
al. 1995). An early example of this was the isolation of Y chromosome specific
sequences by subtracting sonicated female DNA from MboI digested male DNA (Lamar
and Palmer, 1984). These sequences were from small multi gene families however.
which implies that hybridisation did not proceed near enough to completion to allow the
isolation of single copy genes. Despite subsequent refinements of the technique.
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involving enhanced reassociation techniques (Kunkel et al. 1985), or multiple
hybridisations (Straus and Ausubel, 1991; Straus and Ausubel, 1990), it has proved
difficult to drive the reassociation to completion. The result of this is that it remains
difficult to achieve sufficient enrichment in complex genomes to isolate rare target
sequences.
Recently, the polymerase chain reaction has been used to extend the power of
subtractive hybridisation techniques. Originally peR was used to increase the amount
of eDNA (DNA prepared by reverse transcription from mRNA) available for
construction of a library, thus overcoming problems with limited amounts of starting
material (Belyavsky et al. 1989). The same technique can also be used to synthesise the
large amounts of driver eDNA that are required for most subtractions. The most
powerful use of peR in subtractive hybridisation however, is as a tool to amplify the
small amounts of self-annealed tester material remaining after hybridisation (Timblin et
al. 1990). Two further modifications of subtractive hybridisation have been suggested
to facilitate the use of peR in this process. The first entails the ligation of duplex
oligonucleotide adaptors onto blunt ended random hexamer primed eDNA fragments to
facilitate the amplification of cDNA both before and after hybridisation (Duguid and
Dinauer, 1990). The second modification uses an initial digestion of cDNA to small
fragments with frequent cutter enzymes to yield a population of small cDNA fragments
which should be uniformly amplified during peR (Wang and Brown, 1991). These
refinements should permit the isolation of extremely rare mRNA species, down to the
level of approximately 10 copies per cell, by subtractive hybridisation.
Representation Difference Analysis (RDA) has been developed from these
techniques as a tool to examine the differences between complex genomes. In its
original form it combined the digestion of the genomic DNA samples (as opposed to
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cDNA samples), the ligation of adaptors to the ends of the cut DNA fragments, and the
peR amplification of the adaptor ligated DNA fragments at two key stages. peR is first
used to create a sample or representation of the genome after an initial restriction digest
of genomic DNA; it is then also used to amplify self-annealed tester DNA sequences
following subtractive hybridisation (Lisitsyn et al. 1994a).
The use ofPCR in this manner elegantly side-steps one of the most significant
problems in hybridising genomic DNA. It had previously proved difficult to achieve
sufficient enrichment of unique sequences in the tester DNA population by subtractive
hybridisation, as the complexity of the DNA interfered with the progress of
hybridisation to completion. peR amplification of adaptor ligated digested genomic
DNA effectively reduces the complexity of the genome: fragments in the digest larger
than about 2000bp are excluded from any further analysis due to the conditions used in
the amplification. The technique therefore analyses a sample, or representation, of the
whole genome. Subsequent modifications of the technique have also allowed its
successful application to the study of the differences between two cDNA populations.
Enrichment of target sequences unique to the tester DNA during RDA is
achieved by a combination of two processes. Only tester that has re-annealed to itself
will have adaptors at both ends, and therefore be exponentially amplified in each post-
hybridisation peR step (see Figure 6.1). Due to the vast excess of driver used should be
mostly sequences that are unique to the tester. In addition to this, once a target sequence
has been enriched in the tester DNA population by the first or subsequent hybridisation!
amplification steps, second order kinetics of self-reassociation will apply (Wieland et al.
1990). This means that if, for example, a target sequence has become enriched n times
relative to unenriched fragments in the
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Figure 6.1 peR Amplification of Differences Following Hybridisation in RDA
tester DNA (with adaptors) driver DNA (no adaptors)
Hybrid isation
Three Annealed Products;
tester/tester tester/driver driver/driver
Subsequent peR;
tester/tester ---.. Exponential Amplification
tester/driver ---.. Linear Amplification
driver/driver ---.. No Amplification
Following hybridisation, only molecules with adaptors at both end
will be exponentially amplified in subsequent peR. Due to the va t
excess of driver used in each hybridisation, only tester molecules
which are unique to the tester population are likely to re-anneal to
each other.
population, and the mixture is melted and allowed to anneal such that only a small
proportion of double stranded DNA is allowed to reform, double stranded target DNA
will then be present n2 times relative to other double stranded DNA sequences.
The potential applications of RDA are considerable, particularly given that no
advance knowledge of the specific difference that may be found between the two tissues
under investigation is necessary (a feature it shares with all subtractive hybridisation
based techniques). The first published use of the technique was to identity polymorphic
differences between individuals of the same family (Lisitsyn and Wigler, 1993). RDA
is also a powerful technique in the comparative genomic analysis of tumours, where it
can be used in two ways; (1) using tumour DNA as driver and matched normal DNA as
tester to detect the loss of polymorphic loci or homozygous deletions; and (2) with
tumour DNA as tester, and matched normal DNA as driver, to detect restriction
fragments only present, or amplified in, the tumour genome due to rearrangements,
point mutation, or viral infection (Lisitsyn et al. 1995). Perhaps the most exciting
example of the potential ofRDA to date has been its use to identify herpesvirus like
DNA sequences in cases of AIDS-associated Kaposi's sarcoma (Chang et al. 1994). a
disease where epidemiological evidence suggested an infectious aetiology, but no
causative agent had been identified by conventional methods.
In the light of these findings, and in particular, the ability of RDA to identify
genetic differences related to a wide range of pathological processes without any prior
knowledge of the sequence of the differences that might be present, it was decided to
examine a number of cases of canine lymphoma using this technique.
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6.2 MATERIALS ANDMETHODS
6.2.1 Collection of lymphoma Samples
A variety of tissue samples were collected at Post Mortem from dogs that were
euthanased due to a diagnosis of lymphoma. The diagnosis of lymphoma was based
upon clinical presentation, post mortem examination, and confirmed by histopathology.
Deatils of all cases have already been described in chapter 5, (Table 5.1). Tissues were
stored at -70°C prior to DNA preparation.
6.2.2 Preparation of DNA
DNA suitable for restriction digestion was prepared in an area away from all
other RDA manipulations as follows. A small piece of tissue was incubated in a 15 mL
Falcon tube containing 1.0mL of Lysis Buffer (IOOmM TrisHCI pH 8.5, 5mM EDTA
pH 8.0, 0.1% SDS, and 200mM NaCI), and 50f,lLof 10mg/mL Proteinase K overnight
at 55°C. Tubes were shaken vigorously, then centrifuged for IS minutes at 1000g to
obtain a finn pellet. Supernatant was poured into pre-labelled tubes, each containing 1.0
mL ofIsopropanol, and swirled until DNA precipitation was complete. DNA was
recovered by lifting aggregated precipitate from the solution using a disposable yellow
tip. DNA was placed in a pre labelled eppendorf containing ImL ultra-pure sterile
water and left for several hours or overnight to allow complete dissolution.
6.2.3 Difference Analysis Protocol
Representation difference analysis was carried out basically as described by
Lisitsyn et al (Lisitsyn and Wigler, 1995) using the six BamH 1 primers described in this
protocol (R, J, & N 12 and 24mers). Each pair of primers is designed to form a BamH I
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restriction site at one end when annealed together. The two DNA populations that differ
are referred to as tester and driver, with tester DNA proposed to contain target
sequences that are not present in driver. To avoid the generation of differences due to
polymorphic variations between individuals, tester and driver were selected from the
same animal for a given RDA. In addition to conventional tester/driver reactions, a
parallel driver/driver reaction was run for each sample under analysis.
Analysis of tissues by RDA was carried out in 10 separate experiments. In the
first 5 of these experiments, normal tissue (brain) was used as driver, abnormal tissue
(potentially containing additional sequences due to viruses or mutations) as tester, hence
these experiments were intended to identify additional restriction fragments present in
the abnormal tissue. In the second set of 5 experiments, normal tissue was used as
tester, and abnormal tissue as driver, effectively searching for loss of restriction
fragments from the abnormal tissue. The tissues analysed in each experiment are
detailed in Table 6.1.
In common with other molecular biology techniques using repetitive PCR steps,
the potential exists in RDA to contaminate reaction mixes with previously generated
product. To avoid this, all reagents were prepared and dispensed into single use aliquots
in a PCR clean environment. All reactions and precipitations were prepared or carried
out in a UV controlled cabinet (Template Tamer, Oncor), and the cabinet irradiated for
at least 15 minutes between each step in the procedure.
131
Table 6.1 Lymphoma Tissues Examined by Representation Difference Analysis
RD.\ Dug Tester nrh IT
LymphomaK Lymph Node, Brain
: Tonsil
2 LymphomaN Spleen, Brain
; Tonsil,
Tumour
3 LymphomaO · Spleen, Brain
Parotid Salivary Gland
4 . Lymphoma T • Spleen, Brain
• Lymph Node
5 Lymphoma W · Spleen, Brain
SMSG
6 LymphomaK Brain Lymph Node
7 . LymphomaN Brain . Tonsil
8 : LymphomaO ; Brain Tonsil
9 : Lymphoma T i Brain I Lymph Node
lO
1-'
Lymph NodeLymphoma W ; Brain
In addition to the tester/driver reactions detailed above, a driver/driver reaction for
each RDA was also performed to control for non-specific generation of difference
products.
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Restriction of DNA
Ten ug of driver and IOllg of tester DNA were digested overnight with 100
Units of BamH I restriction endonuclease in a total volume of 100f..lL.Digests were
extracted with
equal volumes of phenol/chloroform and chloroform and ethanol precipitated. After
centrifugation samples were resuspended in 50f..lLofT.E. buffer, the concentration was
estimated by measurement ofadsorbance at 260nm, and adjusted to O.If..lg/J.LLfor use in
subsequent stages of the procedure.
Preparation of oligonucleotides
The three sets of paired 24mer and 12mer oligonucleotides (RBam, JBam and
NBam as described by Lisitsyn) were synthesised by Cruachem and supplied after
cartridge purification lyophilised. Oligos were resuspended in sterile distilled water
(SOW) at a concentration of 62 pmol/ul, (12 OD2601'mifor 24-mers and 6 OD2601'mifor
12-mers), dispensed into single use aliquots and stored at -20°C until required.
Ligation of adapters
The ligation reagents, consisting of 20J.LL(Zug) of driver or tester DNA digest.
15ul, of each 24-mer and I2-mer for the first adaptor set (RBam24 and 12), 41lL of
SOW, and 6J.LLof lOx Ligase buffer, were mixed in a I.5mL eppendorf. To anneal the
oligonucleotides, the tubes were placed in a beaker of water at 50-55°C and then moved
to a cold room for approximately 1 hour, until the temperature of the water in the beaker
had decreased to IO-150C. Tubes were then placed on ice for 3 minutes, 21lL (400
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U/IlL) ofT4 DNA ligase added, and reactions incubated overnight at 140C to ligate
annealed adaptors onto restriction fragments of DNA.
Production of tester and driver DNA representations
Representations of tester and driver DNA were produced in multiple 400Jll peR
reactions. Reaction mixes were prepared with 40JlLof lOx peR buffer II. 40Jll of
25mM MgCh, 32JlL nucleotide solution (4mM of each dATP, dGTP, acrr. dTTP),
SilL of 24-mer oligonucleotide (adaptor set 1, RBam24), 6JlL of Amplitaq/Taqstart (I: I
mix by volume), 271 ul. ofSDW and 3JlL (IOOng) of adaptor ligated restriction digested
DNA. Thermal cycling was performed on a DNA Thermal Cycler (Perkin-Eimer), with
an initial 5 minute incubation at 72°C to convert single stranded adaptor ends to
dsDNA, followed by 25 cycles of 1 minute at 95°C and 3 minutes at 72°C, the tinal
cycle followed by a 10 minute extension at 72°C. Ten ul, of reaction products were run
on a 2% agarose gel and visualised by staining with ethidium bromide to check the
quality of the representation.
Change of adaptors on restriction amplicons
After removal of mineral oil, the contents of each PCR tube was
phenoVchloroform and chloroform extracted, then ethanol precipitated and re-suspended
in 350JlL of SDW. Each restriction amplicon was digested overnight at 37°C by
addition of 40JlL of react 3 buffer and 100U (I OJlL)of BamH I to remove adaptor set I.
Following digestion, amplicons were phenol/chloroform and chloroform extracted. then
ethanol precipitated and resuspended in a small volume ofT.E. buffer.
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At this point, a small amount of driver DNA was run on an agarose gel and
visualised by staining with ethidium bromide. The concentration of driver was
estimated by comparison on the same gel with a SOOngsample of genomic DNA
digested with Sau 3A. The concentration of driver DNA was adjusted to 0.5J!g/J!L by
addition ofT.E., and driver stored at -20°C until required.
Tester amplicon DNA digest (and driver amplicon DNA digest for use in
driver/driver reactions) was loaded onto a 2% agarose gel and run briefly to separate
restriction amplicon DNA from cleaved adaptor DNA. Gel containing fragments in the
range 150-1500 bp was excised, and the DNA extracted using a kit (Qiaex gel extraction
kit, Qiagen Ltd.) according to the manufacturer's instructions. DNA was resuspended in
30J!L ofT.E. buffer, and the concentration estimated by comparison to Sau 3A digested
genomic DNA as described previously.
Two ug of purified tester DNA amplicon DNA digest was then ligated to primer
set 2 (JBam24 and 12). in the same manner as described for the ligation to primer set I,
then diluted to a concentration of IOng/fll in T.E. buffer.
DNA hybridisation/amplification steps
For hybridisation 1, 40J.lgof driver amplicon DNA digest (80J!L) and 0.4J.1gof
tester amplicon ligate (40J!L) were mixed and extracted once with phenol/chloroform
and once with chloroform. Each mix was ethanol precipitated by addition of 42J.lLof
7.5M ammonium acetate and 420J!L (2.5 vol.) of ethanol, chilled at -700C for 10
minutes, then incubated at 370C for 2 minutes prior to centrifugation to pellet DNA.
Pellets were resuspended in 4J!L of 3xEE buffer (30mM EPPS, pH 8.0 at 200C, 3mM
EDTA), and overlaid with 35J!L of mineral oil. DNA was denatured by incubation for 5
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minutes at 980C in a heating block, lul, of5M NaCI carefully added to the DNA drop
and hybridisation allowed to proceed for 20h at 67°C.
Hybridisation was stopped by addition of398~L ofT.E. to each tube. For each
hybridisation a tube containing 350~1 ofPCR mix excluding the 24-mer primer was
prepared and 40~1 of hybridised DNA dilution added. Tubes were overlaid with mineral
oil and placed in the thermal cycler to be incubated at noc for 5 minutes to convert
single stranded DNA adaptor ends to dsDNA. Subsequently 1O~L of 24-mer primer
(adaptor set 2, JBam24) was added to each tube and 10 cycles of PCR performed as for
the first representation.
The contents of each tube were phenol/chloroform and chloroform extracted,
ethanol precipitated, and the pellet dissolved in 34~L ofSDW. All single stranded DNA
was then digested by the addition of 4~L of lOx mung bean nuclease buffer and 21lL of
mung bean nuclease (MBN)(l0 U/~L) and incubation at 300C for 30 minutes. Nuclease
was inactivated by addition of 160~L of 50 mM Tris-HCI pH 8.9, and incubation at
980C for 5 minutes. Selective amplification was completed by adding 40llL of MBN
treated difference product to a 360~L preparation of PCR mix containing 24-mer primer
(adaptor set 2, JBam24); thermal cycling parameters were as described previously with
the omission of the initial 5 minute 72°C step as the ends of each adaptor would already
be dsDNA. After 20 cycles, l Oul, of each amplificate was loaded onto a 2% agarose gel
and visualised by staining with ethidium bromide, and, if necessary to improve the yield,
5-10 additional cycles of PCR performed.
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Changeof adaptor on a difference product
Each selective amplicon was then purified, digested with BamH 1 overnight,
purified again and resuspended in T.E. at a concentration of20ng/IlL after quantification
on an agarose gel. Purified, digested difference product (20Ong) was then ligated to
adapter set 3 (Nbam24 and 12) in a total volume of 60llL as described previously, and
the ligated difference product diluted to Ing/ul, by addition of 160llL ofT.E. buffer.
All subsequent ligations were done using 200ng of difference product DNA in 60IlL,
and diluted after ligation as necessary.
Subsequent hybridisation/amplification step.
For the second hybridisation SOng of adaptor ligated difference product and
40llg of driver amplicon DNA digest were combined and hybridisation/amplification
carried out as before.
For the third hybridisation/amplification step, 1OOpgof difference product from
hybridisation/amplification 2 which had been ligated back to adaptor set 2 (J8am 24 and
12) was again combined with 40llg of driver amplicon DNA digest, and hybridisation/
amplification carried out as described previously.
Sixteen ul, of the third selective amplification reaction of each analysis was
mixed with 41lL of loading dye, and run through a 2% agarose gels. Any difference
products were visualised by staining the gel with ethidium bromide.
6.2.4 Cloning and Sequence Analysis of Difference Products
Difference products visualised were extracted from the gel using the Qiaex kit
(Qiagen Ltd.), ligated into the peRIl or 2.1 Vector, and transformed into competent
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E.coli as directed in the TA cloning kit (Invitrogen). Cloned plasmids were prepared
and sequenced as described in Chapter 2.
Sequences obtained from the various clones were compared using programs
from the GCG Wisconsin package (Devereux et al. 1984). Clones isolated from each
band of the final gel were compared to determine whether these bands comprised a
unique sequence, or a mixture of sequences. The main purpose of sequencing at this
stage was to reduce the number of southern blots required to analyse the difference
products generated, by ensuring that only a single clone of each difference product was
used in subsequent analysis. The significance of difference products isolated was also
investigated by the analysis of all clones against the database of all known sequences
(both nucleotide and protein), using the programs Fasta and Blastn for nucleotide
sequence analysis, and Tfasta and Blastx for amino acid based sequence analysis.
6.2.5 Southern Blot and peR Analysis of Difference Products
Specific probes were generated for each difference products by PCR. using
either internal primers, or the JBam 24 primer specific for the adaptors on the ends of
the final difference products.
The presence or absence of the difference product obtained within the tester and
driver DNA samples was determined for some sequences by direct peR using primers
designed with the assistance of Oligo 4.1 software from the difference product
sequence. The PCR amplification of the specific product from genomic DNA samples
was confirmed by blotting gels of the PCR products to nylon membrane, and probing
with the specific difference product probe.
Digests of 10J.lgof genomic DNA from each of the tissues used in a given RDA
with a variety of enzymes (BamHI, EcoRl, EcoRV), and I st representations of the same
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tissues, were separated on 1% and 1.5% agarose gels respectively, and the gels blotted
to nylon membranes. The specific difference product probes were radioactively labelled
and used to analyse these southern blots for each of the sequences in question. As an
exact match between probe and blotted DNA was expected, high stringency conditions
were used in the washing of all blots (Final wash in 0.1 x sse, 0.1% SDS at 600e for
30 minutes).
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6.3 RESULTS
6.3.1 Representation Difference Analysis
Representation difference analysis was used to examine tissues from five dogs
with lymphoma for differences at the DNA level between a variety of tissues and brain.
RDA was carried out using normal tissue as driver in the first five experiments, and as
tester in the second five experiments. Initial experiments were therefore intended to
identify additional restriction fragments present in tumour DNA, and later experiments
designed to identify loss of restriction fragments from tumour DNA.
The initial representation of tester and driver DNA was generated by peR, and
12~L of the reaction electrophoresed on a 2% agarose gel and visualised by staining
with ethidium bromide to confirm the successful production of a representation. After
each successive hybridisation/amplification, the product generated was again
electrophoresed on a 2% agarose gel and visualised as before. A progressive decrease in
the complexity of the representation and the generation of difference product was noted
with each successive cycle of hybrid isation/ amplification. This complete process, from
generation of first representation of tester and driver, to third round selective
amplification, is shown for RDA6 in Figures 6.2a, 6.2b, 6.2c, and 6.2d.
Ingeneral, three rounds of hybridisation/ amplification were performed;
however, in RDA 3 a clear difference product, represented by a sharp band on the
ethidium bromide stained gel, was evident after two rounds only, although this band was
no longer apparent after the third hybridisation/amplification step. Bands on the final
gel were considered for further analysis ifpresent in the tester/driver lane, but absent
from the driver/driver lane. The
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Figure 6.2 Generation of Difference Products by Repeated Cycles of
Hybridisation/Amplification
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The generation of difference products by repeated cycles of hybrid isat ion/amplification;
CA) 1SI representation, CB) 1sI selective amplification, Cc) 2nd selective amplification, (D) 3rd
selective amplification (final difference gel). All gels from RDA6. Lane 1, lOObp ladder; Lane
2, Tester/driver (BrainlLymph Node); Lane 3, Driver/driver (Lymph node/lymph node).
The difference products evident on analysis of the final (third round selective
amplification) gel, are catalogued in Table 6.2.
6.3.2 Sequencing of Cloned Difference Products
Difference products present in the tester/driver reactions, but absent from the
driver/driver reactions were extracted from the agarose gel, ligated into the PCR 2.1™
vector, cloned and sequenced. Approximately 150 clones isolated from the various
difference products were sequenced in total, and the sequences were compared against
other clones isolated in that RDA, and against the database of all known sequences
using a variety of programs from the GCG package. The purpose of sequence analysis at
this stage was to identify whether clones derived from a given band on the final RDA
gel were identical or comprised a number of different sequences; and to ensure that
southern blots were not repeated with identical clones on subsequent analysis.
On sequence analysis, some of the bands present in the final representation gel
were shown to consist of a single sequence, others comprised a mixture of different,
apparently unrelated sequences. The initial results after three rounds of hybridisation
/amplification (both two and three rounds for RDA 3), sequencing, and sequence
comparison, for each of the RDA' s that resulted in the production of apparent
differences between tester/driver and driver/driver are shown in Table 6.3.
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Table 6.2 Initial Results of RDA on Five Cases of Lymphoma
RD.\ Tester Tissue Difference Products On Final (;l'I
: Lymph Node : None identified.
Tonsil . None identified.
2
I
; Spleen ; Diffuse Band, 240bp.
Tonsil None identified.
· Lymph Node ' None identified.
,
..
3 • Spleen Doublet at 540bp & 580bp (single band in other lanes) after
.' 3 rounds of RDA.
: Salivary Gland i Single clear band of 320bp after 2 rounds.
: Diffuse band at 330bp after 3 rounds.
4 i Spleen
,
I None identified.
Lymph Node i Single band of 650bp.
5 !Spleen ! None identified.
Salivary Gland None identified.
6 · Brain (Normal) ; Two difference products identified at about 270bp and
350bp.
7 · Brain (Normal) Single difference product at 290bp.
8 Brain (Normal) None identified.
9 · Brain (Normal) Single band at 800bp and doublet at 400bp.
10 Brain (Normal) Diffuse ladder of bands generated after 3 rounds ofRDA.
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Table 6.3 Sequencing Based Analysis of Clones Generated by RDA
2 Spleen
3 Spleen
Salivary Gland
4 Lymph Node
I
6 ; Brain (Normal)
7 Brain (Normal)
9 Brain (Normal)
10 Brain (Normal)
24 clones sequenced from diffuse band at 240bp. Two main .
sequences identified; Sequences 2/1 (3 clones) and 2/2 (10
clones). Sequence 2/1 showed significant homology to part
of the human retinoblastoma gene, clone 2/2 showed no
significant matches to the GCG database.
_. --
8 clones sequenced, two sequences identified, neither with
significant matches to GCG database.
12 clones derived from clear band after 2 rounds of RDA.
All clones identical on sequencing, but no significant
matches to GCG database identified.
24 clones sequenced from diffuse band at 330bp after 3
rounds. Comprised of at least 7 sequences, all different to
clones generated from 2 rounds of RDA. Some weak
homologies to herpesvirus sequences identified by Blastx
search method.
16 clones analysed from 650bp band. Majority of clones
were the same sequence. No matches to GCG database
_, .-- ,_ .. _-- -__ ._ --_._._._ - ..- '._-- -_. - - - .
16 clones of each difference product generated and
sequenced.4 sequences identified in larger band (including
clone 6/1), and 6 sequences in smaller band (including
clones 6/2 and 6/3). One exact match to canine
mitochondrial DNA, Clone 6/1 showed some homology to
. promoter sequences of canine genes.
8 clones generated from difference product of which 7 had
the same sequence. No significant matches to database.
_-_- .-- _. --.,._.,.-._-
. 24 clones sequenced. 8 clones of 800bp were same
sequence, showed some homology to cytochrome genes. 16
clones of doublet comprised 2 main sequences, no
significant homologies identified.
16 clones sequenced. Ladder of bands was a variety of
different sequences, most clones did not have correct Bam
sites where expected.
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6.3.3 Analysis of Difference Products by Southern Blotting and peR
A large number of potential differences between tumour and normal DNA were
generated by RDA. The significance of each individual difference products identified
was examined, by a combination of peR and southern blotting.
peR Analysis
In some instances, particularly where it was considered that the difference
product might have resulted from the absolute addition or absence of the difference
product from a tissue, direct examination of the tissues by peR was performed, using
primers designed from the difference product.
Analysis was carried out in this way for the various difference products from
RDA numbers 2,3,4 and 7. In all instances it proved possible to amplify a portion of the
difference product from both tester and driver tissue, proving that the differences
generated were not due to the absolute absence from the driver tissue of the sequences
under question.
Southern Blot Analysis
Southern blots were prepared from agarose gels of both restriction digests and 1si
representations of DNA from the tissues of each dog used in the difference analysis
protocol. These blots were probed with the difference products identified, to determine
the presence or absence, and size, of the fragment generated by RDA in both the original
genomic DNA digests and 1st representations.
Analysis of difference products by southern blotting showed that many of the
products were non-specific or artifactual, and were present at the same size in both tester
and driver DNA on blots of both the initial digests and the 151 representations. Non-
specific products of this type were not studied further. Some of the cloned sequences
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from RDA2 and RDA6 hybridised differently between tester and driver DNA
populations on analysis of southern blots however. This shows that the technique is
indeed capable of identifying differences between tester and driver 151 representation
DNA, and thus indicate differences in the genomic DNA from which the first
representations are derived.
RDA2 differences
Two clones (211 and 2/2) isolated from the spleen tester in RDA 2 were shown
to be present at the correct size in the 1st representations of the tester material only
(Figure 6.3). In genomic blots, probes generated from these clones hybridised to
sequences in both tester and driver DNA much larger than would be included in the I st
representation of DNA. One of these sequences showed significant homology over the
whole clone to a portion of the human retinoblastoma gene (Figure 6.4).
RDA 6 Differences
Three sequences isolated from the final gel of RDA 6 showed genuine
differences between driver and tester DNA when hybridised to blots of both genomic
DNA digests and 1st representation DNA from the same dog. All blots were prepared
using similar amounts of digested genomic DNA or 1st representation DNA for tester
and driver lanes (Figure 6.5).
The first sequence (6/1) was identified in two clones from the larger band.
Probes of this clone hybridised strongly to the genomic DNA blot in the tester tissue at
the correct size, while failing to hybridise significantly to the driver lane at the same
position (Figure 6.6a). A similar result was obtained in the Ist representation blot
(Figure 6.6b). This sequence showed
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Figure 6.3 1st Representation Blots of RDA2 Probed with Clones 211 and 212
CA) (B)
Lane 1 234 Lane 2 3 4
Hybridisation at
approximately
200bp ~
Figure 6.3; Hybridisation of probes from clones 2/1 and 2/2 to l" repre entation NA
blotted to nylon menbranes. (A) Probe from clone 2/] . (B) Probe from cl ne 2/2. Lane
1, ex/Haclll Marker; Lane 2, spleen l" representation; Lane 3, tonsil I si repre entati n;
Lane 4, brain 1st representation
Figure 6.4 Alignment of one of the RDA2 (211)Difference Products with the Human
Retinoblastoma Gene
1 GGATCCATGAACGTGG.. 16
I I III II I I
67550 TCAGAGAACTTCCGGATAGCTGAACATGTGGAGGCTCCTGGACAGCTGTC 67501
17 CGCCCAGGGAGGACATAGATGC.TCCGGTCCCTACCCCCATGCCTCCTCC 6~
I I I III II II I I 1111 II I I I I I II 1111 II I I II I I I I I
67500 TGGCCAGGGAGGGCATAGAAGCTTCCCATCCCATCCCCCATACCTCATCC 674~1
66 TATGAGTCTCTTCATCTGTGTCCTCTGCAGTGTGCTTTGTATTCAACCAG 115
II I I II I I I II 1111 I I II I I I I I I I I I I II III I
67450 TATGCATCTTTACATCTGTATCCTTTGTAATATCATCTATAATAAACCAG 67401
116 TAAACGCCAGTGTCTCCCTGAGTTCTGTGAGCTGCTACAGCAAATTAATC 165
I I II I 11111 III 111111 II III II II 111111111 II I
67400 TAAACAGAAGTGTTTCCTTGAGTTTTGTGAACTACTCTAGCAAATTAATC 67351
166 AAACCCAAAGAGGTGGTCATGGGATCC .........•............. 192
I II I II I 111111 III II
67350 GAACCTAA ..GAGGTGTCATGGGAACCCCAACTTGAAGCCCTTTGGTCAG 67303
Upper sequence from RDA2 difference product 211, lower sequence part of human
retinoblastoma gene sequence between exons 11 and 12.
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Figure 6.5 Dog K genomic DNA digests and 1st representations used in southern
blotting experiments
(A) Genomic DNA digests (B) 1st representation
Lane 1 2 3 4 5 6 7 Lane 1 2 3
bp bp
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Figure 6.5; Gels used to produce southern blots suitable for analysis of RDA 6
products. (A) IOug genomic DNA digest electrophoresed on 1.0% agarose gel; Lane 1,
~xlHaeIII marker; Lane 2, 1kb ladder; Lane 3, blank; Lane 4, dog K brain BamH 1
digest; Lane 5, dog K lymph node BamHl digest; Lane 6, dog K brain coRI dige t;
Lane 7, dog K lymph node EcoRl digest. (B) Dog K 1SI representation DNA
electrophoresed on 1.5% agarose gel; Lane 1, ~xlHaeIII marker; Lane 2, brain lSI
representation; Lane 3, lymph node 1SI representation.
Figure 6.6; Blots of Genomic DNA Digests and I" representations of Dog K Tissues
Probed With Clone 6/1
CA) CB)
Lane 1 2 3 4 5 6 Lane 123
Hybridisation at_.
approx imate ly
310bp.
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Figure 6.6; Hybridisation of probe from clone 6/1 to Dog K southern bl ts.
(A) genomic DNA digests; Lane 1, lkb ladder; Lane 2, blank; Lane 3, d g K brain
BamHl digest; Lane 4, dog K lymph node BamHI digest; Lane 5, dog K brain cRI
digest; Lane 6, dog K lymph node EcoRl digest.
(B) 1st representation DNA; Lane 1, cj>x/HaeIIImarker; Lane 2, brain 1SI repre entati n;
Lane 3, lymph node 1st representation.
no absolute matches to canine sequences on analysis of the GCG database. Partial
homologies to a number of canine sequences were identified however, in particular to
the 5' non-coding regions of two canine interferon genes (a.1 and n).
The second and third sequences (6/2 and 6/3), both of which were present in
more than one clone generated from the smaller bands in the final RDA6 gel, also
showed differences in southern blotting between tester and driver DNA. Clone 6/2
showed a small difference in size between the bands which the probe hybridised to in
driver and tester lanes on both the genomic DNA digests and 151 representation blots
(Figure 6.7). Similarly, clone 6/3 also showed a difference in size between the bands
which the probe hybridised to in driver and tester lanes on both genomic digest and I st
representation blots (Figure 6.8). Neither of these sequences showed convincing
homologies to any known sequence (nucleotide or amino acid) in the GenBank
database.
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Figure 6.7 Genomic DNA Digest and I" Representation Blot of Dog K Tissues
Probed With Clone 6/2
CA)
Lane 1 2 3 4 5 6
CB)
Lane 1 2 3
+- 230bp
Figure 6.7; Hybridisation of probe from clone 6/2 to Dog K southern bl ts.
(A) genomic DNA digests; Lane 1, lkb ladder; Lane 2, blank; Lane 3, d g K brain
BamHl digest; Lane 4, dog K lymph node BamHl digest; Lane 5, dog K brain c RI
digest; Lane 6, dog K lymph node EcoRl digest.
(B) 1st representation DNA; Lane 1, ~xJHaeIII marker; Lane 2, brain 1si representati n;
Lane 3, lymph node 1st representation.
Figure 6.8 Genomic DNA Digest and I" Representation Blot of Dog K Tissues
Probed With Clone 6/3
(A) (B)
Lane 1 2 3 4 5 6 Lane 2 3
+-230bp
Figure 6.8; Hybridisation of probe from clone 6/3 to Dog K southern blot.
(A) genomic DNA digests; Lane 1, lkb ladder; Lane 2, blank; ane 3, d g K brain
BamHI digest; Lane 4, dog K lymph node BamHl digest; Lane 5, dog K brain 0 I
digest; Lane 6, dog K lymph node EcoRI digest.
(B) I st representation DNA; Lane 1, ~xlHaeIII marker; Lane 2, brain] SI repre entati n;
Lane 3, lymph node 1st representation.
6.4 DISCUSSION
RDA is a relatively new technique, with a large number of potential applications.
It is of particular use in analysing tumour material due to the wide range of genetic
lesions that it is capable of detecting. Depending on whether tumour DNA is used as
the tester or driver material, the technique is capable of detecting allelic loss of
polymorphic loci and heterozygous deletions leading to loss of restriction fragments
from the tumour; or alternatively small restriction fragments present only in the tumour
genome due to rearrangements, point mutation, or viral infection (Lisitsyn et al. 1995).
It also shares the advantage of all subtractive hybridisation techniques that no
knowledge of the sequence of the differences that are believed to exist is required. In
view of the limited knowledge concerning the aetiology, progression. and genetics of
lymphoma, and of other neoplastic conditions in the dog, RDA is perhaps the ideal
molecular biology technique with which to study both this. and other canine neoplasms.
Representation difference analysis was used to examine five cases of canine
lymphoma for genetic differences from normal tissue. A large number of potential
differences were revealed by the technique; after analysis, the number of true difference
products was considerably reduced. While no genuine virus-like differences were
identified in these experiments, RDA was shown to be a potentially useful technique in
the genetic analysis of lymphoma in the dog.
Generation of non-specific difference products
RDA is a complex technique, and one of its drawbacks is that only a proportion
of the potential differences it isolates are found to be significant on further analysis.
Flavivirus like sequences were detected in 7 out of 72 clones produced by RDA analysis
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of pre and post infection tamarin plasma (Simons et al. 1995b). Similarly, reports on
the analysis of tumours describe the isolation of 'non-informative' clones, which
hybridise to both tester and driver representations (Lisitsyn et al. 1994a). It has been
proposed that the reason for the generation of these false difference products is the
tendency of repetitive sequence elements in the tester DNA to re-anneal despite the vast
excess of driver, leading to exponential amplification of these elements in the
subsequent PCR step (Milner et al. 1995). A second possible source of false differences
is that although PCR is often conveniently regarded as a uniform exponential
amplification of sequences with little variation, quantitative and qualitative differences
in the amount of product generated can occur for different templates and reactions: the
ability ofTaq polymerase to amplify different sequences efficiently may vary. It is a
feature of RDA that both quantitative and absolute differences between the tester and
driver representations may be detected, so differences in the quality of representation
between tissues may affect the final generation of difference products.
For the tissues examined in this study, false difference products that were cloned
and sequenced included repetitive and satellite like DNA sequences. Not surprisingly,
given the examination of lymphoid tissues, immunoglobulin and T-cell receptor like
sequences were also generated as potential differences on a number of occasions; these
may have been genuinely re-arranged in some of the cells making up the tissues, but
would only show up clearly in southern blot analysis of the difference products if the re-
arrangement was consistent throughout the tumour tissue. Other false differences
showed no homology to any known sequences or repetitive elements.
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Analysis of genuine differences
Of the true differences identified between normal and tumour DNA in this study,
perhaps the most fascinating observation was the identification of a retinoblastoma (Rb)
like sequence as a difference product in RDA2. The retinoblastoma gene has an
important role in the regulation of the cell cycle, and loss of its function has shown to be
a component of a number of human lymphoid malignancies including some types of
lymphoma (Dao et al. 1994; Weide et al. 1994). Indeed, it has been suggested that
damage to the Rb gene or its effector pathway, allowing unregulated activity of RNA
polymerases I and III, is a feature in the progression of all neoplasms (White, 1997).
A significant portion of the canine Rb gene sequence has not been published, so
it is difficult to be certain, from the limited sequence obtained in these experiments from
a non-coding region, that the product identified is the true canine homologue of the
human Rb gene. The human Rb gene was the only significant match to the whole of
clone 2/1 identified by any of the database search methods. Clone 2/1 showed 75%
identity to a portion of the human Rb gene at the nucleotide level. The possibility
remains that this is a chance finding, although a higher percentage homology would not
necessarily be expected between intron derived sequences of fairly divergent species.
A feature of the difference products obtained from RDA 2 was that they did not
map in the genomic blots to the size expected in the BamH 1 digest lanes, according to
both the size of the difference products, and the position of hybridisation on the 1sI
representation blots. The failure to detect the canine Rb-like sequence at the expected
size on the genomic southern blots may be due to a number of factors. One possible
explanation may be that the neoplastic cells represent a relatively small proportion of the
total spleen population of cells. Another possibility is that the small size of the product
led to the failure to generate an efficient probe. Capillary transfer of very small DNA
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fragments from agarose gels to nylon membranes is also relatively inefficient. These
two factors may have caused a significant reduction in the sensitivity of the southern
blots.
The three significant difference products identified from RDA 6 showed up as
differences between tester and driver on southern blots of both 1st representation and
genomic digest DNA. Clone 6/1 in particular appears to be either absent, or much
reduced in lanes produced from driver tissue (tumour) in both blots. The faint binding
of probe in the driver (lymph node BamHl digest) lane at the size of the difference
product in the genomic blot may be due to normal stromal cells within the lymph node.
These results appear to indicate that this restriction fragment has been lost from the
tumour tissue. This clone shows partial homologies to canine sequences of a variety of
genes, in particular the 5' non-coding regions of canine interferons a 1 and n. While the
identity of this clone is far from proven, it may represent a marker for a gene that has
been deleted from this particular case of lymphoma.
The southern blots for clones 6/2 and 6/3 are the most difficult to interpret. They
appear to show a small size difference on both genomic and southern blots between the
appropriate restriction fragment in tester and driver lanes, hybridisation being to a
slightly smaller sequence in the tumour DNA. Great care was taken in setting up the
gels of these blots to load similar amounts of driver and tester DNA. and DNA appeared
to migrate through the gels in a similar pattern in each lane. The multiple bands seen in
the 1st representation blots are typical of the appearance of southern blots of peR
products, where probe will bind to single stranded DNA and incomplete products. It is
interesting to note that the small differences in size between the restriction fragments in
tester and driver appear to have been sufficient to allow the generation of difference
products by RDA. The significance of both these clones is also difficult to interpret, as
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they do not map to any known sequence. They both appear to represent small deletions
in a BamHl restriction fragment, the significance of this deletion in the development of
the lymphoma is open to question.
Further experiments
Two of the key features of RDA are that no knowledge of the differences
between two tissues are required prior to analysis, and the selection for small restriction
fragments only. While these are an advantage in many respects, it can make
interpretation of the results obtained difficult, as the products generated may not show
homology to known sequences, particularly in a species such as the dog, where only a
small amount of the genome has been sequenced. As more of the genome ofan
organism is sequenced, the likelihood of being able to identify categorically a difference
product increases, as an exact match to known sequences would be expected.
Classification and interpretation of the significance of the difference products obtained
in these experiments from the limited sequence available has been ditlicult. Clearly.
one solution to this problem would be ifmore of the canine genome were sequenced.
An alternative approach to elucidate the significance of the sequences generated would
be to obtain more flanking sequence, by a chromosome walking based technique or by
the screening of a genomic library. Experiments to obtain additional flanking sequence
for both the retinoblastoma like and canine promoter like difference products in
particular would be the most logical continuance of this work if time were available.
although additional sequence would provide further insights into the nature of all the
genuine differences generated.
There are many other ways in which these experiments could be developed
further. Another important set of experiments would be to use alternative combinations
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of restriction enzymes and adaptors. Hind III and Bgi II restriction enzyme based
protocols are available which effectively produce different samples of the genome in the
first representation. This is particularly important from the point of view of searching
for a possible viral involvement in lymphoma, as a smaller DNA virus, such as proviral
DNA for a retrovirus, may not be present in a representation based on a single restriction
enzyme. As the number of representation based on different enzymes is increased, the
probability that at least one of the restriction digests will include a viral fragment of a
size that can be amplified in the generation of the first representation, increases
considerably. Assuming a mean fragment length for restriction enzyme digests of
genomic and viral DNA of 2699bp (Bishop et al. 1983), it has been calculated that for a
viral genome of 150kbp, RDA based on a single enzyme should give a probability of
detection of greater that 0.99 (Alexander, 1995). For viral genomes of 30kb and 9kb.
the number ofRDA's using different restriction enzymes required to give the same
probability of detection would be 2 and 3-4 respectively.
A second important consideration in further experiments would be to reconsider
the tissues chosen for analysis both for virus hunting and for genetic analysis. For virus
hunting, a variety of tissues and diseases would be worthy of study by this technique.
As was the case for Kaposi's sarcoma, it is possible that an initial consideration of the
epidemiology of an unexplained canine disease might indicate suitable conditions for
study. Where it is possible to transmit an uncharacterised infectious agent. there exists
the possibility in animals of analysing and comparing pre- and post-infection samples;
an important advantage compared to the study of pathogens in human tissues. This
would avoid the generation of differences due to the use of different tissues or
individuals, and would be likely to prove a significant advantage. It would also avoid
one of the assumptions made in these experiments, i.e., that brain tissue is indeed
159
'normal', implying that it would not contain any possible infectious agent; viral
infection of cells in the brain is possible, and would make the isolation of an infectious
agent by comparison with brain tissue less likely. For a blood borne virus, pre and post
infection samples ofPBMC's, plasma, or serum could be analysed by RDA for both
DNA and cDNA differences. A number of years ago, a transmissible agent that was
believed to cause a number of cases of canine hepatitis was identified (Jarrett and 0'
Neil, 1985; Jarrett et al. 1987); but the agent unfortunately proved resistant to
conventional culture and hence further characterisation. The application of RDA, using
protocols for both RNA and DNA encoded pathogens, to the study of this condition
might yield the elusive infectious agent.
For the genetic analysis oflymphoma, the main improvement to the
experimental protocol would perhaps be to analyse DNA from purified tumour cells, or
from tumour cell lines established from each case of lymphoma, rather than the original
tissue samples. While it should not be necessary for the detection of genetic
rearrangements, it has been suggested that the removal of normal stromal cells from the
analysis would be of benefit in detecting the loss of genetic material from a cancer cell
(Lisitsyn and Wigler, 1993). The availability of DNA prepared exclusively from cancer
cells would certainly be of benefit in the preparation and analysis of southern blots to
interpret the difference products generated.
Representation difference analysis is a fascinating, complex, and powerful
technique which can be used to scan two genomes for differences due to infection,
mutation, or individual variation. The technique is still in its early stages, and these
experiments may well be the first example of application of RDA to the study of a
canine disease. Using RDA, these experiments have generated a number of possible
markers to study further the genetic lesions in canine lymphoma, and a fascinating
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possibility that a well known tumour suppressor gene may be involved in at least one
case of the disease. It is unfortunate that time and resources do not permit further study
of these results.
There are many diseases of the dog, and of other animals, which are poorly
understood at the molecular level. Canine lymphoma isjust one example of these
conditions, which despite its relatively high incidence, and possible analogies with
human neoplastic disease, receives little attention or research. Application of RDA to
canine lymphoma has yielded some fascinating results and possible keys to further study
of the condition. The technique could be applied to a variety of other conditions, and
may yield new insights at the genetic level into the aetiology or development of a variety
of animal diseases.
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SUMMARY
The work presented in this thesis initially applied peR based molecular biology
techniques to the study of canine herpesvirus 1. Degenerate primer polymerase chain
reaction was first used to obtain some initial sequence information on the virus,
consisting of a 600bp portion of the gB gene. Although it would have been possible to
use this sequence as a probe to identify a clone containing the whole gB gene and
perhaps other nearby genes such as thymidine kinase, it became clear at this point that
other groups were working on a complete analysis of the sequence and structure of the
eHV -1 genome.
The novel sequence information obtained was instead used in the design of
conventional peR primers for the canine herpesvirus 1 gB gene. These primers were
used successfully to detect viral genome in a wide range of canine tissues, and in a high
proportion of the dogs examined. These findings indicate that the prevalence of eHV -1
may be much higher than previously suggested, and also provide some definitive
evidence for persistence of the viral genome in a wide range of tissues in the adult dog.
Identification of viral genome in a tissue does not in itself prove that true latency is
occurring. These results do provide interesting pointers toward likely sites of canine
herpesvirus 1 latency in the dog, and possible routes of transmission, as viral genome
was frequently found in both neural tissue and salivary gland.
It would of course be possible to test for eHV -1 described in a variety of further
experiments on both fresh and fixed tissues and perhaps attempting to examine different
stages of infection by the virus, from acute fulminating infection in puppies to latency.
peR could also be used as a true diagnostic test for the presence of canine herpesvirus,
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although careful control of contamination would be vital in any diagnostic laboratory
attempting to use peR in this way (Schweiger et al. 1997).
Following the successful use of degenerate primer polymerase chain reaction to
amplify sequence from eHV -1, it was decided to use the same technique to search for
novel gammaherpesvirus sequences. It was decided to use tissues from dogs with
lymphoma as sample material for these studies, as both the known human
gammaherpesviruses are involved in various forms of human lymphoma. It was also
considered possible that a putative canine gammaherpesvirus, whether or not causally
associated, might be more easily detected in cases of lymphoma due to concurrent
immunosuppression.
A degenerate primer peR assay was set up and optimised using known human,
mouse, and equine gammaherpesvirus templates. No gammaherpesvirus sequences were
detected in the canine samples tested however, this could have been due to either
absence of virus, insufficient sensitivity of degenerate compared to conventional peR,
or possibly failure of a putative canine virus to share the necessary regions of
conservation.
Practical problems concerning primer synthesis prevented this work being taken
further. If these could have been circumvented, it might have been interesting to look at
tissues from dogs with diseases other than lymphoma. Issues of sensitivity, and
problems with non-specific products, are a feature of degenerate primer based virus
detection systems. Another suitable template for the degenerate primer system might
therefore be saliva, gammaherpesvirus in other species are often found in saliva, and
use of this as template would reduce the level of background DNA.
The final section of the thesis describes the analysis of five cases of lymphoma
by representation difference analysis. Itwas hoped by using this technique to widen the
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search away from a gammaherpesvirus. By using RDA we hoped to identify either a
novel virus of any family, or alternatively a mutation that might be involved in
lymphoma. One of the advantages of using RDA is that no advance knowledge of the
difference between normal and abnormal tissue is required. In contrast to the earlier
PCR based studies, RDA is both complex and time consuming to perform however.
In this study, no novel viral sequences were identified, but a number of
differences were identified which may point to mutations involved in the particular case
of lymphoma. These differences hybridised at different positions between normal and
tumour tissue in blots of genomic digests and 1st representations. One of the problems of
RDA is to establish the significance of the difference products generated, which are
often relatively small DNA fragments, which mayor may not match to known
sequences. In retrospect, the decision to carry out RDA based analysis may have been a
little over ambitious for a single worker, as insufficient time was available to complete
both the basic analysis and a full investigation of the difference products generated.
Given more time, it would be fascinating to obtain flanking sequence around the
genuine difference products identified in this study. For the Rb-Iike sequence in
particular, this would be likely to provide conclusive proof whether the canine sequence
identified by RDA was part of the Rb gene.
In summary, I believe that this project has contributed to the level of
understanding of the biology and pathogenesis of CHV -1. While the later part of the
project using degenerate primer peR to look for a novel canine gammaherpesvirus, and
using RDA to analyse canine lymphoma, has provided less in the way of clear cut
results, the project as a whole has provided me with an excellent training in the most up
to date molecular biology techniques.
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